"_id","cohorts.0.id","cohorts.0.label","dataUseConditions.id","dataUseConditions.label","description","externalReferences.0.id","externalReferences.0.label","followupState.id","followupState.label","histologicalDiagnosis.id","histologicalDiagnosis.label","icdoMorphology.id","icdoMorphology.label","icdoTopography.id","icdoTopography.label","id","individualId","info.callsetIds.0","info.cnvstatistics.cnvcoverage","info.cnvstatistics.cnvfraction","info.cnvstatistics.delcoverage","info.cnvstatistics.delfraction","info.cnvstatistics.dupcoverage","info.cnvstatistics.dupfraction","info.legacyId.0","pathologicalStage","provenance.geoLocation.geometry.coordinates.0","provenance.geoLocation.geometry.coordinates.1","provenance.geoLocation.geometry.type","provenance.geoLocation.properties.ISO3166alpha3","provenance.geoLocation.properties.city","provenance.geoLocation.properties.country","provenance.geoLocation.properties.label","provenance.geoLocation.properties.latitude","provenance.geoLocation.properties.longitude","provenance.geoLocation.properties.precision","provenance.geoLocation.type","provenance.material.id","provenance.material.label","sampledTissue.id","sampledTissue.label","tumorGrade","updated","info.tnm","pathologicalStage.id","pathologicalStage.label","pathologicalTnmFindings.0.id","pathologicalTnmFindings.0.label","individualAgeAtCollection","externalReferences.1.id","externalReferences.1.label","info.death","info.followupMonths","tumorGrade.id","tumorGrade.label","cohorts.1.id","cohorts.1.label","cohorts.2.id","cohorts.2.label","externalReferences.0.description","externalReferences.1.description","externalReferences.2.description","externalReferences.2.id","externalReferences.2.label","info.tumorStage","info.callsetIds.1","cohorts.3.id","cohorts.3.label","externalReferences.3.description","externalReferences.3.id","externalReferences.3.label","info.provenance","provenance.populations.0.confidence","provenance.populations.0.description","provenance.populations.0.type.id","provenance.populations.0.type.label","provenance.populations.1.confidence","provenance.populations.1.description","provenance.populations.1.type.id","provenance.populations.1.type.label","externalReferences.4.description","externalReferences.4.id","externalReferences.4.label","cohorts.4.id","cohorts.4.label","info.cellLine","info.samplesource","info.seer"
"5bab56c0727983b2e00aaa1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial sarcoma [poorly differentiated]","PMID:9790501","Szymanska J, Serra M et al. (1998): Genetic imbalances in 67 synovial sarcomas...","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva5ye","pgxind-kftx264u","pgxcs-kftvli3x",116974859,0.041,0,0,116974859,0.041,"PGX_AM_BS_SynSarc-36","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.716000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaab5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Small tumor, less than 5 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65f","pgxind-kftx26d9","pgxcs-kftvlk9y",427381839,0.149,212067870,0.074,215313969,0.075,"PGX_AM_BS_STLMS-02","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.932000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaab6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Small tumor, less than 5 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65h","pgxind-kftx26db","pgxcs-kftvlkah",601603880,0.209,272850080,0.095,328753800,0.114,"PGX_AM_BS_STLMS-03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.933000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaab7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Small tumor, less than 5 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65i","pgxind-kftx26dd","pgxcs-kftvlkaz",361397723,0.126,236354617,0.082,125043106,0.043,"PGX_AM_BS_STLMS-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.935000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaab8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Small tumor, less than 5 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65k","pgxind-kftx26df","pgxcs-kftvlkbh",695561073,0.242,331740734,0.115,363820339,0.127,"PGX_AM_BS_STLMS-05","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.936000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaabc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65q","pgxind-kftx26dn","pgxcs-kftvlkdg",577678438,0.201,354453752,0.123,223224686,0.078,"PGX_AM_BS_STLMS-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.942000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaabd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65s","pgxind-kftx26dp","pgxcs-kftvlkdy",778251167,0.271,596212070,0.207,182039097,0.063,"PGX_AM_BS_STLMS-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.943000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaabe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65t","pgxind-kftx26dr","pgxcs-kftvlkeg",649663135,0.226,285129417,0.099,364533718,0.127,"PGX_AM_BS_STLMS-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.944000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65x","pgxind-kftx26dv","pgxcs-kftvlkff",1051808214,0.366,345340748,0.12,706467466,0.246,"PGX_AM_BS_STLMS-13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.948000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65y","pgxind-kftx26dx","pgxcs-kftvlkfw",585845331,0.204,256645000,0.089,329200331,0.115,"PGX_AM_BS_STLMS-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.949000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva660","pgxind-kftx26dy","pgxcs-kftvlkgf",753173726,0.262,449551999,0.156,303621727,0.106,"PGX_AM_BS_STLMS-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.951000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva662","pgxind-kftx26e0","pgxcs-kftvlkgz",1243695899,0.433,469395302,0.163,774300597,0.269,"PGX_AM_BS_STLMS-16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.952000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva663","pgxind-kftx26e3","pgxcs-kftvlkhi",1709417508,0.595,628026650,0.218,1081390858,0.376,"PGX_AM_BS_STLMS-17","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.953000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva667","pgxind-kftx26e7","pgxcs-kftvlkii",1444245444,0.502,297997091,0.104,1146248353,0.399,"PGX_AM_BS_STLMS-19","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.956000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva669","pgxind-kftx26e9","pgxcs-kftvlkj0",1595707744,0.555,19100019,0.007,1576607725,0.548,"PGX_AM_BS_STLMS-20","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.958000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaacd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Very large tumor, more than 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva66i","pgxind-kftx26ek","pgxcs-kftvlkm2",1006811925,0.35,220933463,0.077,785878462,0.273,"PGX_AM_BS_STLMS-26","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.967000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad21","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghiz","pgxind-kftx27bi","pgxcs-kftvlstu",860444649,0.299,48514605,0.017,811930044,0.282,"PGX_AM_BS_AEB-9327749-15",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.802000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghj6","pgxind-kftx27bq","pgxcs-kftvlsvr",486655802,0.169,35400035,0.012,451255767,0.157,"PGX_AM_BS_AEB-9327749-19",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.807000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghjm","pgxind-kftx27ca","pgxcs-kftvlt0f",944538605,0.329,51800051,0.018,892738554,0.311,"PGX_AM_BS_AEB-9327749-28",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.822000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghjo","pgxind-kftx27cc","pgxcs-kftvlt0w",869148293,0.302,320357858,0.111,548790435,0.191,"PGX_AM_BS_AEB-9327749-29",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.823000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad48","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage II]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkq","pgxind-kftx27do","pgxcs-kftvltc8",179094897,0.062,0,0,179094897,0.062,"PGX_AM_BS_AEB-9327749-50",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.856000","T2","NCITstage-C28054","Stage II","TNM-C48724","T2 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad4d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkz","pgxind-kftx27dy","pgxcs-kftvltel",1198239973,0.417,125600124,0.044,1072639849,0.373,"PGX_AM_BS_AEB-9327749-55",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.863000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad87","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:9290705","Packenham JP et al. (1997): Analysis of genetic alterations in uterine...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvghnm","pgxind-kftx27h5","pgxcs-kftvlu7p",179710885,0.063,122674864,0.043,57036021,0.02,"PGX_AM_BS_UtLeio-8","{}",-78.9,35.99,"Point","USA","Durham","United States of America","Durham, United States",35.99,-78.9,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:06.945000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaea4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi0o","pgxind-kftx27ww","pgxcs-kftvly2c",145136109,0.05,0,0,145136109,0.05,"PGX_AM_BS_ChonSar-lar-07b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.344000",,,,,,"P40Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaea7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi0s","pgxind-kftx27x2","pgxcs-kftvly3p",507482721,0.177,51800051,0.018,455682670,0.158,"PGX_AM_BS_ChonSar-lar-08c","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.348000",,,,,,"P64Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaea9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi0w","pgxind-kftx27x7","pgxcs-kftvly4n",537100643,0.187,230823364,0.08,306277279,0.107,"PGX_AM_BS_ChonSar-lar-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.351000",,,,,,"P36Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi0z","pgxind-kftx27xb","pgxcs-kftvly5k",160820851,0.056,0,0,160820851,0.056,"PGX_AM_BS_ChonSar-lar-12a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.354000",,,,,,"P37Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaead","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi12","pgxind-kftx27xf","pgxcs-kftvly6h",1176759512,0.409,0,0,1176759512,0.409,"PGX_AM_BS_ChonSar-lar-13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.356000",,,,,,"P78Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi14","pgxind-kftx27xh","pgxcs-kftvly6y",1176032468,0.409,51800051,0.018,1124232417,0.391,"PGX_AM_BS_ChonSar-lar-14a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.358000",,,,,,"P34Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi17","pgxind-kftx27xl","pgxcs-kftvly7w",923042480,0.321,0,0,923042480,0.321,"PGX_AM_BS_ChonSar-lar-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.361000",,,,,,"P72Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1a","pgxind-kftx27xp","pgxcs-kftvly8u",1358149599,0.472,0,0,1358149599,0.472,"PGX_AM_BS_ChonSar-lar-17a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.364000",,,,,,"P52Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1i","pgxind-kftx27xy","pgxcs-kftvlyb7",1786212027,0.621,373352757,0.13,1412859270,0.491,"PGX_AM_BS_ChonSar-lar-21","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.371000",,,,,,"P27Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1k","pgxind-kftx27y0","pgxcs-kftvlybo",610853469,0.212,110306090,0.038,500547379,0.174,"PGX_AM_BS_ChonSar-lar-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.372000",,,,,,"P43Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1m","pgxind-kftx27y2","pgxcs-kftvlyc4",1144199139,0.398,0,0,1144199139,0.398,"PGX_AM_BS_ChonSar-lar-23","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.374000",,,,,,"P53Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf17","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma [dedifferentiated]","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi5v","pgxind-kftx283b","pgxcs-kftvlzm0",1200755658,0.418,604911059,0.21,595844599,0.207,"PGX_AM_BS_8834171-szy-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.507000",,,,,,"P71Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf1a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma [pleomorphic]","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi60","pgxind-kftx283h","pgxcs-kftvlzp6",944804039,0.329,191414748,0.067,753389291,0.262,"PGX_AM_BS_8834171-szy-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.511000",,,,,,"P63Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c2727983b2e00ac044","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial sarcoma [cell line Fuji]","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgnpv","pgxind-kftx2ev1","pgxcs-kftvnnkh",365637647,0.127,109042790,0.038,256594857,0.089,"PGX_AM_BS_20164920_Fuji","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:13.758000",,,,,,,"geo:GSE19399",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac250","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Upper trunk]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodq","pgxind-kftx2foo","pgxcs-kftvnupl",1329127181,0.462,307514884,0.107,1021612297,0.355,"PGX_AM_BS_20159821_MPNST-bre-013","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.481000",,,,,,"P26Y",,,"1",79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac252","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodu","pgxind-kftx2fos","pgxcs-kftvnuqj",1636953920,0.569,725961202,0.253,910992718,0.317,"PGX_AM_BS_20159821_MPNST-bre-021","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.484000",,,,,,"P18Y",,,"1",15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac254","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodx","pgxind-kftx2fow","pgxcs-kftvnuri",1937835042,0.674,951076918,0.331,986758124,0.343,"PGX_AM_BS_20159821_MPNST-bre-024","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.487000",,,,,,"P41Y",,,"0",122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac259","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe5","pgxind-kftx2fp5","pgxcs-kftvnutw",1851316984,0.644,604400129,0.21,1246916855,0.434,"PGX_AM_BS_20159821_MPNST-bre-035","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.494000",,,,,,"P42Y",,,"1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe7","pgxind-kftx2fp8","pgxcs-kftvnuud",2832113038,0.985,1257209528,0.437,1574903510,0.548,"PGX_AM_BS_20159821_MPNST-bre-037","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.496000",,,,,,"P34Y",,,"1",16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoea","pgxind-kftx2fpc","pgxcs-kftvnuvc",1009805081,0.351,120236424,0.042,889568657,0.309,"PGX_AM_BS_20159821_MPNST-bre-040","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.498000",,,,,,"P50Y",,,"0",122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoee","pgxind-kftx2fpg","pgxcs-kftvnuwa",2617449835,0.91,989113185,0.344,1628336650,0.566,"PGX_AM_BS_20159821_MPNST-bre-044","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.501000",,,,,,"P17Y",,,"1",5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Knee]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoef","pgxind-kftx2fpi","pgxcs-kftvnuwr",532438858,0.185,390043997,0.136,142394861,0.05,"PGX_AM_BS_20159821_MPNST-bre-046","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.503000",,,,,,"P45Y",,,"0",125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac263","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Buttock]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoem","pgxind-kftx2fpq","pgxcs-kftvnuyn",1984268799,0.69,489597598,0.17,1494671201,0.52,"PGX_AM_BS_20159821_MPNST-bre-051","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.508000",,,,,,"P73Y",,,"1",8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac265","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoep","pgxind-kftx2fpu","pgxcs-kftvnuzl",811243086,0.282,494740890,0.172,316502196,0.11,"PGX_AM_BS_20159821_MPNST-bre-053","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.511000",,,,,,"P15Y",,,"1",19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac266","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoer","pgxind-kftx2fpw","pgxcs-kftvnv02",1491366828,0.519,825593611,0.287,665773217,0.232,"PGX_AM_BS_20159821_MPNST-bre-056","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.513000",,,,,,"P24Y",,,"0",185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac267","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Intrathoracic]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoet","pgxind-kftx2fpy","pgxcs-kftvnv0j",1489346799,0.518,494635615,0.172,994711184,0.346,"PGX_AM_BS_20159821_MPNST-bre-057","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.514000",,,,,,"P24Y",,,"1",32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac268","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoeu","pgxind-kftx2fq0","pgxcs-kftvnv10",2120591325,0.738,1024960418,0.357,1095630907,0.381,"PGX_AM_BS_20159821_MPNST-bre-058","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.516000",,,,,,"P26Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac269","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Shoulder]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoew","pgxind-kftx2fq2","pgxcs-kftvnv1h",835898392,0.291,609102445,0.212,226795947,0.079,"PGX_AM_BS_20159821_MPNST-bre-060","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.517000",,,,,,"P20Y",,,"0",369,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Under arm]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoex","pgxind-kftx2fq4","pgxcs-kftvnv1y",1099256834,0.382,876843898,0.305,222412936,0.077,"PGX_AM_BS_20159821_MPNST-bre-061","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.519000",,,,,,"P59Y",,,"0",142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thoracic wall]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof1","pgxind-kftx2fq8","pgxcs-kftvnv2w",1437003163,0.5,557693347,0.194,879309816,0.306,"PGX_AM_BS_20159821_MPNST-bre-064","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.522000",,,,,,"P26Y",,,"1",29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Right shoulder]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof2","pgxind-kftx2fqa","pgxcs-kftvnv3e",1350313022,0.47,810871505,0.282,539441517,0.188,"PGX_AM_BS_20159821_MPNST-bre-065","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.523000",,,,,,"P53Y",,,"1",14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof6","pgxind-kftx2fqe","pgxcs-kftvnv4c",1407853388,0.49,769905657,0.268,637947731,0.222,"PGX_AM_BS_20159821_MPNST-bre-068","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.526000",,,,,,"P41Y",,,"1",39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac270","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Mediastinum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof7","pgxind-kftx2fqg","pgxcs-kftvnv4s",2510212230,0.873,1444256608,0.502,1065955622,0.371,"PGX_AM_BS_20159821_MPNST-bre-070","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.528000",,,,,,"P73Y",,,"1",14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac276","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofh","pgxind-kftx2fqs","pgxcs-kftvnv7n",2496649693,0.868,1151180206,0.4,1345469487,0.468,"PGX_AM_BS_20159821_MPNST-bre-086","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.536000",,,,,,"P42Y",,,"1",7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac277","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Axilla]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofi","pgxind-kftx2fqu","pgxcs-kftvnv84",1267780766,0.441,194785694,0.068,1072995072,0.373,"PGX_AM_BS_20159821_MPNST-bre-087","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.538000",,,,,,"P40Y",,,"0",168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac278","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofk","pgxind-kftx2fqw","pgxcs-kftvnv8l",2312561261,0.804,946983195,0.329,1365578066,0.475,"PGX_AM_BS_20159821_MPNST-bre-088","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.539000",,,,,,"P32Y",,,"1",40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac27a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofn","pgxind-kftx2fr0","pgxcs-kftvnv9k",142617759,0.05,44717661,0.016,97900098,0.034,"PGX_AM_BS_20159821_MPNST-bre-096","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.542000",,,,,,"P15Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac27b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Back]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofp","pgxind-kftx2fr2","pgxcs-kftvnva1",196600196,0.068,196600196,0.068,0,0,"PGX_AM_BS_20159821_MPNST-bre-115","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.544000",,,,,,"P54Y",,,"1",19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac28b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgogf","pgxind-kftx2fry","pgxcs-kftvnvhj",1830651586,0.637,654808603,0.228,1175842983,0.409,"PGX_AM_BS_20159821_MPNST-bre-080","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.566000",,,,,,"P25Y",,,"1",10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac290","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Buttock]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgogn","pgxind-kftx2fs8","pgxcs-kftvnvjv",382244997,0.133,197906177,0.069,184338820,0.064,"PGX_AM_BS_20159821_MPNST-bre-091","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.573000",,,,,,"P45Y",,,"1",123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv66","pgxind-kftx2o64","pgxcs-kftvpy4s",808665157,0.281,183954817,0.064,624710340,0.217,"PGX_AM_BS_OSCl-sel-HOS","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.961000",,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv68","pgxind-kftx2o66","pgxcs-kftvpy59",1766719390,0.615,1131100928,0.393,635618462,0.221,"PGX_AM_BS_OSCl-sel-MG-63","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.962000",,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line SAOS-2]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv69","pgxind-kftx2o68","pgxcs-kftvpy5r",1663862856,0.579,232910394,0.081,1430952462,0.498,"PGX_AM_BS_OSCl-sel-SAOS-2","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.964000",,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad78a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE8398",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgv6w","pgxind-kftx2o70","pgxcs-kftvpych",759419484,0.264,358181149,0.125,401238335,0.14,"PGX_AM_BS_17952124-cig-14","{}",-3.7,40.42,"Point","ESP","Madrid","Spain","Madrid, Spain",40.42,-3.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:21.984000",,,,,,,"PMID:17952124","Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad794","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line U-2OS]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv7c","pgxind-kftx2o7k","pgxcs-kftvpyhb",1667341894,0.58,1031230263,0.359,636111631,0.221,"PGX_AM_BS_OSCl-sel-U-2OS","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.998000",,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae21e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Lower leg, subcutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgywp","pgxind-kftx2sfh","pgxcs-kftvr0b4",747336584,0.26,460527249,0.16,286809335,0.1,"PGX_AM_BS_16938566_LMS-lar-01","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.739000",,,,,,"P44Y",,,"0",138.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae21f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Head and neck, cutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgywr","pgxind-kftx2sfj","pgxcs-kftvr0bm",322306301,0.112,116600117,0.041,205706184,0.072,"PGX_AM_BS_16938566_LMS-lar-02","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.740000",,,,,,"P36Y",,,"0",182.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae220","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Foot, subcutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyws","pgxind-kftx2sfl","pgxcs-kftvr0c3",1197454304,0.417,758015693,0.264,439438611,0.153,"PGX_AM_BS_16938566_LMS-lar-03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.742000",,,,,,"P64Y",,,"0",77.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae221","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Upper trunk, cutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgywu","pgxind-kftx2sfn","pgxcs-kftvr0ck",519905917,0.181,472205870,0.164,47700047,0.017,"PGX_AM_BS_16938566_LMS-lar-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.743000",,,,,,"P57Y",,,"0",97.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae225","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Hand, subcutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx1","pgxind-kftx2sfv","pgxcs-kftvr0eg",1066993592,0.371,751023957,0.261,315969635,0.11,"PGX_AM_BS_16938566_LMS-lar-08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.749000",,,,,,"P80Y",,,"1",72.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae226","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, deep]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx2","pgxind-kftx2sfx","pgxcs-kftvr0ey",1035413741,0.36,362307646,0.126,673106095,0.234,"PGX_AM_BS_16938566_LMS-lar-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.750000",,,,,,"P61Y",,,"0",211.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae227","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, cutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx4","pgxind-kftx2sfz","pgxcs-kftvr0ff",911611248,0.317,619503455,0.215,292107793,0.102,"PGX_AM_BS_16938566_LMS-lar-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.752000",,,,,,"P46Y",,,"0",49.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae455","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzm9","pgxind-kftx2tav","pgxcs-kftvr868",519905917,0.181,472205870,0.164,47700047,0.017,"PGX_AM_BS_LMS-sva-02","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.908000",,,,,,"P57Y",,,"0",97.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae456","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmb","pgxind-kftx2tax","pgxcs-kftvr86p",322306301,0.112,116600117,0.041,205706184,0.072,"PGX_AM_BS_LMS-sva-03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.909000",,,,,,"P36Y",,,"0",182.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae458","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzme","pgxind-kftx2tb1","pgxcs-kftvr89l",1197454304,0.417,758015693,0.264,439438611,0.153,"PGX_AM_BS_LMS-sva-05","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.912000",,,,,,"P64Y",,,"0",77.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae459","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmf","pgxind-kftx2tb3","pgxcs-kftvr8a3",747336584,0.26,460527249,0.16,286809335,0.1,"PGX_AM_BS_LMS-sva-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.914000",,,,,,"P44Y",,,"0",138.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae45d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmm","pgxind-kftx2tbb","pgxcs-kftvr8c1",820074047,0.285,412414969,0.143,407659078,0.142,"PGX_AM_BS_LMS-sva-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.919000",,,,,,"P55Y",,,"0",137.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae45f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmq","pgxind-kftx2tbf","pgxcs-kftvr8cz",911611248,0.317,619503455,0.215,292107793,0.102,"PGX_AM_BS_LMS-sva-12","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.922000",,,,,,"P46Y",,,"0",49.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae461","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmt","pgxind-kftx2tbj","pgxcs-kftvr8dy",859969166,0.299,472768129,0.164,387201037,0.135,"PGX_AM_BS_LMS-sva-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.925000",,,,,,"P59Y",,,"0",193.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae462","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmv","pgxind-kftx2tbl","pgxcs-kftvr8eg",491264897,0.171,298869988,0.104,192394909,0.067,"PGX_AM_BS_LMS-sva-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.926000",,,,,,"P49Y",,,"0",68.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae463","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmw","pgxind-kftx2tbn","pgxcs-kftvr8ex",1211003198,0.421,582834380,0.203,628168818,0.218,"PGX_AM_BS_LMS-sva-16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.928000",,,,,,"P62Y",,,"0",159.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae464","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmy","pgxind-kftx2tbp","pgxcs-kftvr8ff",1066993592,0.371,751023957,0.261,315969635,0.11,"PGX_AM_BS_LMS-sva-17","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.929000",,,,,,"P80Y",,,"1",72.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae465","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmz","pgxind-kftx2tbr","pgxcs-kftvr8fx",1035413741,0.36,362307646,0.126,673106095,0.234,"PGX_AM_BS_LMS-sva-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.930000",,,,,,"P61Y",,,"0",211.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae468","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzn4","pgxind-kftx2tbx","pgxcs-kftvr8hd",809198499,0.281,525812014,0.183,283386485,0.099,"PGX_AM_BS_LMS-sva-21","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.934000",,,,,,"P79Y",,,"1",28.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae469","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzn6","pgxind-kftx2tbz","pgxcs-kftvr8hv",788193984,0.274,411758430,0.143,376435554,0.131,"PGX_AM_BS_LMS-sva-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.936000",,,,,,"P71Y",,,"1",130.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae46d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznc","pgxind-kftx2tc7","pgxcs-kftvr8jt",1040532638,0.362,551134841,0.192,489397797,0.17,"PGX_AM_BS_LMS-sva-26","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.941000",,,,,,"P70Y",,,"0",55.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae478","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgznu","pgxind-kftx2tcu","pgxcs-kftvr8p3",893155207,0.311,619762715,0.216,273392492,0.095,"PGX_AM_BS_LMS-sva-37","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.957000",,,,,,"P48Y",,,"1",9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae47b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgznz","pgxind-kftx2td0","pgxcs-kftvr8qj",941220220,0.327,566020781,0.197,375199439,0.131,"PGX_AM_BS_LMS-sva-40","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.961000",,,,,,"P69Y",,,"1",25.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae47c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzo1","pgxind-kftx2td2","pgxcs-kftvr8r1",173508646,0.06,87213842,0.03,86294804,0.03,"PGX_AM_BS_LMS-sva-41","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.962000",,,,,,"P69Y",,,"1",35.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae47d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzo2","pgxind-kftx2td4","pgxcs-kftvr8ri",908783586,0.316,565920144,0.197,342863442,0.119,"PGX_AM_BS_LMS-sva-42","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.964000",,,,,,"P58Y",,,"0",26.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae47e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzo4","pgxind-kftx2td6","pgxcs-kftvr8rz",832085086,0.289,691418256,0.24,140666830,0.049,"PGX_AM_BS_LMS-sva-43","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.965000",,,,,,"P71Y",,,"1",6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae481","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzo9","pgxind-kftx2tdc","pgxcs-kftvr8tf",607720436,0.211,335018058,0.117,272702378,0.095,"PGX_AM_BS_LMS-sva-46","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.969000",,,,,,"P38Y",,,"0",41.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae483","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzoc","pgxind-kftx2tdg","pgxcs-kftvr8ue",1134287499,0.395,773623435,0.269,360664064,0.125,"PGX_AM_BS_LMS-sva-48","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.972000",,,,,,"P69Y",,,"1",121.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae485","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzof","pgxind-kftx2tdk","pgxcs-kftvr8vd",2094418516,0.728,1203911998,0.419,890506518,0.31,"PGX_AM_BS_LMS-sva-50","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.975000",,,,,,"P53Y",,,"1",21.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae486","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzoh","pgxind-kftx2tdm","pgxcs-kftvr8vu",1203902361,0.419,156329167,0.054,1047573194,0.364,"PGX_AM_BS_LMS-sva-51","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.977000",,,,,,"P81Y",,,"1",3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae490","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzox","pgxind-kftx2te7","pgxcs-kftvr90o",799182250,0.278,229542721,0.08,569639529,0.198,"PGX_AM_BS_MFHbo-tar-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.991000",,,,,,"P44Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae495","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp6","pgxind-kftx2tei","pgxcs-kftvr933",1394441198,0.485,381057937,0.133,1013383261,0.352,"PGX_AM_BS_MFHbo-tar-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.998000",,,,,,"P18Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7b4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal sarcoma [Aorta]","PMID:16096408","Sebenik M, Ricci A et al. (2005): Undifferentiated intimal sarcoma of large systemic...","pgxfus-0004","alive","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0pb","pgxind-kftx2uni","pgxcs-kftvrkd9",454332585,0.158,32800032,0.011,421532553,0.147,"PGX_AM_BS_VessIntSarc-seb-08-r","{}",-74.14,40.56,"Point","USA","Staten Island","United States of America","Staten Island, United States",40.56,-74.14,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:28.113000",,,,,,"P58Y",,,"0",322,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7bc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0po","pgxind-kftx2uny","pgxcs-kftvrkh3",706824251,0.246,378755339,0.132,328068912,0.114,"PGX_AM_BS_AEB-16080954-15","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.125000",,,,,,"P47Y",,,"1",4,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7be","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0pr","pgxind-kftx2uo3","pgxcs-kftvrki2",970214915,0.337,711454595,0.247,258760320,0.09,"PGX_AM_BS_AEB-16080954-17","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.127000",,,,,,"P59Y",,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7c2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0px","pgxind-kftx2uob","pgxcs-kftvrklj",1360897768,0.473,626850543,0.218,734047225,0.255,"PGX_AM_BS_AEB-16080954-5","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.133000",,,,,,"P50Y",,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed5e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [IOR/OS9 cell line, osteoblastic, metastasis]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2ik","pgxind-kftx2wx6","pgxcs-kftvs4n4",812497948,0.283,366390453,0.127,446107495,0.155,"PGX_AM_BS_15540165_OS-ati-01","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.124000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed60","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2in","pgxind-kftx2wxa","pgxcs-kftvs4o4",1175719699,0.409,32800033,0.011,1142919666,0.398,"PGX_AM_BS_15540165_OS-ati-03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.127000",,,,,,"P31Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed61","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2ip","pgxind-kftx2wxc","pgxcs-kftvs4on",342523476,0.119,213723347,0.074,128800129,0.045,"PGX_AM_BS_15540165_OS-ati-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.128000",,,,,,"P18Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed65","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2iw","pgxind-kftx2wxk","pgxcs-kftvs4qk",356705573,0.124,0,0,356705573,0.124,"PGX_AM_BS_15540165_OS-ati-08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.133000",,,,,,"P16Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed67","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, tibia]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2iz","pgxind-kftx2wxo","pgxcs-kftvs4ri",934472891,0.325,146497569,0.051,787975322,0.274,"PGX_AM_BS_15540165_OS-ati-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.136000",,,,,,"P16Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed69","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2j2","pgxind-kftx2wxs","pgxcs-kftvs4sj",78000078,0.027,0,0,78000078,0.027,"PGX_AM_BS_15540165_OS-ati-12","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.139000",,,,,,"P22Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af6fc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","PMID:14506695","Squire JA, Pei J et al. (2003): High-resolution mapping of amplifications and deletions...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C71.9","Brain, NOS","pgxbs-kftvh5lk","pgxind-kftx30s4","pgxcs-kftvt307",163800162,0.057,11200011,0.004,152600151,0.053,"PGX_AM_BS_14506695_OS-squ-OSM1","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000955","brain","{}","2020-09-10 17:44:33.537000",,,,,,"P17Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af6fd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","PMID:14506695","Squire JA, Pei J et al. (2003): High-resolution mapping of amplifications and deletions...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C71.9","Brain, NOS","pgxbs-kftvh5lm","pgxind-kftx30s6","pgxcs-kftvt30o",781434137,0.272,0,0,781434137,0.272,"PGX_AM_BS_14506695_OS-squ-OSM2","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000955","brain","{}","2020-09-10 17:44:33.539000",,,,,,"P14Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af6fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","PMID:14506695","Squire JA, Pei J et al. (2003): High-resolution mapping of amplifications and deletions...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C71.9","Brain, NOS","pgxbs-kftvh5lo","pgxind-kftx30s8","pgxcs-kftvt315",1239205568,0.431,11200011,0.004,1228005557,0.427,"PGX_AM_BS_14506695_OS-squ-OSM3","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000955","brain","{}","2020-09-10 17:44:33.540000",,,,,,"P7Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af6ff","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","PMID:14506695","Squire JA, Pei J et al. (2003): High-resolution mapping of amplifications and deletions...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C71.9","Brain, NOS","pgxbs-kftvh5lp","pgxind-kftx30sa","pgxcs-kftvt31n",1364436825,0.475,1033497856,0.359,330938969,0.115,"PGX_AM_BS_14506695_OS-squ-OSM4","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000955","brain","{}","2020-09-10 17:44:33.542000",,,,,,"P14Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af701","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","PMID:14506695","Squire JA, Pei J et al. (2003): High-resolution mapping of amplifications and deletions...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C71.9","Brain, NOS","pgxbs-kftvh5lt","pgxind-kftx30se","pgxcs-kftvt32m",1442842905,0.502,474103318,0.165,968739587,0.337,"PGX_AM_BS_14506695_OS-squ-OSM6","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000955","brain","{}","2020-09-10 17:44:33.545000",,,,,,"P15Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7f0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Buttock, grade 3, ]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5wi","pgxind-kftx315h","pgxcs-kftvt6ep",472086155,0.164,0,0,472086155,0.164,"PGX_AM_BS_LMS-A5","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.872000",,,,,,"P84Y",,,"1",3,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Retro abdo, grade 2, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5wk","pgxind-kftx315j","pgxcs-kftvt6f7",699695187,0.243,516709505,0.18,182985682,0.064,"PGX_AM_BS_LMS-STS158","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.873000",,,,,,"P53Y",,,"1",18,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7f5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Shoulder, grade 1, AWD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5wq","pgxind-kftx315r","pgxcs-kftvt6h4",258666398,0.09,236466376,0.082,22200022,0.008,"PGX_AM_BS_LMS-STS245","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.879000",,,,,,"P36Y",,,"0",84.2,"NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7f8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Buttock, grade 2, AWD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5wv","pgxind-kftx315w","pgxcs-kftvt6ik",435464799,0.151,235550043,0.082,199914756,0.07,"PGX_AM_BS_LMS-STS326","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.883000",,,,,,"P67Y",,,"0",71.8,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7fb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, grade 3, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5x0","pgxind-kftx3162","pgxcs-kftvt6jz",306144130,0.106,95413850,0.033,210730280,0.073,"PGX_AM_BS_LMS-STS389","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.888000",,,,,,"P76Y",,,"1",19.3,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, grade 2, AWD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5x5","pgxind-kftx3168","pgxcs-kftvt6lg",918333384,0.319,16100016,0.006,902233368,0.314,"PGX_AM_BS_LMS-STS438","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.892000",,,,,,"P69Y",,,"0",33.6,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af807","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Retro Pelvis, grade 2, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5xk","pgxind-kftx316p","pgxcs-kftvt6pt",633958516,0.221,190214746,0.066,443743770,0.154,"PGX_AM_BS_LMS-STS587","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.904000",,,,,,"P67Y",,,"1",2.7,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb79","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic rhabdomyosarcoma [limb, PAX3-FKHR neg.]","PMID:12550764","Gordon A, McManus A et al. (2003): Chromosomal imbalances in pleomorphic rhabdomyosarcomas and...","pgxfus-0002","no followup status","NCIT:C27369","Adult Pleomorphic Rhabdomyosarcoma","icdom-89013","Pleomorphic rhabdomyosarcoma, adult type","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh719","pgxind-kftx32ke","pgxcs-kftvtj2o",1024757072,0.356,703456751,0.245,321300321,0.112,"PGX_AM_BS_Rhabd-STS023","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.121000",,,,,,"P54Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb7b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic rhabdomyosarcoma [buttock, PAX3-FKHR neg.]","PMID:12550764","Gordon A, McManus A et al. (2003): Chromosomal imbalances in pleomorphic rhabdomyosarcomas and...","pgxfus-0002","no followup status","NCIT:C27369","Adult Pleomorphic Rhabdomyosarcoma","icdom-89013","Pleomorphic rhabdomyosarcoma, adult type","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh71d","pgxind-kftx32ki","pgxcs-kftvtj3q",1238415158,0.431,653026796,0.227,585388362,0.204,"PGX_AM_BS_Rhabd-STS187","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.124000",,,,,,"P84Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb7c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic rhabdomyosarcoma [limb, PAX3-FKHR neg.]","PMID:12550764","Gordon A, McManus A et al. (2003): Chromosomal imbalances in pleomorphic rhabdomyosarcomas and...","pgxfus-0002","no followup status","NCIT:C27369","Adult Pleomorphic Rhabdomyosarcoma","icdom-89013","Pleomorphic rhabdomyosarcoma, adult type","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh71e","pgxind-kftx32kk","pgxcs-kftvtj48",1317493887,0.458,645439639,0.225,672054248,0.234,"PGX_AM_BS_Rhabd-STS309-311","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.125000",,,,,,"P68Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb84","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","double-component liposarcoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4253","Mixed Liposarcoma","icdom-88553","Mixed liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh71r","pgxind-kftx32l0","pgxcs-kftvtj85",788281505,0.274,455421112,0.158,332860393,0.116,"PGX_AM_BS_Chib-LPS02","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.136000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afbae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh73m","pgxind-kftx32nd","pgxcs-kftvtjsp",845418804,0.294,741543959,0.258,103874845,0.036,"PGX_AM_BS_Chib-MFH15","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.193000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd2b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7kv","pgxind-kftx338u","pgxcs-kftvtp6d",1203438907,0.419,584438288,0.203,619000619,0.215,"PGX_AM_BS_OstSarc-oza-01","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.717000",,,,,,"P35Y",,,"1",16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd2c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal ulna, Primary, Fibroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7kw","pgxind-kftx338w","pgxcs-kftvtp6u",773488058,0.269,410144507,0.143,363343551,0.126,"PGX_AM_BS_OstSarc-oza-02","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.718000",,,,,,"P17Y",,,"0",40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Tibia, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7ky","pgxind-kftx338y","pgxcs-kftvtp7c",622773520,0.217,204249739,0.071,418523781,0.146,"PGX_AM_BS_OstSarc-oza-03","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.720000",,,,,,"P6Y",,,"0",37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Tibia, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l3","pgxind-kftx3395","pgxcs-kftvtp8t",850675112,0.296,288202680,0.1,562472432,0.196,"PGX_AM_BS_OstSarc-oza-06","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.724000",,,,,,"P13Y",,,"1",25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd33","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Tibia, Primary, Fibroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l8","pgxind-kftx339b","pgxcs-kftvtpa9",2082369258,0.724,980903263,0.341,1101465995,0.383,"PGX_AM_BS_OstSarc-oza-09","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.728000",,,,,,"P21Y",,,"0",33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd34","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l9","pgxind-kftx339d","pgxcs-kftvtpaq",1666218807,0.58,692786238,0.241,973432569,0.339,"PGX_AM_BS_OstSarc-oza-10","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.729000",,,,,,"P13Y",,,"0",34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd35","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lb","pgxind-kftx339f","pgxcs-kftvtpb8",1501280965,0.522,742773633,0.258,758507332,0.264,"PGX_AM_BS_OstSarc-oza-11","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.731000",,,,,,"P20Y",,,"0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd37","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Ilium-Sacrum, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7le","pgxind-kftx339j","pgxcs-kftvtpc6",1161507906,0.404,518626044,0.18,642881862,0.224,"PGX_AM_BS_OstSarc-oza-13","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.734000",,,,,,"P20Y",,,"1",20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd39","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Radius, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lh","pgxind-kftx339n","pgxcs-kftvtpd5",1411384860,0.491,646939617,0.225,764445243,0.266,"PGX_AM_BS_OstSarc-oza-15","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.736000",,,,,,"P24Y",,,"0",30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd3d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Fibroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lo","pgxind-kftx339v","pgxcs-kftvtpf2",1320240031,0.459,721951079,0.251,598288952,0.208,"PGX_AM_BS_OstSarc-oza-19","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.742000",,,,,,"P16Y",,,"0",27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd3f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lr","pgxind-kftx339z","pgxcs-kftvtpg0",539472904,0.188,243333970,0.085,296138934,0.103,"PGX_AM_BS_OstSarc-oza-21","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.745000",,,,,,"P6Y",,,"1",16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd41","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lu","pgxind-kftx33a3","pgxcs-kftvtpgz",1223174437,0.425,355501627,0.124,867672810,0.302,"PGX_AM_BS_OstSarc-oza-23","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.748000",,,,,,"P16Y",,,"0",29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd45","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m1","pgxind-kftx33ab","pgxcs-kftvtpiw",1066209058,0.371,305540977,0.106,760668081,0.265,"PGX_AM_BS_OstSarc-oza-27","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.754000",,,,,,"P9Y",,,"0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m2","pgxind-kftx33ad","pgxcs-kftvtpje",1441051519,0.501,549761945,0.191,891289574,0.31,"PGX_AM_BS_OstSarc-oza-28","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.755000",,,,,,"P34Y",,,"0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd48","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m6","pgxind-kftx33ah","pgxcs-kftvtpkc",333706311,0.116,236006215,0.082,97700096,0.034,"PGX_AM_BS_OstSarc-oza-30","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.758000",,,,,,"P12Y",,,"0",26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd49","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Humerus, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m7","pgxind-kftx33aj","pgxcs-kftvtpku",1625674673,0.565,863740888,0.3,761933785,0.265,"PGX_AM_BS_OstSarc-oza-31","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.759000",,,,,,"P18Y",,,"0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Tibia, Primary, Fibroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m9","pgxind-kftx33al","pgxcs-kftvtplb",960795565,0.334,423246068,0.147,537549497,0.187,"PGX_AM_BS_OstSarc-oza-32","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.761000",,,,,,"P14Y",,,"0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mc","pgxind-kftx33ap","pgxcs-kftvtpma",1733374586,0.603,825134628,0.287,908239958,0.316,"PGX_AM_BS_OstSarc-oza-34","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.764000",,,,,,"P15Y",,,"0",19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Pelvis-Sacrum-L5, Primary, Chondroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7me","pgxind-kftx33ar","pgxcs-kftvtpms",464831803,0.162,301793004,0.105,163038799,0.057,"PGX_AM_BS_OstSarc-oza-35","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.765000",,,,,,"P10Y",,,"0",40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Fibula, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mf","pgxind-kftx33au","pgxcs-kftvtpn9",2221143758,0.773,929870284,0.323,1291273474,0.449,"PGX_AM_BS_OstSarc-oza-36","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.767000",,,,,,"P14Y",,,"0",36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Fibula, Primary, Chondroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mh","pgxind-kftx33aw","pgxcs-kftvtpnq",1281988926,0.446,618196385,0.215,663792541,0.231,"PGX_AM_BS_OstSarc-oza-37","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.768000",,,,,,"P11Y",,,"0",32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd52","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mm","pgxind-kftx33b2","pgxcs-kftvtpp7",1834850234,0.638,856494751,0.298,978355483,0.34,"PGX_AM_BS_OstSarc-oza-40","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.772000",,,,,,"P12Y",,,"0",10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd59","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Recurrence, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7my","pgxind-kftx33bg","pgxcs-kftvtpsl",629041888,0.219,269700271,0.094,359341617,0.125,"PGX_AM_BS_OstSarc-oza-47","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.782000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0109","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [NF1-associated]","PMID:12081210","Koga T, Iwasaki H et al. (2002): Frequent genomic imbalances in chromosomes 17,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvh8ti","pgxind-kftx34sp","pgxcs-kftvu2zi",404766923,0.141,300366819,0.104,104400104,0.036,"PGX_AM_BS_MB-PNST-02","{}",130.42,33.61,"Point","JPN","Fukuoka-shi","Japan","Fukuoka-shi, Japan",33.61,130.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:37.079000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b010a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [NF1-associated]","PMID:12081210","Koga T, Iwasaki H et al. (2002): Frequent genomic imbalances in chromosomes 17,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvh8tj","pgxind-kftx34sr","pgxcs-kftvu2zz",48900048,0.017,0,0,48900048,0.017,"PGX_AM_BS_MB-PNST-03","{}",130.42,33.61,"Point","JPN","Fukuoka-shi","Japan","Fukuoka-shi, Japan",33.61,130.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:37.081000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b010e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [sporadic]","PMID:12081210","Koga T, Iwasaki H et al. (2002): Frequent genomic imbalances in chromosomes 17,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvh8tq","pgxind-kftx34sz","pgxcs-kftvu31w",602051180,0.209,264550844,0.092,337500336,0.117,"PGX_AM_BS_MB-PNST-07","{}",130.42,33.61,"Point","JPN","Fukuoka-shi","Japan","Fukuoka-shi, Japan",33.61,130.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:37.086000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02a3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9c5","pgxind-kftx35fw","pgxcs-kftvu8sc",836664060,0.291,309550123,0.108,527113937,0.183,"PGX_AM_BS_LipSarc-02","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.651000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02a5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9c8","pgxind-kftx35g0","pgxcs-kftvu8tb",673385437,0.234,195401312,0.068,477984125,0.166,"PGX_AM_BS_LipSarc-04","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.654000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02a6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9ca","pgxind-kftx35g2","pgxcs-kftvu8ts",816899503,0.284,264671555,0.092,552227948,0.192,"PGX_AM_BS_LipSarc-05","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.655000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02a7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cc","pgxind-kftx35g5","pgxcs-kftvu8u9",663291168,0.231,61943043,0.022,601348125,0.209,"PGX_AM_BS_LipSarc-06","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.656000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02a8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cd","pgxind-kftx35g7","pgxcs-kftvu8ur",1329160221,0.462,610605689,0.212,718554532,0.25,"PGX_AM_BS_LipSarc-07","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.658000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02ac","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9ck","pgxind-kftx35gf","pgxcs-kftvu8wo",772092075,0.269,255022096,0.089,517069979,0.18,"PGX_AM_BS_LipSarc-11","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.664000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02ad","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cm","pgxind-kftx35gh","pgxcs-kftvu8x5",679288189,0.236,216416077,0.075,462872112,0.161,"PGX_AM_BS_LipSarc-12","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.665000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02b6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9d0","pgxind-kftx35gz","pgxcs-kftvu91f",241913620,0.084,0,0,241913620,0.084,"PGX_AM_BS_LipSarc-21","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.678000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02f3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, bone]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9fs","pgxind-kftx35kg","pgxcs-kftvu9x0",941927495,0.328,78774821,0.027,863152674,0.3,"PGX_AM_BS_FibSarc-01b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.761000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, lower extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9g2","pgxind-kftx35kt","pgxcs-kftvu9zw",1057120267,0.368,71891504,0.025,985228763,0.343,"PGX_AM_BS_FibSarc-05b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.769000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0305","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 1, lower extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9gm","pgxind-kftx35lh","pgxcs-kftvua5p",880464879,0.306,22200022,0.008,858264857,0.299,"PGX_AM_BS_FibSarc-16a","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.785000",,,,,,,,,,,"NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0306","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, lower extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9gn","pgxind-kftx35lj","pgxcs-kftvua66",1173546039,0.408,155997578,0.054,1017548461,0.354,"PGX_AM_BS_FibSarc-16b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.787000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b033f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9j9","pgxind-kftx35os","pgxcs-kftvuaxo",666277527,0.232,333381029,0.116,332896498,0.116,"PGX_AM_BS_AdrCortPA-37","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.865000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0340","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9jb","pgxind-kftx35ou","pgxcs-kftvuay5",893942296,0.311,588743112,0.205,305199184,0.106,"PGX_AM_BS_AdrCortPA-38","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.866000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0342","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9je","pgxind-kftx35oy","pgxcs-kftvuaz3",182169643,0.063,81700082,0.028,100469561,0.035,"PGX_AM_BS_AdrCortPA-40","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.869000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0344","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9jh","pgxind-kftx35p2","pgxcs-kftvub23",472618195,0.164,183543165,0.064,289075030,0.101,"PGX_AM_BS_AdrCortPA-42","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.872000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05c5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Extraskeletal osteosarcoma CB G4, Lower lege]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhaca","pgxind-kftx36p4","pgxcs-kftvuk03",356560251,0.124,95413850,0.033,261146401,0.091,"PGX_AM_BS_RadSarc-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:38.755000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05d4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Fibrosarcoma G3, Neck]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhacy","pgxind-kftx36pz","pgxcs-kftvuk77",326071058,0.113,0,0,326071058,0.113,"PGX_AM_BS_RadSarc-20b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:38.776000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b066b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhajq","pgxind-kftx36yh","pgxcs-kftvumbk",148038784,0.051,40300040,0.014,107738744,0.037,"PGX_AM_BS_OS-04","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.981000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b066c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhajs","pgxind-kftx36yj","pgxcs-kftvumc1",38300038,0.013,0,0,38300038,0.013,"PGX_AM_BS_OS-05","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.983000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b066f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhajx","pgxind-kftx36yp","pgxcs-kftvumdi",273227687,0.095,28100028,0.01,245127659,0.085,"PGX_AM_BS_OS-08","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.987000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0670","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhajy","pgxind-kftx36yr","pgxcs-kftvumdz",356527769,0.124,28100028,0.01,328427741,0.114,"PGX_AM_BS_OS-09","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.988000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0672","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhak2","pgxind-kftx36yv","pgxcs-kftvumez",235731606,0.082,0,0,235731606,0.082,"PGX_AM_BS_OS-11","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.991000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0673","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhak3","pgxind-kftx36yx","pgxcs-kftvumfh",285181281,0.099,0,0,285181281,0.099,"PGX_AM_BS_OS-12","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.992000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0697","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [G4]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhalq","pgxind-kftx370y","pgxcs-kftvumx2",697397232,0.243,173927427,0.06,523469805,0.182,"PGX_AM_BS_sts-07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.041000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b069b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma [grade 3]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhalx","pgxind-kftx3716","pgxcs-kftvumyz",531432146,0.185,363850082,0.127,167582064,0.058,"PGX_AM_BS_sts-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:39.046000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b069d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma G3","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvham0","pgxind-kftx371a","pgxcs-kftvumzy",131527385,0.046,109327363,0.038,22200022,0.008,"PGX_AM_BS_sts-13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.049000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06ab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [G4, local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamn","pgxind-kftx3723","pgxcs-kftvun6q",964148308,0.335,125600124,0.044,838548184,0.292,"PGX_AM_BS_sts-lr07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.068000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06ae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma G1a [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhams","pgxind-kftx3729","pgxcs-kftvun87",648594229,0.226,539879565,0.188,108714664,0.038,"PGX_AM_BS_sts-lr10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.072000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06af","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma G3 [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamu","pgxind-kftx372b","pgxcs-kftvun8o",828636191,0.288,306217460,0.107,522418731,0.182,"PGX_AM_BS_sts-lr11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.073000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06b1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma G3 [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamx","pgxind-kftx372f","pgxcs-kftvun9n",958213066,0.333,342829475,0.119,615383591,0.214,"PGX_AM_BS_sts-lr13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.076000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4b","pgxind-kftx38xa","pgxcs-kftvv40j",1446529630,0.503,975929906,0.339,470599724,0.164,"PGX_AM_BS_EmbSarc3a","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.712000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b54","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4h","pgxind-kftx38xi","pgxcs-kftvv42j",1309977861,0.456,226797648,0.079,1083180213,0.377,"PGX_AM_BS_EmbSarc6","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.718000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b7d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [metastasis]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc6b","pgxind-kftx38zk","pgxcs-kftvv4mh",325343389,0.113,157393687,0.055,167949702,0.058,"PGX_AM_BS_11369052_WDLPS-forus-2a","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.774000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b81","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [metastasis]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc6h","pgxind-kftx38zs","pgxcs-kftvv4qb",789164493,0.274,385712416,0.134,403452077,0.14,"PGX_AM_BS_11369052_WDLPS-forus-3b","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.779000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c22","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcdp","pgxind-kftx398r","pgxcs-kftvv6y7",1826767959,0.635,691006974,0.24,1135760985,0.395,"PGX_AM_BS_LMS-12","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.006000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c24","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcds","pgxind-kftx398v","pgxcs-kftvv6z6",855969003,0.298,494915448,0.172,361053555,0.126,"PGX_AM_BS_LMS-14","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.008000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcdz","pgxind-kftx3993","pgxcs-kftvv714",1120450618,0.39,365910549,0.127,754540069,0.262,"PGX_AM_BS_LMS-18","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.014000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c29","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhce0","pgxind-kftx3995","pgxcs-kftvv71m",719510009,0.25,78264753,0.027,641245256,0.223,"PGX_AM_BS_LMS-19","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.016000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c31","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcee","pgxind-kftx399l","pgxcs-kftvv777",627038683,0.218,382738439,0.133,244300244,0.085,"PGX_AM_BS_LMS-7","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.027000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c32","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcef","pgxind-kftx399n","pgxcs-kftvv77q",1625466078,0.565,706773689,0.246,918692389,0.32,"PGX_AM_BS_LMS-8","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.028000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c33","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhceh","pgxind-kftx399p","pgxcs-kftvv788",610279676,0.212,390770983,0.136,219508693,0.076,"PGX_AM_BS_LMS-9","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.029000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c7e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [grade high, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhcht","pgxind-kftx39dx","pgxcs-kftvv88p",891445722,0.31,0,0,891445722,0.31,"PGX_AM_BS_sarc01","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:41.135000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c80","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [grade high, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhchx","pgxind-kftx39e1","pgxcs-kftvv89o",714703694,0.249,589682144,0.205,125021550,0.043,"PGX_AM_BS_sarc03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:41.138000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c81","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [grade high, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhchy","pgxind-kftx39e3","pgxcs-kftvv8a5",1519358322,0.528,703153330,0.245,816204992,0.284,"PGX_AM_BS_sarc04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:41.139000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c84","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci3","pgxind-kftx39ea","pgxcs-kftvv8bm",1099594097,0.382,609533366,0.212,490060731,0.17,"PGX_AM_BS_sarc07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.143000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c85","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade III, local recurrence]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci5","pgxind-kftx39ec","pgxcs-kftvv8c4",1237803441,0.431,299212278,0.104,938591163,0.326,"PGX_AM_BS_sarc08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.145000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c88","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci9","pgxind-kftx39ei","pgxcs-kftvv8fi",457925649,0.159,67894786,0.024,390030863,0.136,"PGX_AM_BS_sarc11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.149000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c8d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Leiomyosarcoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhcih","pgxind-kftx39es","pgxcs-kftvv8hz",1125884014,0.392,928862393,0.323,197021621,0.069,"PGX_AM_BS_sarc16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.156000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c90","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Epitheliod Leiomyosarcoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C3700","Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhcim","pgxind-kftx39ez","pgxcs-kftvv8jg",805429092,0.28,184943165,0.064,620485927,0.216,"PGX_AM_BS_sarc19","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.160000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c93","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma, dedifferentiated [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhcir","pgxind-kftx39f5","pgxcs-kftvv8kx",838662578,0.292,42500043,0.015,796162535,0.277,"PGX_AM_BS_sarc22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.165000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c96","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant schwannoma [grade 2]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhciw","pgxind-kftx39fb","pgxcs-kftvv8md",908145184,0.316,432550936,0.15,475594248,0.165,"PGX_AM_BS_sarc27","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:41.169000",,,,,,,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b100b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [uterus, primary, grade III]","PMID:11060455","Otao-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhdn2","pgxind-kftx3at9","pgxcs-kftvvl3e",473878838,0.165,200521625,0.07,273357213,0.095,"PGX_AM_BS_LeioMy02","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus",,"2020-09-10 17:44:42.390000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b100f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [thoracic wall, primary, grade III]","PMID:11060455","Otao-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhdn9","pgxind-kftx3ath","pgxcs-kftvvl5b",1117106130,0.389,388293917,0.135,728812213,0.253,"PGX_AM_BS_LeioMy06","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:42.395000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1011","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [retroperitoneum, recurrence, grade III]","PMID:11060455","Otao-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.9","retroperitoneum and peritoneum","pgxbs-kftvhdnc","pgxind-kftx3atl","pgxcs-kftvvl6c",434893528,0.151,212097635,0.074,222795893,0.077,"PGX_AM_BS_LeioMy08","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space",,"2020-09-10 17:44:42.398000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1013","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [small pelvis, recurrence, grade III]","PMID:11060455","Otao-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhdnf","pgxind-kftx3atp","pgxcs-kftvvl7d",401537996,0.14,129143111,0.045,272394885,0.095,"PGX_AM_BS_LeioMy10","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:42.401000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1014","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [femoral vein, primary, grade III]","PMID:11060455","Otao-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhdnh","pgxind-kftx3atr","pgxcs-kftvvl7v",569169744,0.198,226634641,0.079,342535103,0.119,"PGX_AM_BS_LeioMy11","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:42.402000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1015","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [uterus, recurrence, grade III]","PMID:11060455","Otao-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhdnj","pgxind-kftx3att","pgxcs-kftvvl8d",807596273,0.281,300438731,0.105,507157542,0.176,"PGX_AM_BS_LeioMy12","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus",,"2020-09-10 17:44:42.403000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1151","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","uterine leiomyosarcoma","PMID:10958933","Levy B, Mukherjee T et al. (2000): Molecular cytogenetic analysis of uterine leiomyoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhe1w","pgxind-kftx3bbm","pgxcs-kftvvpnu",540032039,0.188,183768769,0.064,356263270,0.124,"PGX_AM_BS_ULMS04","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:42.841000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1153","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","uterine leiomyosarcoma","PMID:10958933","Levy B, Mukherjee T et al. (2000): Molecular cytogenetic analysis of uterine leiomyoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhe20","pgxind-kftx3bbq","pgxcs-kftvvpot",353885536,0.123,103089726,0.036,250795810,0.087,"PGX_AM_BS_ULMS06","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:42.844000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1155","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","uterine leiomyosarcoma","PMID:10958933","Levy B, Mukherjee T et al. (2000): Molecular cytogenetic analysis of uterine leiomyoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhe23","pgxind-kftx3bbu","pgxcs-kftvvppt",976688834,0.34,496465220,0.173,480223614,0.167,"PGX_AM_BS_ULMS08","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:42.846000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b12f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:10822134","Schmidt H, Taubert H et al. (2000): Gains in chromosomes 7, 8q, 15q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvheku","pgxind-kftx3bz2","pgxcs-kftvvvig",576618995,0.201,147352531,0.051,429266464,0.149,"PGX_AM_BS_MalBen-PNST-01","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:43.410000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b12f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:10822134","Schmidt H, Taubert H et al. (2000): Gains in chromosomes 7, 8q, 15q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhel7","pgxind-kftx3bzi","pgxcs-kftvvvma",488979922,0.17,84817238,0.03,404162684,0.141,"PGX_AM_BS_MalBen-PNST-04b2","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:43.421000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1352","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhep9","pgxind-kftx3c4k","pgxcs-kftvvwvh",1659616741,0.577,814852381,0.283,844764360,0.294,"PGX_AM_BS_MFH-MFH46","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.549000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1355","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepe","pgxind-kftx3c4q","pgxcs-kftvvwwy",1727417170,0.601,823113412,0.286,904303758,0.315,"PGX_AM_BS_MFH-MFH49","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.554000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1358","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepj","pgxind-kftx3c4w","pgxcs-kftvvwye",1399231767,0.487,730428934,0.254,668802833,0.233,"PGX_AM_BS_MFH-MFH9","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.559000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1359","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepl","pgxind-kftx3c4y","pgxcs-kftvvwyw",1904604601,0.662,1019834921,0.355,884769680,0.308,"PGX_AM_BS_MFH-T100","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.560000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepp","pgxind-kftx3c54","pgxcs-kftvvx0d",1328133162,0.462,739161449,0.257,588971713,0.205,"PGX_AM_BS_MFH-T103","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.565000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhept","pgxind-kftx3c58","pgxcs-kftvvx1d",1489839035,0.518,985906790,0.343,503932245,0.175,"PGX_AM_BS_MFH-T105","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.568000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1360","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepw","pgxind-kftx3c5c","pgxcs-kftvvx2c",1811581511,0.63,848586826,0.295,962994685,0.335,"PGX_AM_BS_MFH-T108","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.571000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1361","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepy","pgxind-kftx3c5e","pgxcs-kftvvx2t",1077548243,0.375,563149392,0.196,514398851,0.179,"PGX_AM_BS_MFH-T109","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.572000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1365","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheq4","pgxind-kftx3c5m","pgxcs-kftvvx4r",643372788,0.224,180513934,0.063,462858854,0.161,"PGX_AM_BS_MFH-T129","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.578000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1366","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheq6","pgxind-kftx3c5o","pgxcs-kftvvx59",1844542467,0.642,1031217652,0.359,813324815,0.283,"PGX_AM_BS_MFH-T80","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.579000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1367","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheq7","pgxind-kftx3c5q","pgxcs-kftvvx5r",942362759,0.328,294450779,0.102,647911980,0.225,"PGX_AM_BS_MFH-V19","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.581000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14ca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf6a","pgxind-kftx3cpi","pgxcs-kftvw25y",648288063,0.225,280349999,0.098,367938064,0.128,"PGX_AM_BS_stt-05","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.078000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14fc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf8l","pgxind-kftx3cs8","pgxcs-kftvw2ua",699612050,0.243,677412028,0.236,22200022,0.008,"PGX_AM_BS_stt-58","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.146000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf8o","pgxind-kftx3csc","pgxcs-kftvw2va",682912453,0.238,539512312,0.188,143400141,0.05,"PGX_AM_BS_stt-61","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.149000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1516","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma, well differentiated","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf9r","pgxind-kftx3ctn","pgxcs-kftvw36z",308662153,0.107,177652038,0.062,131010115,0.046,"PGX_AM_BS_stt-93","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.182000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b156b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade I, femur]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdm","pgxind-kftx3cye","pgxcs-kftvw4dv",537100643,0.187,230823364,0.08,306277279,0.107,"PGX_AM_BS_AEB-10534175-08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.298000",,,,,,"P36Y",,,"0",80,"NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b156c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade I, pelvis]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdo","pgxind-kftx3cyg","pgxcs-kftvw4ee",871242429,0.303,0,0,871242429,0.303,"PGX_AM_BS_AEB-10534175-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.299000",,,,,,"P72Y",,,"0",40,"NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1571","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, tibia]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdw","pgxind-kftx3cyq","pgxcs-kftvw4gw",160820851,0.056,0,0,160820851,0.056,"PGX_AM_BS_AEB-10534175-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.306000",,,,,,"P37Y",,,"0",61,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1572","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, rib VIII]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdx","pgxind-kftx3cys","pgxcs-kftvw4hd",1176759512,0.409,0,0,1176759512,0.409,"PGX_AM_BS_AEB-10534175-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.307000",,,,,,"P78Y",,,"1",60,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1573","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, femur]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdz","pgxind-kftx3cyu","pgxcs-kftvw4hv",1176032468,0.409,51800051,0.018,1124232417,0.391,"PGX_AM_BS_AEB-10534175-16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.309000",,,,,,"P34Y",,,"0",47,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b157a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, scapula]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfea","pgxind-kftx3cz8","pgxcs-kftvw4n6",145136109,0.05,0,0,145136109,0.05,"PGX_AM_BS_AEB-10534175-22b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.318000",,,,,,"P40Y",,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b157c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, soft tissue]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfee","pgxind-kftx3czc","pgxcs-kftvw4o6",622482836,0.217,51800051,0.018,570682785,0.198,"PGX_AM_BS_AEB-10534175-23b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:44.321000",,,,,,"P64Y",,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1583","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, tibia]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfep","pgxind-kftx3czq","pgxcs-kftvw4rl",610853469,0.212,110306090,0.038,500547379,0.174,"PGX_AM_BS_AEB-10534175-28","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.330000",,,,,,"P43Y",,,"1",8,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1586","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, femur]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfeu","pgxind-kftx3czw","pgxcs-kftvw4t2",1786212027,0.621,373352757,0.13,1412859270,0.491,"PGX_AM_BS_AEB-10534175-31","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.335000",,,,,,"P27Y",,,"0",69,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b158c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, pelvis]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhff4","pgxind-kftx3d08","pgxcs-kftvw4vz",303331437,0.106,0,0,303331437,0.106,"PGX_AM_BS_AEB-10534175-37","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.343000",,,,,,"P45Y",,,"0",77,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b158f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, soft tissue]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhff9","pgxind-kftx3d0e","pgxcs-kftvw4xg",1144199139,0.398,0,0,1144199139,0.398,"PGX_AM_BS_AEB-10534175-40","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:44.347000",,,,,,"P53Y",,,"1",4,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b15a7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma [Knee region]","PMID:10526533","Tarkkanen M, Kiuru-Kuhlefelt S et al. (1999): Clinical correlations of genetic changes by...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvhfgc","pgxind-kftx3d1r","pgxcs-kftvw597",604502231,0.21,0,0,604502231,0.21,"PGX_AM_BS_EWSRT-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:44.380000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b15ab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma [Spine]","PMID:10526533","Tarkkanen M, Kiuru-Kuhlefelt S et al. (1999): Clinical correlations of genetic changes by...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvhfgi","pgxind-kftx3d1z","pgxcs-kftvw5b8",340243489,0.118,50627305,0.018,289616184,0.101,"PGX_AM_BS_EWSRT-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:44.385000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1707","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Abdominal cavity, grade GII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwg","pgxind-kftx3dld","pgxcs-kftvwa9t",2314190997,0.805,746482941,0.26,1567708056,0.545,"PGX_AM_BS_MPNST-04","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.865000",,,,,,,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1708","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Inguinal region, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwi","pgxind-kftx3dlf","pgxcs-kftvwaaa",744472707,0.259,158710142,0.055,585762565,0.204,"PGX_AM_BS_MPNST-05","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.866000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1714","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [neurofibromatosis 1, primary tumor, Upper arm, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfx1","pgxind-kftx3dm3","pgxcs-kftvwag5",592982919,0.206,25600025,0.009,567382894,0.197,"PGX_AM_BS_MPNST-17","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.883000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1723","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxq","pgxind-kftx3dmy","pgxcs-kftvwang",1300065920,0.452,0,0,1300065920,0.452,"PGX_AM_BS_MetSarc-tar-07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.904000",,,,,,"P22Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1724","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxs","pgxind-kftx3dn0","pgxcs-kftvwany",1300065920,0.452,0,0,1300065920,0.452,"PGX_AM_BS_MetSarc-tar-07M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.905000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1725","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant    brous histiocytoma [myxoid, metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxt","pgxind-kftx3dn2","pgxcs-kftvwaog",531132145,0.185,357050075,0.124,174082070,0.061,"PGX_AM_BS_MetSarc-tar-08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.906000",,,,,,"P50Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1726","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [myxoid, metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxv","pgxind-kftx3dn4","pgxcs-kftvwaox",531132145,0.185,357050075,0.124,174082070,0.061,"PGX_AM_BS_MetSarc-tar-08M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.908000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1729","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant    brous histiocytoma [storiform-pleomorphic, metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfy0","pgxind-kftx3dna","pgxcs-kftvwaqe",987202805,0.343,722780686,0.251,264422119,0.092,"PGX_AM_BS_MetSarc-tar-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.912000",,,,,,"P54Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b172a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [storiform-pleomorphic, metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfy2","pgxind-kftx3dnc","pgxcs-kftvwaqv",987202805,0.343,722780686,0.251,264422119,0.092,"PGX_AM_BS_MetSarc-tar-10M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.913000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b172f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant    brous histiocytoma [storiform-pleomorphic, metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfya","pgxind-kftx3dnm","pgxcs-kftvwatb",940555195,0.327,540568594,0.188,399986601,0.139,"PGX_AM_BS_MetSarc-tar-13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.920000",,,,,,"P59Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1730","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [storiform-pleomorphic, metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfyc","pgxind-kftx3dno","pgxcs-kftvwatt",940555195,0.327,540568594,0.188,399986601,0.139,"PGX_AM_BS_MetSarc-tar-13M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.922000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1793","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [groin, recurrence]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgci","pgxind-kftx3dt7","pgxcs-kftvwc9u",280886021,0.098,22200022,0.008,258685999,0.09,"PGX_AM_BS_PNST-01","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.058000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b179c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [left thigh, metastasis]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgcw","pgxind-kftx3dtq","pgxcs-kftvwce6",937279680,0.326,0,0,937279680,0.326,"PGX_AM_BS_PNST-11","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.070000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [left thigh, primary]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgd4","pgxind-kftx3dtz","pgxcs-kftvwcgm",1219556648,0.424,174708261,0.061,1044848387,0.363,"PGX_AM_BS_PNST-14","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.077000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [left thorax, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgd8","pgxind-kftx3du3","pgxcs-kftvwchl",590346475,0.205,161200160,0.056,429146315,0.149,"PGX_AM_BS_PNST-16a3","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.080000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [mediastinum, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdb","pgxind-kftx3du7","pgxcs-kftvwcik",858099895,0.298,500964454,0.174,357135441,0.124,"PGX_AM_BS_PNST-16c","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.083000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [thorax wall, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdc","pgxind-kftx3du9","pgxcs-kftvwcj1",891849649,0.31,409464362,0.142,482385287,0.168,"PGX_AM_BS_PNST-16d","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.084000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [left lower arm, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgde","pgxind-kftx3duc","pgxcs-kftvwcjj",620336586,0.216,233066407,0.081,387270179,0.135,"PGX_AM_BS_PNST-17","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.086000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [right thigh, primary]","PMID:10379866","Schmidt H, Wrl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdg","pgxind-kftx3due","pgxcs-kftvwck1",851743959,0.296,0,0,851743959,0.296,"PGX_AM_BS_PNST-18","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.087000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1925","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhguy","pgxind-kftx3efj","pgxcs-kftvwhwa",934857767,0.325,187593718,0.065,747264049,0.26,"PGX_AM_BS_HG-Osarc-05","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.614000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1932","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvk","pgxind-kftx3ega","pgxcs-kftvwi2l",342523476,0.119,213723347,0.074,128800129,0.045,"PGX_AM_BS_HG-Osarc-26","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.632000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1933","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvl","pgxind-kftx3egc","pgxcs-kftvwi32",1055595937,0.367,32800033,0.011,1022795904,0.356,"PGX_AM_BS_HG-Osarc-27","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.634000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvs","pgxind-kftx3egk","pgxcs-kftvwi50",1090717915,0.379,61943043,0.022,1028774872,0.358,"PGX_AM_BS_HG-Osarc-31","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.639000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a059b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bf4fc4a5-ae1e-4363-a440-a841464ae81a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhhqv","pgxind-kftx3fi3","pgxcs-kftvwrk8",2453704512,0.853,1011275244,0.352,1442429268,0.502,"bf4fc4a5-ae1e-4363-a440-a841464ae81a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:46.574000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a05c3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1bf5ea0f-6279-4278-a7d6-4b17d479283a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhhsq","pgxind-kftx3fk9","pgxcs-kftvws3k",757720775,0.264,433147730,0.151,324573044,0.113,"1bf5ea0f-6279-4278-a7d6-4b17d479283a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:46.632000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported","pgxcs-kftvyjlm",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a05cc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e4a19b22-ced3-4123-863d-2cde750226ee","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhht5","pgxind-kftx3fkp","pgxcs-kftvws9y",1719533572,0.598,732659930,0.255,986873642,0.343,"e4a19b22-ced3-4123-863d-2cde750226ee","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:46.644000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a05d9","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4a0e20e2-81e5-4950-a4d1-2d28d2f1ae57","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.1","Specified parts of peritoneum","pgxbs-kftvhhtr","pgxind-kftx3flf","pgxcs-kftvwsga",1164318161,0.405,740695852,0.258,423622309,0.147,"4a0e20e2-81e5-4950-a4d1-2d28d2f1ae57","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003688","omentum","{}","2020-09-10 17:44:46.663000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a06f4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-fc7de482-3113-4857-9766-d8268784f9aa","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhi6u","pgxind-kftx3g14","pgxcs-kftvwwid",1859229278,0.647,1003768104,0.349,855461174,0.298,"fc7de482-3113-4857-9766-d8268784f9aa","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:47.394000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0700","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bb4fa564-3128-44cb-a852-2bf4d26cb981","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhi7e","pgxind-kftx3g1s","pgxcs-kftvwwo7",1701904474,0.592,643529773,0.224,1058374701,0.368,"bb4fa564-3128-44cb-a852-2bf4d26cb981","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:47.412000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a085b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-155fb0dc-2c45-46a8-84c9-a1447111bb8c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhin6","pgxind-kftx3gkp","pgxcs-kftvx1ko",1187495505,0.413,794396274,0.276,393099231,0.137,"155fb0dc-2c45-46a8-84c9-a1447111bb8c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:47.897000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0888","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c852155c-abfc-4d54-8dd0-136a27508954","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhip8","pgxind-kftx3gn3","pgxcs-kftvx28h",1869394605,0.65,994008582,0.346,875386023,0.304,"c852155c-abfc-4d54-8dd0-136a27508954","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:47.960000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0901","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-406df608-27db-4a3d-a692-a6eefc2eb238","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4279","Biphasic Synovial Sarcoma","icdom-90433","Synovial sarcoma, biphasic","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhius","pgxind-kftx3gth","pgxcs-kftvx3x5",260480180,0.091,260381504,0.091,98676,0,"406df608-27db-4a3d-a692-a6eefc2eb238","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:48.131000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a093d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3d257887-d0f2-40d1-945b-a46db90e63df","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhixi","pgxind-kftx3gwf","pgxcs-kftvx4sa",2819661717,0.981,837341658,0.291,1982320059,0.69,"3d257887-d0f2-40d1-945b-a46db90e63df","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:48.216000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0947","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0c5a0353-bf76-4a2b-a941-76bf24a8540f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhixz","pgxind-kftx3gwz","pgxcs-kftvx4x3",2179144028,0.758,1001213780,0.348,1177930248,0.41,"0c5a0353-bf76-4a2b-a941-76bf24a8540f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:48.230000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0958","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bedf1833-c215-49c8-84ff-49f84c192ffd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C16.9","Stomach, NOS","pgxbs-kftvhiyr","pgxind-kftx3gxx","pgxcs-kftvx55a",2204904344,0.767,794792713,0.276,1410111631,0.49,"bedf1833-c215-49c8-84ff-49f84c192ffd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000945","stomach","{}","2020-09-10 17:44:48.254000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a09cc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-6245d97d-1af8-4c78-8bbf-840ee4e7bd44","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhj41","pgxind-kftx3h3q","pgxcs-kftvx6ro",2499486325,0.869,1431783459,0.498,1067702866,0.371,"6245d97d-1af8-4c78-8bbf-840ee4e7bd44","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:48.416000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0a7c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a2679d7d-8c31-4caa-b310-33b627d7bab6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhjc1","pgxind-kftx3hd0","pgxcs-kftvx990",910398171,0.317,478014054,0.166,432384117,0.15,"a2679d7d-8c31-4caa-b310-33b627d7bab6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:48.661000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0aee","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f854db6b-57cb-4da7-9252-b2ade22c2675","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhjh6","pgxind-kftx3hj6","pgxcs-kftvxawb",1717158895,0.597,519444469,0.181,1197714426,0.417,"f854db6b-57cb-4da7-9252-b2ade22c2675","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:48.827000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0b22","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f7e730b2-be2b-4b47-8a55-2c888758ed6a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhjjj","pgxind-kftx3hm2","pgxcs-kftvxblc",1852924407,0.644,890179015,0.31,962745392,0.335,"f7e730b2-be2b-4b47-8a55-2c888758ed6a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:48.901000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0d60","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-04080cb8-430b-42fd-9d6f-0b76fbc6e297","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhk9q","pgxind-kftx3ifj","pgxcs-kftvxjs8",1527056734,0.531,517229804,0.18,1009826930,0.351,"04080cb8-430b-42fd-9d6f-0b76fbc6e297","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:49.712000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0d8a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-9eff3f89-cd15-46ee-ac86-006586e1cefe","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhkbo","pgxind-kftx3ihr","pgxcs-kftvxkcp",2464824049,0.857,881349673,0.307,1583474376,0.551,"9eff3f89-cd15-46ee-ac86-006586e1cefe","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:49.771000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0dbb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-29fda349-d725-4f69-bb11-95d5454400f4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhkdv","pgxind-kftx3ikd","pgxcs-kftvxl3a",395903101,0.138,219234761,0.076,176668340,0.061,"29fda349-d725-4f69-bb11-95d5454400f4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:49.840000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0eae","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f035a57e-be4d-49ff-a96f-1ca75f4a6b92","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhkoy","pgxind-kftx3iw2","pgxcs-kftvxok4",2334310542,0.812,1070706803,0.372,1263603739,0.44,"f035a57e-be4d-49ff-a96f-1ca75f4a6b92","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:50.182000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ec0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3d38f7c9-00dd-47c1-8649-c50574953aab","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhkpr","pgxind-kftx3iwx","pgxcs-kftvxoss",1934816375,0.673,872718418,0.304,1062097957,0.369,"3d38f7c9-00dd-47c1-8649-c50574953aab","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.207000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ec1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4df7599a-680c-452a-b472-2370b8f190a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C54.2","Myometrium","pgxbs-kftvhkpt","pgxind-kftx3fw1","pgxcs-kftvxota",2084231085,0.725,1032667465,0.359,1051563620,0.366,"4df7599a-680c-452a-b472-2370b8f190a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0001296","myometrium","{}","2020-09-10 17:44:50.208000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ee7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7b8b0be7-184d-4334-88f3-58bf561ce055","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C54.2","Myometrium","pgxbs-kftvhkrj","pgxind-kftx3iyu","pgxcs-kftvxpbi",2201358915,0.766,1070011772,0.372,1131347143,0.394,"7b8b0be7-184d-4334-88f3-58bf561ce055","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0001296","myometrium","{}","2020-09-10 17:44:50.262000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1000","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e84cc153-84e6-4a2f-93bd-082169b4fd5c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhl4b","pgxind-kftx3jd4","pgxcs-kftvxtba",2532578540,0.881,613839507,0.214,1918739033,0.667,"e84cc153-84e6-4a2f-93bd-082169b4fd5c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.657000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a101c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bbde8af5-f8d9-4d21-bb26-6486435f0f5a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhl5l","pgxind-kftx3jei","pgxcs-kftvxtrm",414834776,0.144,290223470,0.101,124611306,0.043,"bbde8af5-f8d9-4d21-bb26-6486435f0f5a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:50.697000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1033","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-42e7b86b-5089-4042-b0df-ebc37290dcf1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhl6n","pgxind-kftx3jfl","pgxcs-kftvxu2m",1962735786,0.683,807113337,0.281,1155622449,0.402,"42e7b86b-5089-4042-b0df-ebc37290dcf1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:50.729000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1035","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7cc6eb42-fac5-48c6-a2ee-5bc49d0b3f8f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhl6r","pgxind-kftx3jfp","pgxcs-kftvxu3l",290483309,0.101,265128096,0.092,25355213,0.009,"7cc6eb42-fac5-48c6-a2ee-5bc49d0b3f8f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:50.732000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a107d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-03a583f8-5976-4f26-a074-a9d058138447","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhla0","pgxind-kftx3jj4","pgxcs-kftvxv4k",1568360375,0.546,968709179,0.337,599651196,0.209,"03a583f8-5976-4f26-a074-a9d058138447","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:50.832000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a10a7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a868d01c-7148-418a-b36c-808dbc7e068d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhlbw","pgxind-kftx3jlb","pgxcs-kftvxvpb",1632152958,0.568,798941967,0.278,833210991,0.29,"a868d01c-7148-418a-b36c-808dbc7e068d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:50.891000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1100","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ccba79c4-8873-478a-ad99-0db99c034a91","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C48.0","Retroperitoneum","pgxbs-kftvhlfx","pgxind-kftx3jpf","pgxcs-kftvxwyd",1856577719,0.646,758072955,0.264,1098504764,0.382,"ccba79c4-8873-478a-ad99-0db99c034a91","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:51.015000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1142","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-023378d5-5729-407a-9633-9f4dee67c869","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhliw","pgxind-kftx3jso","pgxcs-kftvxxwg",1256695339,0.437,553842156,0.193,702853183,0.244,"023378d5-5729-407a-9633-9f4dee67c869","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:51.109000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1200","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-9947f0b3-1a35-4370-ad31-633b0740b0bf","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhlrh","pgxind-kftx3k1s","pgxcs-kftvy0l0",1936083208,0.673,890893148,0.31,1045190060,0.364,"9947f0b3-1a35-4370-ad31-633b0740b0bf","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:51.376000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1314","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-64235d51-b1b8-46ab-87ef-a7caeb394a6d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhm41","pgxind-kftx3kec","pgxcs-kftvy4hr",1623611185,0.565,655490778,0.228,968120407,0.337,"64235d51-b1b8-46ab-87ef-a7caeb394a6d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:51.763000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1342","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1ecbab38-1736-465c-9ee2-bf39706c9663","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhm65","pgxind-kftx3hkn","pgxcs-kftvy56y",1678950266,0.584,813880657,0.283,865069609,0.301,"1ecbab38-1736-465c-9ee2-bf39706c9663","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:51.829000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1416","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c3c63af2-7525-46b9-bd01-8509f3c081f8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhmfr","pgxind-kftx3kzd","pgxcs-kftvy89b",1593166897,0.554,862340604,0.3,730826293,0.254,"c3c63af2-7525-46b9-bd01-8509f3c081f8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:52.129000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1428","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-18258ddc-34e3-4590-87e7-c11d7a41d0d3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhmgk","pgxind-kftx3l08","pgxcs-kftvy8kw",2109282403,0.734,1351543752,0.47,757738651,0.264,"18258ddc-34e3-4590-87e7-c11d7a41d0d3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:52.155000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1597","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-29928748-9899-49b8-8830-da26ecd88e0e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhmx4","pgxind-kftx3ga2","pgxcs-kftvydsr",2507767300,0.872,1358335062,0.472,1149432238,0.4,"29928748-9899-49b8-8830-da26ecd88e0e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:52.671000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a15b1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-08011518-9de2-4be0-b0eb-72f099bb7e9f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhmyb","pgxind-kftx3liq","pgxcs-kftvye5d",1353698918,0.471,677700175,0.236,675998743,0.235,"08011518-9de2-4be0-b0eb-72f099bb7e9f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:52.708000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a15e7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ed0e5f9d-7df8-4af8-9916-d30139a9b807","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhn0s","pgxind-kftx3ll8","pgxcs-kftvyey5",781156377,0.272,429738676,0.149,351417701,0.122,"ed0e5f9d-7df8-4af8-9916-d30139a9b807","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:52.783000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a170b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7328589c-0287-4784-83a6-4bd0cd072d1c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhne0","pgxind-kftx3ly6","pgxcs-kftvyj38",1741621068,0.606,593941286,0.207,1147679782,0.399,"7328589c-0287-4784-83a6-4bd0cd072d1c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:53.192000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a196e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-eaf6c1e3-0365-4f55-ba58-7353a6703116","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvho5w","pgxind-kftx3mp2","pgxcs-kftvyrs2",669479035,0.233,461327549,0.16,208151486,0.072,"eaf6c1e3-0365-4f55-ba58-7353a6703116","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:54.057000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a198d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8549c8fa-ef3e-451a-8d20-f13249d8cc47","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvho7b","pgxind-kftx3mqf","pgxcs-kftvys7l",2198576404,0.765,686568928,0.239,1512007476,0.526,"8549c8fa-ef3e-451a-8d20-f13249d8cc47","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:54.102000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1b45","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8eacd13b-b2d6-4002-a22d-26fe426e47ab","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhord","pgxind-kftx3n89","pgxcs-kftvyyll",1465337136,0.51,658891199,0.229,806445937,0.281,"8eacd13b-b2d6-4002-a22d-26fe426e47ab","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:54.728000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1bd3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-467e7743-8c7e-4a22-ace1-492a9bc17a89","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhoxs","pgxind-kftx3ne8","pgxcs-kftvz0nn",1964219009,0.683,1155524307,0.402,808694702,0.281,"467e7743-8c7e-4a22-ace1-492a9bc17a89","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:54.927000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c1f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-310b09b7-7762-40a9-aefa-b356c6341cf5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhp19","pgxind-kftx3nhd","pgxcs-kftvz1r4",2255408622,0.784,1031103671,0.359,1224304951,0.426,"310b09b7-7762-40a9-aefa-b356c6341cf5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:55.038000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c50","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e7e97623-5c8a-42b4-abc6-e7b424816713","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhp3h","pgxind-kftx3njb","pgxcs-kftvz2f8",2372709797,0.825,754953189,0.263,1617756608,0.563,"e7e97623-5c8a-42b4-abc6-e7b424816713","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:55.109000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c6b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-80690d38-0d5c-4f52-8aad-110769f818c3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhp4p","pgxind-kftx3nkh","pgxcs-kftvz2uu",1784459822,0.621,884900189,0.308,899559633,0.313,"80690d38-0d5c-4f52-8aad-110769f818c3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:55.148000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1cc0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8faedd92-d7fa-452a-8210-741118e516f7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","Ovary","pgxbs-kftvhp8j","pgxind-kftx3nnv","pgxcs-kftvz42w",1079560707,0.375,672652421,0.234,406908286,0.142,"8faedd92-d7fa-452a-8210-741118e516f7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000992","ovary","{}","2020-09-10 17:44:55.269000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1db3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-94b19fa7-a291-4ffd-a4e0-4d3e2f48da1d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhpjm","pgxind-kftx3nxp","pgxcs-kftvz7ha",1690009562,0.588,767453634,0.267,922555928,0.321,"94b19fa7-a291-4ffd-a4e0-4d3e2f48da1d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:55.616000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1ec5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-42a7c11e-04e9-4403-9ba9-9dd44b77c90f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhpw3","pgxind-kftx3o9a","pgxcs-kftvzbg9",2452036860,0.853,872108250,0.303,1579928610,0.55,"42a7c11e-04e9-4403-9ba9-9dd44b77c90f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:56.005000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1efe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f64f2f08-7f2a-44a2-a1a6-90a77dc43d06","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhpyp","pgxind-kftx3obp","pgxcs-kftvzc8n",1225271966,0.426,501218411,0.174,724053555,0.252,"f64f2f08-7f2a-44a2-a1a6-90a77dc43d06","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:56.085000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1fce","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-926c06e9-448d-44c2-be23-d3b62cc14c6b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvhq86","pgxind-kftx3ojg","pgxcs-kftvzfab",1309645973,0.456,596652120,0.208,712993853,0.248,"926c06e9-448d-44c2-be23-d3b62cc14c6b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:44:56.375000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a200e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a60b467b-e29d-4ac0-a221-dae30011a183","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhqb4","pgxind-kftx3olq","pgxcs-kftvzg5o",1770340748,0.616,625626667,0.218,1144714081,0.398,"a60b467b-e29d-4ac0-a221-dae30011a183","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:56.464000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a201e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-892e17af-42c6-437a-8816-0441e56362a4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhqbu","pgxind-kftx3omc","pgxcs-kftvzggl",2278794249,0.793,925742913,0.322,1353051336,0.471,"892e17af-42c6-437a-8816-0441e56362a4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:56.486000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2089","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4421de00-0d62-42d7-a8ca-1c8ab38d1c57","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhqgs","pgxind-kftx3gid","pgxcs-kftvzhzs",2223101027,0.773,1179292380,0.41,1043808647,0.363,"4421de00-0d62-42d7-a8ca-1c8ab38d1c57","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:56.636000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a21c0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ea02c527-63bd-4793-98c3-86025d2bf13d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhquw","pgxind-kftx3gbs","pgxcs-kftvzmgd",2015489359,0.701,1063566593,0.37,951922766,0.331,"ea02c527-63bd-4793-98c3-86025d2bf13d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:57.075000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a224b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Recurrent Tumor","TCGA-b9221759-78fd-4d62-9f55-f7e3d06e02c3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhr15","pgxind-kftx3p5e","pgxcs-kftvzohu",2172502186,0.756,1007807168,0.351,1164695018,0.405,"b9221759-78fd-4d62-9f55-f7e3d06e02c3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:57.275000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2254","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-2de5878a-85d4-4a26-9e7d-8d0834cb72ec","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhr1k","pgxind-kftx3p5u","pgxcs-kftvzom8",1144287858,0.398,470210650,0.164,674077208,0.234,"2de5878a-85d4-4a26-9e7d-8d0834cb72ec","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:57.288000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a237d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-cae57e14-aca3-4c70-9ee2-6c786dc87c5a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhrf2","pgxind-kftx3pgx","pgxcs-kftvzsuh",1625268117,0.565,969913106,0.337,655355011,0.228,"cae57e14-aca3-4c70-9ee2-6c786dc87c5a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:57.705000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a23e4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-07a15d4d-8902-4a54-a053-2fd306e44456","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhrjq","pgxind-kftx3pki","pgxcs-kftvzuds",1417364476,0.493,518195134,0.18,899169342,0.313,"07a15d4d-8902-4a54-a053-2fd306e44456","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:57.850000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2466","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1857e1ed-2584-4b12-b889-791caf08dc5e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhrpm","pgxind-kftx3jr9","pgxcs-kftvzw7l",2675995118,0.931,686011335,0.239,1989983783,0.692,"1857e1ed-2584-4b12-b889-791caf08dc5e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:58.032000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a259b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-910cd9b0-5bbe-47e5-8f4c-a6e8aa580281","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhs3r","pgxind-kftx3pzd","pgxcs-kftw00rv",1895533745,0.659,852648054,0.297,1042885691,0.363,"910cd9b0-5bbe-47e5-8f4c-a6e8aa580281","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.467000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a25b8","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-50906d74-4ce3-4e48-a0fd-605a80ed0f32","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhs51","pgxind-kftx3pjw","pgxcs-kftw015t",1527475518,0.531,889324684,0.309,638150834,0.222,"50906d74-4ce3-4e48-a0fd-605a80ed0f32","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.509000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a25bf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-01d4c0b5-ba01-4672-82f0-66a7bd5d0073","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhs5d","pgxind-kftx3hg3","pgxcs-kftw0198",859186056,0.299,624932249,0.217,234253807,0.081,"01d4c0b5-ba01-4672-82f0-66a7bd5d0073","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.520000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2669","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a75f6d0f-1977-4d64-9e79-c100b471b272","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.8","Overlapping lesion of connective, subcutaneous and other soft tissues","pgxbs-kftvhsd2","pgxind-kftx3q69","pgxcs-kftw03q5",367567809,0.128,340261122,0.118,27306687,0.009,"a75f6d0f-1977-4d64-9e79-c100b471b272","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:58.760000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a268e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-83587c69-b0a0-4e1d-9522-0a580a2467cd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhser","pgxind-kftx3p5e","pgxcs-kftw04b1",735609316,0.256,290659677,0.101,444949639,0.155,"83587c69-b0a0-4e1d-9522-0a580a2467cd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.812000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a26d4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-34835d28-928d-4853-a55d-76a574277355","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhshx","pgxind-kftx3q9s","pgxcs-kftw059x",346258477,0.12,306820817,0.107,39437660,0.014,"34835d28-928d-4853-a55d-76a574277355","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:58.910000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a28e5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e9c18a21-a583-4031-80d6-4abc8c67fc28","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvht5y","pgxind-kftx3mr1","pgxcs-kftw0czs",639079209,0.223,284522095,0.099,354557113,0.123,"e9c18a21-a583-4031-80d6-4abc8c67fc28","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:59.659000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported","pgxcs-kftw4bgx",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2954","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d6dd84fa-2295-4b22-8a12-13e8da9cf3a9","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhtb0","pgxind-kftx3qul","pgxcs-kftw0en1",1899472626,0.661,724706206,0.252,1174766420,0.409,"d6dd84fa-2295-4b22-8a12-13e8da9cf3a9","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:59.815000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2a1a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1bd6b341-57ee-4a60-a69b-0822550ba6d1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhtjx","pgxind-kftx3r0s","pgxcs-kftw0hic",1834673664,0.638,876187365,0.305,958486299,0.333,"1bd6b341-57ee-4a60-a69b-0822550ba6d1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:00.092000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2a48","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3328fb12-bf55-4f73-87e8-902249996a62","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtlz","pgxind-kftx3r2p","pgxcs-kftw0i8q",1653471568,0.575,783603744,0.273,869867824,0.303,"3328fb12-bf55-4f73-87e8-902249996a62","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.156000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b16","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3e8c0319-b011-4030-b0d4-3ea2f48fe7d8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtvd","pgxind-kftx3q1c","pgxcs-kftw0l73",1787739569,0.622,857806175,0.298,929933394,0.323,"3e8c0319-b011-4030-b0d4-3ea2f48fe7d8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.446000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b17","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5666b6b0-84b1-4a95-a8a6-43d61d0930e1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvhtve","pgxind-kftx3r8o","pgxcs-kftw0l7k",957692326,0.333,547842554,0.191,409849772,0.143,"5666b6b0-84b1-4a95-a8a6-43d61d0930e1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:00.448000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b51","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0f2659dc-b65f-440d-a0a8-aefa23363346","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhty1","pgxind-kftx3f7e","pgxcs-kftw0m2r",2369600549,0.824,612154060,0.213,1757446489,0.611,"0f2659dc-b65f-440d-a0a8-aefa23363346","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:00.529000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b5d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f0a72e67-1bdb-4561-9826-af117c53bbf2","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtyk","pgxind-kftx3qqr","pgxcs-kftw0m8m",2404661523,0.836,1383635658,0.481,1021025865,0.355,"f0a72e67-1bdb-4561-9826-af117c53bbf2","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.547000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b63","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3db0de29-f0a6-4cea-bec5-22164e795a43","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhtyu","pgxind-kftx3g3l","pgxcs-kftw0mbk",585203495,0.204,402932940,0.14,182270555,0.063,"3db0de29-f0a6-4cea-bec5-22164e795a43","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:00.555000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2dd3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Recurrent Tumor","TCGA-359fec0b-7bc1-4bb4-a9d9-11eea9366ac6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhv0g","pgxind-kftx3g3l","pgxcs-kftw0vdu",671910185,0.234,469355779,0.163,202554406,0.07,"359fec0b-7bc1-4bb4-a9d9-11eea9366ac6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:01.437000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2dd6","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a1b3e6c9-9503-49a6-91c1-d57ced424229","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.4","Connective, Subcutaneous and other soft tissues of abdomen","pgxbs-kftvhv0l","pgxind-kftx3rs6","pgxcs-kftw0vft",558401701,0.194,445249868,0.155,113151833,0.039,"a1b3e6c9-9503-49a6-91c1-d57ced424229","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:45:01.441000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2de0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-254a48ae-81ee-4334-805c-3aa2a90d1c47","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhv12","pgxind-kftx3o6x","pgxcs-kftw0vkn",1985556902,0.691,909005905,0.316,1076550997,0.374,"254a48ae-81ee-4334-805c-3aa2a90d1c47","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:01.455000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2e08","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3f0974a2-b39b-4265-b1f9-e7d8c54cbac5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhv2v","pgxind-kftx3gso","pgxcs-kftw0w7d",2747302698,0.956,1708371712,0.594,1038930986,0.361,"3f0974a2-b39b-4265-b1f9-e7d8c54cbac5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:01.513000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2e25","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-cb6ac223-425a-430b-b44b-4a127757621d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhv46","pgxind-kftx3run","pgxcs-kftw0wlt",2023336423,0.704,1002227629,0.349,1021108794,0.355,"cb6ac223-425a-430b-b44b-4a127757621d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:01.555000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2e98","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-64db482b-943a-42f4-9af9-03d1704cd9da","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhv9c","pgxind-kftx3gd3","pgxcs-kftw0y98",536976783,0.187,213389539,0.074,323587244,0.113,"64db482b-943a-42f4-9af9-03d1704cd9da","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:01.715000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2f26","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-901dfd62-799d-4e40-926e-22a5fd859b5a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhvfq","pgxind-kftx3rrq","pgxcs-kftw10bi",1519087533,0.528,703931229,0.245,815156304,0.284,"901dfd62-799d-4e40-926e-22a5fd859b5a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:01.916000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2f39","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-40fc700c-6348-4fb6-88ea-95e5b61196b2","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhvgk","pgxind-kftx3rr2","pgxcs-kftw10kp",489484271,0.17,384013775,0.134,105470496,0.037,"40fc700c-6348-4fb6-88ea-95e5b61196b2","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:01.942000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a3234","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-544d66c8-2e7b-4234-aefd-deb441e3b28e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhwf7","pgxind-kftx3soh","pgxcs-kftw1bl0",668646586,0.233,387465960,0.135,281180626,0.098,"544d66c8-2e7b-4234-aefd-deb441e3b28e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:03.013000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a32ea","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-9963da13-6ea7-48a3-a3de-1c6a38f977b9","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhwnh","pgxind-kftx3stl","pgxcs-kftw1e75",225084879,0.078,190179036,0.066,34905843,0.012,"9963da13-6ea7-48a3-a3de-1c6a38f977b9","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:03.271000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a330b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ceeba881-5a1d-4fdc-8c9d-d60b3facecf2","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhwp1","pgxind-kftx3sug","pgxcs-kftw1emx",2491265552,0.867,733481110,0.255,1757784442,0.611,"ceeba881-5a1d-4fdc-8c9d-d60b3facecf2","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:03.316000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a33c4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-153bf526-77df-46a0-b890-57e2d57a50f4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhwxc","pgxind-kftx3syh","pgxcs-kftw1hb8",206408015,0.072,206238556,0.072,169459,0,"153bf526-77df-46a0-b890-57e2d57a50f4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:03.578000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a3405","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e17a6932-a117-4877-aa31-6b813d953823","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhx0b","pgxind-kftx3nb5","pgxcs-kftw1ia3",230601570,0.08,194077022,0.068,36524548,0.013,"e17a6932-a117-4877-aa31-6b813d953823","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:03.669000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a34a9","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5f5ead4e-89be-4438-a32d-52aa089da9ac","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhx7r","pgxind-kftx3rdq","pgxcs-kftw1kp8",704276543,0.245,507600360,0.177,196676183,0.068,"5f5ead4e-89be-4438-a32d-52aa089da9ac","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:03.899000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a34c7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Metastatic","TCGA-17a09318-d777-4b79-b321-faa8fc4b0153","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhx93","pgxind-kftx3k1s","pgxcs-kftw1l3s",1485703743,0.517,866520354,0.301,619183389,0.215,"17a09318-d777-4b79-b321-faa8fc4b0153","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:03.941000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3641","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-61d4dff3-db42-43cf-a8c4-72cb4719d7be","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhxq4","pgxind-kftx3iqo","pgxcs-kftw1qkw",1093654171,0.38,661688740,0.23,431965431,0.15,"61d4dff3-db42-43cf-a8c4-72cb4719d7be","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:04.824000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3778","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8cb1ebb2-30e4-4cc8-a221-9bcf1867176b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhy46","pgxind-kftx3imc","pgxcs-kftw1v1h",1514837030,0.527,557887027,0.194,956950003,0.333,"8cb1ebb2-30e4-4cc8-a221-9bcf1867176b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:45:05.261000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a37a7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Recurrent Tumor","TCGA-82bae7ab-9577-43ea-978b-d0d31fb5eca8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhy6b","pgxind-kftx3obp","pgxcs-kftw1vqq",1012200121,0.352,470224515,0.164,541975606,0.189,"82bae7ab-9577-43ea-978b-d0d31fb5eca8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:05.326000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3818","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8c227ef2-2f70-4143-81d9-de2fb8ef9607","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhybg","pgxind-kftx3tqo","pgxcs-kftw1xc4",1938681113,0.674,1300282757,0.452,638398356,0.222,"8c227ef2-2f70-4143-81d9-de2fb8ef9607","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:05.485000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a38d7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-94c1cb38-5eca-402d-867b-ab3fe7c30a74","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhyk2","pgxind-kftx3tv2","pgxcs-kftw202y",1618297303,0.563,446935417,0.155,1171361886,0.407,"94c1cb38-5eca-402d-867b-ab3fe7c30a74","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:05.753000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3951","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1d7c6c1d-8b93-48c4-9e7f-496331430a47","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhypj","pgxind-kftx3txf","pgxcs-kftw21wp",967767867,0.337,490394534,0.171,477373333,0.166,"1d7c6c1d-8b93-48c4-9e7f-496331430a47","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:05.925000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3965","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5bd8ce88-7364-4dcf-bc4b-ac5c9f3fef4c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhyqf","pgxind-kftx3ty1","pgxcs-kftw226s",738122248,0.257,629613940,0.219,108508308,0.038,"5bd8ce88-7364-4dcf-bc4b-ac5c9f3fef4c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:05.953000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3a66","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-976afd99-08ba-440d-8ecd-9918ae4279cb","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhz23","pgxind-kftx3str","pgxcs-kftw25wz",2219487939,0.772,1121321247,0.39,1098166692,0.382,"976afd99-08ba-440d-8ecd-9918ae4279cb","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:06.315000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3abe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-34b60937-76b3-401c-a8dd-3f78e2b20a38","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhz63","pgxind-kftx3sjv","pgxcs-kftw277k",1835878933,0.639,848862528,0.295,987016405,0.343,"34b60937-76b3-401c-a8dd-3f78e2b20a38","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:06.438000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3bbf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c0327a7b-4afa-47b5-91b8-93162b16e144","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhzhs","pgxind-kftx3qtc","pgxcs-kftw2aya",1883684534,0.655,770041072,0.268,1113643462,0.387,"c0327a7b-4afa-47b5-91b8-93162b16e144","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.801000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3c80","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e2a08e48-2ebe-4de3-85ac-47dc7a412a9e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhzqh","pgxind-kftx3ntq","pgxcs-kftw2dqr",619689913,0.216,438302817,0.152,181387096,0.063,"e2a08e48-2ebe-4de3-85ac-47dc7a412a9e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:07.072000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d17","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d7fe16e1-e892-4a4c-a491-1a6cded8467a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhzxb","pgxind-kftx3rpf","pgxcs-kftw2fze",2072758031,0.721,1273000571,0.443,799757460,0.278,"d7fe16e1-e892-4a4c-a491-1a6cded8467a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.287000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d32","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ddeae3ba-7bf7-42f1-879f-c4bec9e2d318","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhzyj","pgxind-kftx3ugf","pgxcs-kftw2gch",1947776504,0.677,809602910,0.282,1138173594,0.396,"ddeae3ba-7bf7-42f1-879f-c4bec9e2d318","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.324000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d99","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0e5df0a8-ad22-4e91-9190-11d0ca9c86c1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi037","pgxind-kftx3r5b","pgxcs-kftw2hsy",2074585435,0.722,1132804012,0.394,941781423,0.328,"0e5df0a8-ad22-4e91-9190-11d0ca9c86c1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.472000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3dd7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-943d3db6-7f56-4be1-8f67-33c2c1c02f0a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3701","Myxoid Leiomyosarcoma","icdom-88963","Myxoid leiomyosarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi05z","pgxind-kftx3i3e","pgxcs-kftw2ipq",1649656971,0.574,823658675,0.286,825998296,0.287,"943d3db6-7f56-4be1-8f67-33c2c1c02f0a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:07.559000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3eb5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-52254562-f812-4023-bb00-55e2d766eadb","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi0fz","pgxind-kftx3unp","pgxcs-kftw2lyu",2146979987,0.747,913527427,0.318,1233452560,0.429,"52254562-f812-4023-bb00-55e2d766eadb","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:07.869000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3edc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ddc3d466-4e2b-4e0f-a123-3d7e7fb94508","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi0hs","pgxind-kftx3p8n","pgxcs-kftw2mhr",1572587273,0.547,448428576,0.156,1124158697,0.391,"ddc3d466-4e2b-4e0f-a123-3d7e7fb94508","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:07.924000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3fbb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d22369d7-9f7a-4e54-badc-6c800eeb7e4c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi0rx","pgxind-kftx3us1","pgxcs-kftw2pqp",2581050945,0.898,1346262572,0.468,1234788373,0.429,"d22369d7-9f7a-4e54-badc-6c800eeb7e4c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:08.234000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a405d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-15811e5d-9d25-4562-b902-ccb24a1a97cf","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi0za","pgxind-kftx3ijh","pgxcs-kftw2s3q",1482090267,0.516,421529663,0.147,1060560604,0.369,"15811e5d-9d25-4562-b902-ccb24a1a97cf","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:08.461000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a40bd","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5a234a83-b7e4-4282-a8c2-f74daf2c1d4d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi13l","pgxind-kftx3uw3","pgxcs-kftw2th5",2576339639,0.896,1180880938,0.411,1395458701,0.485,"5a234a83-b7e4-4282-a8c2-f74daf2c1d4d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:08.595000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a40f4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5ff35d01-c4ab-408a-92cb-422aa4b3b4b5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi162","pgxind-kftx3ux4","pgxcs-kftw2u8v",1808681213,0.629,863740766,0.3,944940447,0.329,"5ff35d01-c4ab-408a-92cb-422aa4b3b4b5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:08.671000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a421c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5a9ebcfd-6f27-4c33-9da5-661ac5e7814e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi1jh","pgxind-kftx3v28","pgxcs-kftw2ymg",1121347990,0.39,586922362,0.204,534425628,0.186,"5a9ebcfd-6f27-4c33-9da5-661ac5e7814e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:09.088000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4242","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96d18f04-a2c7-4f86-a648-c18b5796a2a8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi1l7","pgxind-kftx3lg3","pgxcs-kftw2z58",2027103086,0.705,1049223633,0.365,977879453,0.34,"96d18f04-a2c7-4f86-a648-c18b5796a2a8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:09.141000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a42ca","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-414e11c3-8430-49a2-b08c-0b496e336cd7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C40.3","Short bones of lower limb and associated joints","pgxbs-kftvi1rc","pgxind-kftx3pj4","pgxcs-kftw315u",1496943656,0.521,1028040786,0.358,468902870,0.163,"414e11c3-8430-49a2-b08c-0b496e336cd7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0013630","short bone","{}","2020-09-10 17:45:09.331000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a433a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-20f9b5a5-8c63-43be-9247-1ec3f2d07cea","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvi1we","pgxind-kftx3v66","pgxcs-kftw32r3",2633921377,0.916,1200513881,0.418,1433407496,0.499,"20f9b5a5-8c63-43be-9247-1ec3f2d07cea","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:45:09.489000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4351","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e36ce5cc-f8b6-47f8-8102-7a18053d3dfc","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi1xg","pgxind-kftx3fpt","pgxcs-kftw332s",1763938100,0.614,655269016,0.228,1108669084,0.386,"e36ce5cc-f8b6-47f8-8102-7a18053d3dfc","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:09.522000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4359","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3dd4532a-8cfe-4900-8d7e-af4303645705","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi1xt","pgxind-kftx3rck","pgxcs-kftw336o",2228582292,0.775,935651135,0.325,1292931157,0.45,"3dd4532a-8cfe-4900-8d7e-af4303645705","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:09.533000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a447d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-b0969599-1e56-489e-ad92-97fac0754a24","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi2b3","pgxind-kftx3hu0","pgxcs-kftw37fs",1622814874,0.564,549879572,0.191,1072935302,0.373,"b0969599-1e56-489e-ad92-97fac0754a24","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:09.943000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a453d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ecbc891e-ed99-4541-bda5-ede1f28aba8a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi2jt","pgxind-kftx3vek","pgxcs-kftw3a70",1471574794,0.512,505148002,0.176,966426792,0.336,"ecbc891e-ed99-4541-bda5-ede1f28aba8a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:10.212000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a45e3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d25910e1-1d3d-4499-b914-448141230eb5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi2rb","pgxind-kftx3v6n","pgxcs-kftw3cls",2303219423,0.801,1269720750,0.442,1033498673,0.359,"d25910e1-1d3d-4499-b914-448141230eb5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:10.443000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a45eb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-05fc5924-07b1-422e-9d7c-7c0051f72368","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi2rn","pgxind-kftx3k28","pgxcs-kftw3cpn",1831364177,0.637,960897265,0.334,870466912,0.303,"05fc5924-07b1-422e-9d7c-7c0051f72368","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:10.454000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a466a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4cec0557-6a01-463c-944e-4c11556222c7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi2xf","pgxind-kftx3viy","pgxcs-kftw3ej2",748131071,0.26,516832015,0.18,231299056,0.08,"4cec0557-6a01-463c-944e-4c11556222c7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:10.631000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a46a5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-75b173e9-5215-4e75-b547-5db57d4b0f33","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvi301","pgxind-kftx3s96","pgxcs-kftw3fev",403071824,0.14,276043887,0.096,127027937,0.044,"75b173e9-5215-4e75-b547-5db57d4b0f33","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:10.714000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a470e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-673f7169-6924-42a2-b705-1815d4445044","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi34v","pgxind-kftx3rep","pgxcs-kftw3gx7",2722153331,0.947,824649460,0.287,1897503871,0.66,"673f7169-6924-42a2-b705-1815d4445044","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:10.862000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4796","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-84c516a9-e31e-486b-b6a6-15d6e2a6ce18","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi3b5","pgxind-kftx3no7","pgxcs-kftw3iys",2520073906,0.877,851657612,0.296,1668416294,0.58,"84c516a9-e31e-486b-b6a6-15d6e2a6ce18","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:11.053000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4880","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c9f8d00b-b831-4ce9-9133-9551f03c133f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi3lr","pgxind-kftx3nkj","pgxcs-kftw3me6",757056262,0.263,430516663,0.15,326539599,0.114,"c9f8d00b-b831-4ce9-9133-9551f03c133f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:11.381000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a48b1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c91f6f45-ebfb-45cc-a0dd-9862b375336c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi3nz","pgxind-kftx3vqj","pgxcs-kftw3n28",1924704644,0.669,1088360550,0.379,836344094,0.291,"c91f6f45-ebfb-45cc-a0dd-9862b375336c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:11.450000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a49bd","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96ef5730-651a-4a02-a879-fb5c6bbfff4b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi404","pgxind-kftx3r5t","pgxcs-kftw3qyv",1537157112,0.535,522513538,0.182,1014643574,0.353,"96ef5730-651a-4a02-a879-fb5c6bbfff4b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:11.824000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a49bf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-884945c4-393f-46d2-b23e-edeb096f8b71","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvi408","pgxind-kftx3vtm","pgxcs-kftw3qzv",2064139825,0.718,1127584045,0.392,936555780,0.326,"884945c4-393f-46d2-b23e-edeb096f8b71","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:45:11.826000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4b00","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e8ea3d4d-36e5-460f-a0cf-0f40d9bb0c8f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi4eq","pgxind-kftx3utx","pgxcs-kftw3voh",1942741604,0.676,499541812,0.174,1443199792,0.502,"e8ea3d4d-36e5-460f-a0cf-0f40d9bb0c8f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:12.275000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4b08","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5fe06294-b8b6-4e3f-a6ea-dc981cd9bb05","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi4f3","pgxind-kftx3rs2","pgxcs-kftw3vsf",2339964037,0.814,1280802642,0.445,1059161395,0.368,"5fe06294-b8b6-4e3f-a6ea-dc981cd9bb05","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:12.287000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4baa","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-83b89602-d430-4b8c-b29b-ebdecd9415a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi4mf","pgxind-kftx3vza","pgxcs-kftw3y5x",2658144151,0.925,983499215,0.342,1674644936,0.582,"83b89602-d430-4b8c-b29b-ebdecd9415a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:12.515000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4bbe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bcaea097-8911-4503-8af9-e7e0515d1529","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi4nb","pgxind-kftx3l4q","pgxcs-kftw3yfn",2198804728,0.765,811515192,0.282,1387289536,0.483,"bcaea097-8911-4503-8af9-e7e0515d1529","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:12.542000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4c9e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-32f8354a-7d2f-467b-afed-e7f91369615f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi4xh","pgxind-kftx3nya","pgxcs-kftw41t2",1846789075,0.642,958849074,0.334,887940001,0.309,"32f8354a-7d2f-467b-afed-e7f91369615f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:12.858000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4cfd","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a612b7da-1ddd-4a92-8d9a-674f26f98d8a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi51s","pgxind-kftx3u6d","pgxcs-kftw437v",2242826857,0.78,892251375,0.31,1350575482,0.47,"a612b7da-1ddd-4a92-8d9a-674f26f98d8a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:12.991000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d44","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-030ed394-9316-4ce3-96e3-680e3bcb1595","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi54z","pgxind-kftx3w33","pgxcs-kftw44az",1064166550,0.37,480467380,0.167,583699170,0.203,"030ed394-9316-4ce3-96e3-680e3bcb1595","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:13.091000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d4f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4c93c0a4-73c4-48ef-91e0-40b2143833bc","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi55h","pgxind-kftx3uww","pgxcs-kftw44gu",1807991295,0.629,692376126,0.241,1115615169,0.388,"4c93c0a4-73c4-48ef-91e0-40b2143833bc","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:13.106000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d5d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d49488be-65dd-419f-a768-e60d454417a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi564","pgxind-kftx3tch","pgxcs-kftw44np",1855867186,0.646,804469447,0.28,1051397739,0.366,"d49488be-65dd-419f-a768-e60d454417a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.126000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4ebb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-46be2946-a6f4-426a-a589-3a616cb77eca","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi5lu","pgxind-kftx3sat","pgxcs-kftw49tj",1940428698,0.675,822175370,0.286,1118253328,0.389,"46be2946-a6f4-426a-a589-3a616cb77eca","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.613000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4f12","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-80c1a2ac-afff-46c8-b4a6-8f2f46f32211","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi5pw","pgxind-kftx3ts9","pgxcs-kftw4b3a",2099979925,0.73,789924984,0.275,1310054941,0.456,"80c1a2ac-afff-46c8-b4a6-8f2f46f32211","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.735000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a50e5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96403ba9-28a3-4bfd-a53c-6d9ecd05ebb4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi6b4","pgxind-kftx3ueq","pgxcs-kftw4hzf",1633487118,0.568,948924216,0.33,684562902,0.238,"96403ba9-28a3-4bfd-a53c-6d9ecd05ebb4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:14.389000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a510f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-af8434cf-5c2f-48cc-b3ac-132dfb505dbd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi6d1","pgxind-kftx3i3c","pgxcs-kftw4iki",1568328654,0.546,648218419,0.225,920110235,0.32,"af8434cf-5c2f-48cc-b3ac-132dfb505dbd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:14.449000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5118","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-2faec76f-76eb-4beb-9b30-02f8fd087fd7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi6df","pgxind-kftx3fbl","pgxcs-kftw4iox",130866471,0.046,36909719,0.013,93956752,0.033,"2faec76f-76eb-4beb-9b30-02f8fd087fd7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:14.461000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a523a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-567ffcaa-e226-438a-8fb7-184dd6f563ae","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi6ql","pgxind-kftx3ucx","pgxcs-kftw4n0t",1677769074,0.584,769749497,0.268,908019577,0.316,"567ffcaa-e226-438a-8fb7-184dd6f563ae","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:14.876000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a52e8","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1548e53f-f0dd-4a13-825d-093345664406","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi6yg","pgxind-kftx3gp0","pgxcs-kftw4plg",2066011112,0.719,878724821,0.306,1187286291,0.413,"1548e53f-f0dd-4a13-825d-093345664406","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:15.128000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a52f1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7254c2ac-d8ac-4d6e-b444-4cb5f8a6eb36","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi6yv","pgxind-kftx3icq","pgxcs-kftw4ppx",2524011527,0.878,1030425828,0.358,1493585699,0.52,"7254c2ac-d8ac-4d6e-b444-4cb5f8a6eb36","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:15.141000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5381","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a8673ba9-ef34-42ca-a73e-1efb4f186e88","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi75c","pgxind-kftx3j3z","pgxcs-kftw4rte",833885606,0.29,466832458,0.162,367053148,0.128,"a8673ba9-ef34-42ca-a73e-1efb4f186e88","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:15.340000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a539c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-84abf456-ce66-4930-bf43-33141447ce5f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi76k","pgxind-kftx3s7m","pgxcs-kftw4s92",1894614874,0.659,712058566,0.248,1182556308,0.411,"84abf456-ce66-4930-bf43-33141447ce5f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:15.379000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a53ac","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-586f6a69-fcb9-422f-b71e-aa8b2354694f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi77a","pgxind-kftx3w99","pgxcs-kftw4sgv",749436150,0.261,408282718,0.142,341153432,0.119,"586f6a69-fcb9-422f-b71e-aa8b2354694f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:15.401000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5435","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-06990702-c200-403c-ad6f-5cb78a15bf55","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi7dg","pgxind-kftx3i5l","pgxcs-kftw4ufg",1747299411,0.608,693243041,0.241,1054056370,0.367,"06990702-c200-403c-ad6f-5cb78a15bf55","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:15.591000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a54cf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ae587287-a6c6-47b4-ab4d-ec4b9bc59fb9","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi7kg","pgxind-kftx3v4n","pgxcs-kftw4wpr",740135609,0.257,588933106,0.205,151202503,0.053,"ae587287-a6c6-47b4-ab4d-ec4b9bc59fb9","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:15.806000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a566a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-30c8f2c5-9aac-4c5b-b621-31e6c5f3c84d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi83a","pgxind-kftx3spo","pgxcs-kftw52rb",1618952613,0.563,527548684,0.183,1091403929,0.38,"30c8f2c5-9aac-4c5b-b621-31e6c5f3c84d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:16.380000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a570d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-431a0f2f-5cf4-46f5-a32f-60af3851e969","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi8an","pgxind-kftx3i86","pgxcs-kftw554n",1363680542,0.474,572463649,0.199,791216893,0.275,"431a0f2f-5cf4-46f5-a32f-60af3851e969","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:16.608000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a57ca","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1c323559-f2d0-480b-9dab-9ac014fa9c41","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi8j8","pgxind-kftx3t5i","pgxcs-kftw57w0",1066954044,0.371,347971391,0.121,718982653,0.25,"1c323559-f2d0-480b-9dab-9ac014fa9c41","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:16.869000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5839","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-980d8a35-44ef-415f-b7b2-89a4bc18515b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi8o8","pgxind-kftx3pnl","pgxcs-kftw59gp",1705807032,0.593,791809429,0.275,913997603,0.318,"980d8a35-44ef-415f-b7b2-89a4bc18515b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:17.024000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a58ad","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-988185cf-a54c-4335-a4ab-f59ce3a470ea","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C54.9","Corpus uteri","pgxbs-kftvi8tg","pgxind-kftx3vbs","pgxcs-kftw5b7f",2429697265,0.845,636302559,0.221,1793394706,0.624,"988185cf-a54c-4335-a4ab-f59ce3a470ea","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:45:17.189000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5a3c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-784f6b88-9046-4fff-b061-81ee0bb27392","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi9kx","pgxind-kftx3m0j","pgxcs-kftw5gyv",2151668254,0.748,1083826448,0.377,1067841806,0.371,"784f6b88-9046-4fff-b061-81ee0bb27392","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:17.750000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,,
"5c865cb309d374f2dc2fb445","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievq","pgxind-kftx42ok","pgxcs-kftw749p",940263124,0.327,378705952,0.132,561557172,0.195,"PGX_AM_BS_GSM197635","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.088000",,,,,,"P66Y","geo:GSE8046","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM197635","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.9,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865cb309d374f2dc2fb446","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSE8046","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievs","pgxind-kftx42om","pgxcs-kftw74a7",640228838,0.223,345736770,0.12,294492068,0.102,"PGX_AM_BS_GSM198454","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.089000",,,,,,"P65Y","geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198454","","arraymap import",0.6,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865cb309d374f2dc2fb448","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievv","pgxind-kftx42oq","pgxcs-kftw74b5",1679511679,0.584,663457338,0.231,1016054341,0.353,"PGX_AM_BS_GSM198510","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.092000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,,"geo:gsm","geo:GSM198510","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865cb309d374f2dc2fb449","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievx","pgxind-kftx42os","pgxcs-kftw74bn",1559887469,0.543,722728318,0.251,837159151,0.291,"PGX_AM_BS_GSM198600","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.094000",,,,,,,"geo:GSE8046","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198600","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c865cb309d374f2dc2fb44a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievy","pgxind-kftx42ou","pgxcs-kftw74c5",1675245781,0.583,844253896,0.294,830991885,0.289,"PGX_AM_BS_GSM198601","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.095000",,,,,,"P72Y","geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,,"geo:gsm","geo:GSM198601","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865cb309d374f2dc2fb44f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM198668","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftview7","pgxind-kftx42p4","pgxcs-kftw74ek",1534475541,0.534,617963022,0.215,916512519,0.319,"PGX_AM_BS_GSM198668","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.102000",,,,,,,"PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE8046","",,,,,"geo:gpl","geo:GPL2005","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c865cb309d374f2dc2fb454","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewf","pgxind-kftx42pe","pgxcs-kftw74gy",890829903,0.31,483144153,0.168,407685750,0.142,"PGX_AM_BS_GSM198673","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.109000",,,,,,"P68Y","geo:GSE8046","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198673","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865cb309d374f2dc2fb455","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM198674","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewh","pgxind-kftx42pg","pgxcs-kftw74hg",1290218754,0.449,623486605,0.217,666732149,0.232,"PGX_AM_BS_GSM198674","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.111000",,,,,,"P78Y","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE8046","",,,,,"geo:gpl","geo:GPL2005","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865cb309d374f2dc2fb458","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSE8046","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewm","pgxind-kftx42pn","pgxcs-kftw74iw",810088207,0.282,296183381,0.103,513904826,0.179,"PGX_AM_BS_GSM198677","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.115000",,,,,,"P60Y","geo:GPL2005","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198677","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865cb309d374f2dc2fb459","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewn","pgxind-kftx42pp","pgxcs-kftw74je",985382943,0.343,415514970,0.145,569867973,0.198,"PGX_AM_BS_GSM198678","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.116000",,,,,,"P60Y","geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,,"geo:gsm","geo:GSM198678","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865cb309d374f2dc2fb45a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewp","pgxind-kftx42pr","pgxcs-kftw74jv",1171231880,0.407,504390290,0.175,666841590,0.232,"PGX_AM_BS_GSM198679","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.118000",,,,,,"P69Y","geo:GSE8046","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198679","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865da009d374f2dc31626f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6e","pgxind-kftx46q8","pgxcs-kftw84lp",2122922120,0.738,1455589607,0.506,667332513,0.232,"PGX_AM_BS_GSM312349","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.795000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312349","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316274","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312354","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6m","pgxind-kftx46qi","pgxcs-kftw84o3",634980010,0.221,463458840,0.161,171521170,0.06,"PGX_AM_BS_GSM312354","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.802000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316275","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312355","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6o","pgxind-kftx46qk","pgxcs-kftw84ol",705515286,0.245,289640598,0.101,415874688,0.145,"PGX_AM_BS_GSM312355","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.804000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316276","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6q","pgxind-kftx46qm","pgxcs-kftw84p2",1712668274,0.596,746343140,0.26,966325134,0.336,"PGX_AM_BS_GSM312356","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.805000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312356","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316278","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6t","pgxind-kftx46qq","pgxcs-kftw84q0",1806171104,0.628,731301668,0.254,1074869436,0.374,"PGX_AM_BS_GSM312358","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.808000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312358","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316279","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6v","pgxind-kftx46qs","pgxcs-kftw84qi",1628029635,0.566,1128501297,0.393,499528338,0.174,"PGX_AM_BS_GSM312359","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.810000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312359","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc31627b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6y","pgxind-kftx46qw","pgxcs-kftw84tb",2125269965,0.739,1265520484,0.44,859749481,0.299,"PGX_AM_BS_GSM312361","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.813000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM312361","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc31627f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312365","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii74","pgxind-kftx46r4","pgxcs-kftw84va",561122110,0.195,145817058,0.051,415305052,0.144,"PGX_AM_BS_GSM312365","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.818000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12439","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316281","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii77","pgxind-kftx46r8","pgxcs-kftw84w9",447662691,0.156,302836039,0.105,144826652,0.05,"PGX_AM_BS_GSM312367","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.821000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312367","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316288","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312374","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7j","pgxind-kftx46rm","pgxcs-kftw84zm",2429798533,0.845,1492887556,0.519,936910977,0.326,"PGX_AM_BS_GSM312374","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.831000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc31628f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312381","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7u","pgxind-kftx46s0","pgxcs-kftw8530",1461382828,0.508,922115360,0.321,539267468,0.188,"PGX_AM_BS_GSM312381","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.841000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12439","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316290","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7w","pgxind-kftx46s2","pgxcs-kftw853i",1813458566,0.631,783031554,0.272,1030427012,0.358,"PGX_AM_BS_GSM312382","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.842000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312382","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316294","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312386","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii83","pgxind-kftx46sa","pgxcs-kftw855f",752604429,0.262,686347787,0.239,66256642,0.023,"PGX_AM_BS_GSM312386","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.848000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc31629a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSE12439","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8d","pgxind-kftx46sm","pgxcs-kftw858b",1885133806,0.656,943714840,0.328,941418966,0.327,"PGX_AM_BS_GSM312392","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.856000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312392","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc31629f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312397","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8l","pgxind-kftx46sw","pgxcs-kftw85at",2440530047,0.849,1270749807,0.442,1169780240,0.407,"PGX_AM_BS_GSM312397","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.863000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12439","",,,,,"geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8q","pgxind-kftx46t3","pgxcs-kftw85cb",697001109,0.242,572592960,0.199,124408149,0.043,"PGX_AM_BS_GSM312400","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.867000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM312400","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312403","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8v","pgxind-kftx46t9","pgxcs-kftw85dt",1003196336,0.349,490138598,0.17,513057738,0.178,"PGX_AM_BS_GSM312403","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.871000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315235","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8y","pgxind-kftx46td","pgxcs-kftw85er",1448904201,0.504,718746350,0.25,730157851,0.254,"PGX_AM_BS_GSM315235","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.874000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL7203","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315237","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii91","pgxind-kftx46th","pgxcs-kftw85fr",1520315510,0.529,698227293,0.243,822088217,0.286,"PGX_AM_BS_GSM315237","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.877000",,,,,,,"geo:GPL7203","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12439","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162aa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315238","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii93","pgxind-kftx46tj","pgxcs-kftw85g8",1086980978,0.378,627931056,0.218,459049922,0.16,"PGX_AM_BS_GSM315238","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.879000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12439","",,,,,"geo:gpl","geo:GPL7203","","arraymap import",,,,,,,,,,,,,,,,
"5c865da209d374f2dc3162ab","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315239","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii95","pgxind-kftx46tl","pgxcs-kftw85gq",2699662705,0.939,1014365662,0.353,1685297043,0.586,"PGX_AM_BS_GSM315239","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.880000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL7203","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbe09d374f2dc318d1b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322063","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviilu","pgxind-kftx4798","pgxcs-kftw89d4",1603708719,0.558,833238141,0.29,770470578,0.268,"PGX_AM_BS_GSM322063","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.277000",,,,,,,"geo:GPL4091","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12830","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d22","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviim5","pgxind-kftx479m","pgxcs-kftw89gh",1486175803,0.517,860328301,0.299,625847502,0.218,"PGX_AM_BS_GSM322076","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.287000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM322076","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d23","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322077","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviim7","pgxind-kftx479o","pgxcs-kftw89gz",1003604095,0.349,842072053,0.293,161532042,0.056,"PGX_AM_BS_GSM322077","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.289000",,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4091","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE12830","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d24","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322078","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviim8","pgxind-kftx479q","pgxcs-kftw89hg",1008394991,0.351,845384857,0.294,163010134,0.057,"PGX_AM_BS_GSM322078","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.290000",,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4091","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE12830","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d25","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322079","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviima","pgxind-kftx479s","pgxcs-kftw89hy",1511156054,0.526,875068180,0.304,636087874,0.221,"PGX_AM_BS_GSM322079","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.292000",,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12830","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL4091","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d26","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL4091","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimc","pgxind-kftx479u","pgxcs-kftw89ig",1584602300,0.551,869442765,0.302,715159535,0.249,"PGX_AM_BS_GSM322086","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.293000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM322086","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322087","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimd","pgxind-kftx479w","pgxcs-kftw89iy",1356898124,0.472,1010844155,0.352,346053969,0.12,"PGX_AM_BS_GSM322087","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.295000",,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12830","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL4091","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d28","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322088","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimf","pgxind-kftx479y","pgxcs-kftw89jf",1473578856,0.513,1044495155,0.363,429083701,0.149,"PGX_AM_BS_GSM322088","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.296000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4091","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d29","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322089","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimg","pgxind-kftx47a0","pgxcs-kftw89jx",2170434741,0.755,1290913247,0.449,879521494,0.306,"PGX_AM_BS_GSM322089","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.298000",,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4091","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE12830","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d2b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL4091","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimk","pgxind-kftx47a4","pgxcs-kftw89kf",1884082055,0.655,1118815556,0.389,765266499,0.266,"PGX_AM_BS_GSM322090","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.301000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM322090","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a44f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346703","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviip0","pgxind-kftx47d5","pgxcs-kftw8adi",1095664715,0.381,952601038,0.331,143063677,0.05,"PGX_AM_BS_GSM346703","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.377000",,,,,,,"PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE13775","",,,,,"geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a451","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346705","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviip3","pgxind-kftx47d9","pgxcs-kftw8aeh",1296364779,0.451,210511910,0.073,1085852869,0.378,"PGX_AM_BS_GSM346705","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.380000",,,,,,,"PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE13775","",,,,,"geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a452","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviip5","pgxind-kftx47db","pgxcs-kftw8aez",841628626,0.293,609552330,0.212,232076296,0.081,"PGX_AM_BS_GSM346706","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.381000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346706","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a453","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346707","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviip7","pgxind-kftx47dd","pgxcs-kftw8afg",297325895,0.103,1451646,0.001,295874249,0.103,"PGX_AM_BS_GSM346707","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.382000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a455","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSE13775","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipa","pgxind-kftx47dh","pgxcs-kftw8agf",1135153935,0.395,858014736,0.298,277139199,0.096,"PGX_AM_BS_GSM346709","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.385000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346709","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a456","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346710","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipc","pgxind-kftx47dj","pgxcs-kftw8agx",453215778,0.158,3634565,0.001,449581213,0.156,"PGX_AM_BS_GSM346710","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.387000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a458","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346712","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipf","pgxind-kftx47dn","pgxcs-kftw8ahx",91409284,0.032,48858057,0.017,42551227,0.015,"PGX_AM_BS_GSM346712","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.390000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a45b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346715","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipk","pgxind-kftx47dt","pgxcs-kftw8ajf",1424348389,0.495,1275125112,0.444,149223277,0.052,"PGX_AM_BS_GSM346715","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.394000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a45e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346718","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipp","pgxind-kftx47dz","pgxcs-kftw8akx",922697769,0.321,85668314,0.03,837029455,0.291,"PGX_AM_BS_GSM346718","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.398000",,,,,,,"PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE13775","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a45f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipq","pgxind-kftx47e1","pgxcs-kftw8alh",398398385,0.139,384878208,0.134,13520177,0.005,"PGX_AM_BS_GSM346719","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.399000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE13775","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM346719","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a461","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346721","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipu","pgxind-kftx47e5","pgxcs-kftw8amg",1664421599,0.579,1557819036,0.542,106602563,0.037,"PGX_AM_BS_GSM346721","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.402000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a464","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipz","pgxind-kftx47ec","pgxcs-kftw8anx",690685514,0.24,52041419,0.018,638644095,0.222,"PGX_AM_BS_GSM346724","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.406000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM346724","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a465","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiq0","pgxind-kftx47ee","pgxcs-kftw8aof",533817451,0.186,237109717,0.082,296707734,0.103,"PGX_AM_BS_GSM346725","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.408000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"pubmed","geo:gpl","geo:gse","geo:GSE13775","",,,,,"geo:gsm","geo:GSM346725","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a467","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346727","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiq3","pgxind-kftx47ei","pgxcs-kftw8apd",658262265,0.229,299707187,0.104,358555078,0.125,"PGX_AM_BS_GSM346727","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.411000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a468","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346728","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiq5","pgxind-kftx47ek","pgxcs-kftw8apu",377144692,0.131,11197996,0.004,365946696,0.127,"PGX_AM_BS_GSM346728","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.412000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346730","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiq8","pgxind-kftx47eo","pgxcs-kftw8aqt",1156603218,0.402,292481903,0.102,864121315,0.301,"PGX_AM_BS_GSM346730","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.415000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqc","pgxind-kftx47es","pgxcs-kftw8ars",789218621,0.275,458748504,0.16,330470117,0.115,"PGX_AM_BS_GSM346732","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.418000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM346732","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346733","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqd","pgxind-kftx47eu","pgxcs-kftw8asa",778893100,0.271,675419917,0.235,103473183,0.036,"PGX_AM_BS_GSM346733","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.419000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346734","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqf","pgxind-kftx47ew","pgxcs-kftw8ass",841083707,0.293,198860207,0.069,642223500,0.223,"PGX_AM_BS_GSM346734","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.421000",,,,,,,"PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE13775","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a470","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSE13775","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqi","pgxind-kftx47f0","pgxcs-kftw8atr",1005897874,0.35,173282832,0.06,832615042,0.29,"PGX_AM_BS_GSM346736","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.424000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346736","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a473","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSE13775","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqn","pgxind-kftx47f6","pgxcs-kftw8av7",1145351518,0.398,911886247,0.317,233465271,0.081,"PGX_AM_BS_GSM346739","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.428000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346739","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a474","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqp","pgxind-kftx47f8","pgxcs-kftw8avo",1683322260,0.586,295768307,0.103,1387553953,0.483,"PGX_AM_BS_GSM346740","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.429000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","geo:gpl","geo:gse","geo:GSE13775","",,,,,"geo:gsm","geo:GSM346740","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a478","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346744","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqv","pgxind-kftx47fg","pgxcs-kftw8aze",1104219917,0.384,844066867,0.294,260153050,0.09,"PGX_AM_BS_GSM346744","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.435000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865ea909d374f2dc32ee24","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvilws","pgxind-kftx4ayg","pgxcs-kftw96so",556050716,0.193,125063820,0.044,430986896,0.15,"PGX_AM_BS_GSM185087","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:31.636000",,,,,,,"geo:GSE7692","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gse","geo:gpl","geo:GPL4894","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM185087","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0312","",,,,,
"5c865ea909d374f2dc32ee25","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvilwu","pgxind-kftx4ayi","pgxcs-kftw96t6",498756075,0.173,111890630,0.039,386865445,0.135,"PGX_AM_BS_GSM185088","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:31.638000",,,,,,,"geo:GSE7692","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gse","geo:gpl","geo:GPL4894","",,,,,"geo:gsm","geo:GSM185088","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0312","",,,,,
"5c865ead09d374f2dc32eebb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM185262","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvim3o","pgxind-kftx4b70","pgxcs-kftw98yk",369168892,0.128,350358260,0.122,18810632,0.007,"PGX_AM_BS_GSM185262","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:31.851000",,,,,,,"geo:GSE7692","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL4894","",,,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,,
"5c865ead09d374f2dc32eebc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvim3p","pgxind-kftx4b73","pgxcs-kftw98z1",314602355,0.109,270783110,0.094,43819245,0.015,"PGX_AM_BS_GSM185263","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:31.852000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gsm","geo:GSM185263","","arraymap import",,,,,,,,,,,,,,,,
"5c865ead09d374f2dc32eeca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM185277","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvim4d","pgxind-kftx4b7v","pgxcs-kftw995s",34433176,0.012,14880064,0.005,19553112,0.007,"PGX_AM_BS_GSM185277","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:31.871000",,,,,,,"PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","pubmed","geo:gpl","geo:GPL4894","",,,,,"geo:gse","geo:GSE7692","","arraymap import",,,,,,,,,,,,,,,,
"5c865ead09d374f2dc32eecb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM185278","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvim4e","pgxind-kftx4b7x","pgxcs-kftw996a",131701311,0.046,118227279,0.041,13474032,0.005,"PGX_AM_BS_GSM185278","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:31.873000",,,,,,,"geo:GSE7692","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL4894","",,,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,,
"5c865ead09d374f2dc32eece","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvim4j","pgxind-kftx4b83","pgxcs-kftw997p",37410771,0.013,23783884,0.008,13626887,0.005,"PGX_AM_BS_GSM185281","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:31.877000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","geo:gpl","geo:gse","geo:GSE7692","",,,,,"geo:gsm","geo:GSM185281","","arraymap import",,,,,,,,,,,,,,,,
"5c865ead09d374f2dc32eeda","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma [Sacrum]","geo:GSM185311","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvim53","pgxind-kftx4b8s","pgxcs-kftw99di",78850427,0.027,14292699,0.005,64557728,0.022,"PGX_AM_BS_GSM185311","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:31.894000",,,,,,,"PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","pubmed","geo:gpl","geo:GPL4894","",,,,,"geo:gse","geo:GSE7692","","arraymap import",,,,,,,,,,,,,,,,
"5c865eb109d374f2dc32ef7f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-240S]","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvimco","pgxind-kftx4bi2","pgxcs-kftw9bp2",1121069329,0.39,646305059,0.225,474764270,0.165,"PGX_AM_BS_GSM186426","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:32.125000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","cellosaurus","cellosaurus:CVCL_2544","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM186426","",,,,,
"5c865eb109d374f2dc32ef80","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-240S]","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvimcq","pgxind-kftx4bi4","pgxcs-kftw9bpk",1666468642,0.58,941732408,0.328,724736234,0.252,"PGX_AM_BS_GSM186427","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:32.127000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE7692","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM186427","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_2544","",,,,,
"5c865eb109d374f2dc32ef81","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS/NP]","cellosaurus:CVCL_2546","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvimcr","pgxind-kftx4bi6","pgxcs-kftw9bq2",571568539,0.199,119820900,0.042,451747639,0.157,"PGX_AM_BS_GSM186428","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:32.128000",,,,,,,"geo:GSM186428","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL4894","","arraymap import",,,,,,,,,"geo:gse","geo:GSE7692","",,,,,
"5c865eb109d374f2dc32ef82","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS/NP]","cellosaurus:CVCL_2546","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvimct","pgxind-kftx4bi8","pgxcs-kftw9bqk",782596640,0.272,353833613,0.123,428763027,0.149,"PGX_AM_BS_GSM186429","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:32.130000",,,,,,,"geo:GSM186429","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE7692","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL4894","",,,,,
"5c865eb109d374f2dc32ef94","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma [cell line Rh18c]","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvimdm","pgxind-kftx4bj8","pgxcs-kftw9c1h",1537631620,0.535,860854338,0.299,676777282,0.235,"PGX_AM_BS_GSM186447","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.156000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE7692","",,,,,"cellosaurus","cellosaurus:CVCL_DG02","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM186447","",,,,,
"5c865eb109d374f2dc32ef95","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma [cell line Rh18c]","cellosaurus:CVCL_DG02","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvimdo","pgxind-kftx4bja","pgxcs-kftw9c1z",1869065666,0.65,1038104689,0.361,830960977,0.289,"PGX_AM_BS_GSM186448","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.158000",,,,,,,"geo:GSM186448","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gpl","geo:GPL4894","","arraymap import",,,,,,,,,"geo:gse","geo:GSE7692","",,,,,
"5c865eb309d374f2dc32efcf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM186529","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C76.2","abdomen, NOS","pgxbs-kftvimga","pgxind-kftx4bmk","pgxcs-kftw9cub",392935497,0.137,247039608,0.086,145895889,0.051,"PGX_AM_BS_GSM186529","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000916","abdomen","{}","2020-09-10 17:45:32.243000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE7692","",,,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,,
"5c865eb409d374f2dc32efff","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvimih","pgxind-kftx4bpb","pgxcs-kftw9djh",343581316,0.12,250069282,0.087,93512034,0.033,"PGX_AM_BS_GSM186581","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.310000",,,,,,,"geo:GSE7692","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"pubmed","geo:gse","geo:gpl","geo:GPL4894","",,,,,"geo:gsm","geo:GSM186581","","arraymap import",,,,,,,,,,,,,,,,
"5c865eb409d374f2dc32f00c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvimj2","pgxind-kftx4bq1","pgxcs-kftw9dpt",654466399,0.228,540100799,0.188,114365600,0.04,"PGX_AM_BS_GSM186597","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.328000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gsm","geo:GSM186597","","arraymap import",,,,,,,,,,,,,,,,
"5c865eb509d374f2dc32f03c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM186645","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftviml8","pgxind-kftx4bsr","pgxcs-kftw9eda",240581874,0.084,18358391,0.006,222223483,0.077,"PGX_AM_BS_GSM186645","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.395000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE7692","",,,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,,
"5c865eb509d374f2dc32f03d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvimla","pgxind-kftx4bst","pgxcs-kftw9eds",339812170,0.118,0,0,339812170,0.118,"PGX_AM_BS_GSM186646","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.396000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gsm","geo:GSM186646","","arraymap import",,,,,,,,,,,,,,,,
"5c865f1a09d374f2dc33da6c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL2879","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinoi","pgxind-kftx4d4z","pgxcs-kftw9qo1",272880734,0.095,118044460,0.041,154836274,0.054,"PGX_AM_BS_GSM475469","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.608000",,,,,,,"geo:GSE19180","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:24330824","Yang J, Zhao L, Tian W et al. (2013): Correlation of WWOX, RUNX2 and VEGFA...",,,,,"geo:gsm","geo:GSM475469","","arraymap import",,,,,,,,,,,,,,,,
"5c865f1a09d374f2dc33da6e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL2879","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinol","pgxind-kftx4d53","pgxcs-kftw9qn2",1056479349,0.367,925575544,0.322,130903805,0.046,"PGX_AM_BS_GSM475467","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.611000",,,,,,,"geo:GSE19180","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:24330824","Yang J, Zhao L, Tian W et al. (2013): Correlation of WWOX, RUNX2 and VEGFA...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM475467","","arraymap import",,,,,,,,,,,,,,,,
"5c865f1a09d374f2dc33da74","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL2879","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinov","pgxind-kftx4d5f","pgxcs-kftw9qqy",696567989,0.242,398584087,0.139,297983902,0.104,"PGX_AM_BS_GSM475475","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.619000",,,,,,,"geo:GSE19180","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:24330824","Yang J, Zhao L, Tian W et al. (2013): Correlation of WWOX, RUNX2 and VEGFA...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM475475","","arraymap import",,,,,,,,,,,,,,,,
"5c865f1a09d374f2dc33da75","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:24330824","Yang J, Zhao L, Tian W et al. (2013): Correlation of WWOX, RUNX2 and VEGFA...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinox","pgxind-kftx4d5h","pgxcs-kftw9qpz",178124022,0.062,135753813,0.047,42370209,0.015,"PGX_AM_BS_GSM475473","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.620000",,,,,,,"geo:GSE19180","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL2879","",,,,,"geo:gsm","geo:GSM475473","","arraymap import",,,,,,,,,,,,,,,,
"5c865f1f09d374f2dc33e2fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GSE11411","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinqr","pgxind-kftx4d7r","pgxcs-kftw9rd0",1655331216,0.576,686401728,0.239,968929488,0.337,"PGX_AM_BS_GSM287989","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.677000",,,,,,,"geo:GPL4091","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:18698372","Sadikovic B, Yoshimoto M et al. (2008): In vitro analysis of integrated global...",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM287989","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0042","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c865f1f09d374f2dc33e2fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GSM287990","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinqt","pgxind-kftx4d7u","pgxcs-kftw9rdi",1865776283,0.649,725469507,0.252,1140306776,0.397,"PGX_AM_BS_GSM287990","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.678000",,,,,,,"cellosaurus:CVCL_0042","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:18698372","Sadikovic B, Yoshimoto M et al. (2008): In vitro analysis of integrated global...",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE11411","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL4091","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c865fd909d374f2dc35ed04","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM484745","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviq2h","pgxind-kftx4g3k","pgxcs-kftwah3v",598387269,0.208,121321974,0.042,477065295,0.166,"PGX_AM_BS_GSM484745","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:36.691000",,,,,,,"PMID:20197395","Mitchell MA, Johnson JE et al. (2010): Doxorubicin resistance in a novel in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL2005","",,,,,"geo:gse","geo:GSE19449","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865fd909d374f2dc35ed05","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviq2i","pgxind-kftx4g3m","pgxcs-kftwah4c",1446761250,0.503,628127728,0.218,818633522,0.285,"PGX_AM_BS_GSM484746","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:36.693000",,,,,,,"geo:GSE19449","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20197395","Mitchell MA, Johnson JE et al. (2010): Doxorubicin resistance in a novel in...",,,,,"geo:gsm","geo:GSM484746","","arraymap import",0.68,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865fd909d374f2dc35ed06","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM484747","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviq2k","pgxind-kftx4g3o","pgxcs-kftwah4u",899966485,0.313,441489784,0.154,458476701,0.159,"PGX_AM_BS_GSM484747","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:36.694000",,,,,,,"PMID:20197395","Mitchell MA, Johnson JE et al. (2010): Doxorubicin resistance in a novel in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL2005","",,,,,"geo:gse","geo:GSE19449","","arraymap import",0.76,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwo","pgxind-kftx4m28","pgxcs-kftwbyob",520390337,0.181,401613683,0.14,118776654,0.041,"PGX_AM_BS_GSM528893","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.120000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528893","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528894","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwp","pgxind-kftx4m2a","pgxcs-kftwbyos",475419851,0.165,195924110,0.068,279495741,0.097,"PGX_AM_BS_GSM528894","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.122000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.36,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwu","pgxind-kftx4m2h","pgxcs-kftwbyq8",872467567,0.303,554894499,0.193,317573068,0.11,"PGX_AM_BS_GSM528897","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.126000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528897","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuww","pgxind-kftx4m2j","pgxcs-kftwbyqp",622248002,0.216,380966453,0.133,241281549,0.084,"PGX_AM_BS_GSM528898","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.127000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528898","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviux2","pgxind-kftx4m2r","pgxcs-kftwbyuz",1256721844,0.437,672245684,0.234,584476160,0.203,"PGX_AM_BS_GSM528902","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.133000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528902","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aaf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528905","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviux7","pgxind-kftx4m2x","pgxcs-kftwbywf",407930050,0.142,358868276,0.125,49061774,0.017,"PGX_AM_BS_GSM528905","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.137000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxc","pgxind-kftx4m34","pgxcs-kftwbyxw",293098349,0.102,226356690,0.079,66741659,0.023,"PGX_AM_BS_GSM528908","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.142000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528908","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxf","pgxind-kftx4m38","pgxcs-kftwbyyu",799829315,0.278,376057846,0.131,423771469,0.147,"PGX_AM_BS_GSM528910","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.145000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528910","","arraymap import",0.24,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxh","pgxind-kftx4m3a","pgxcs-kftwbyzb",721432721,0.251,257143664,0.089,464289057,0.161,"PGX_AM_BS_GSM528911","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.146000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528911","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxj","pgxind-kftx4m3c","pgxcs-kftwbyzt",897945068,0.312,293403037,0.102,604542031,0.21,"PGX_AM_BS_GSM528912","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.148000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528912","","arraymap import",0.58,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxk","pgxind-kftx4m3e","pgxcs-kftwbz0a",1438950868,0.501,746550317,0.26,692400551,0.241,"PGX_AM_BS_GSM528913","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.149000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528913","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528914","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxm","pgxind-kftx4m3g","pgxcs-kftwbz0s",926470137,0.322,623322151,0.217,303147986,0.105,"PGX_AM_BS_GSM528914","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.151000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5c86618709d374f2dc3b7ab9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxo","pgxind-kftx4m3i","pgxcs-kftwbz19",364377066,0.127,300222129,0.104,64154937,0.022,"PGX_AM_BS_GSM528915","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.152000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528915","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7abb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxr","pgxind-kftx4m3m","pgxcs-kftwbz28",1246886353,0.434,593623791,0.206,653262562,0.227,"PGX_AM_BS_GSM528917","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.155000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528917","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7abc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxt","pgxind-kftx4m3o","pgxcs-kftwbz2p",650159485,0.226,424194664,0.148,225964821,0.079,"PGX_AM_BS_GSM528918","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.156000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528918","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5c86618809d374f2dc3b7acd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuym","pgxind-kftx4m4n","pgxcs-kftwbzav",1397122176,0.486,621179273,0.216,775942903,0.27,"PGX_AM_BS_GSM528935","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.181000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528935","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7ace","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuyn","pgxind-kftx4m4p","pgxcs-kftwbzbd",967629684,0.337,497014426,0.173,470615258,0.164,"PGX_AM_BS_GSM528936","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.182000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528936","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618809d374f2dc3b7acf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuyp","pgxind-kftx4m4r","pgxcs-kftwbzbv",669202016,0.233,344125390,0.12,325076626,0.113,"PGX_AM_BS_GSM528937","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.184000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528937","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7ae0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuzh","pgxind-kftx4m5q","pgxcs-kftwbzve",465872924,0.162,325466229,0.113,140406695,0.049,"PGX_AM_BS_GSM528977","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.209000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528977","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618809d374f2dc3b7ae8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuzu","pgxind-kftx4m66","pgxcs-kftwbzo0",500935780,0.174,447436287,0.156,53499493,0.019,"PGX_AM_BS_GSM528962","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.220000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528962","","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5c86618809d374f2dc3b7ae9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuzw","pgxind-kftx4m68","pgxcs-kftwbzoi",819166493,0.285,674781520,0.235,144384973,0.05,"PGX_AM_BS_GSM528963","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.221000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528963","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7aea","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuzy","pgxind-kftx4m6a","pgxcs-kftwbzoz",516631954,0.18,349850738,0.122,166781216,0.058,"PGX_AM_BS_GSM528964","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.223000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528964","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7aeb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv00","pgxind-kftx4m6c","pgxcs-kftwbzph",422428940,0.147,320500143,0.111,101928797,0.035,"PGX_AM_BS_GSM528965","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.224000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528965","","arraymap import",0.46,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.88,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7aec","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv02","pgxind-kftx4m6e","pgxcs-kftwbzpz",1940276534,0.675,728166677,0.253,1212109857,0.422,"PGX_AM_BS_GSM528966","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.226000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528966","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7aed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv03","pgxind-kftx4m6g","pgxcs-kftwbzqh",1004566582,0.349,467617174,0.163,536949408,0.187,"PGX_AM_BS_GSM528967","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.227000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528967","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7aee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv05","pgxind-kftx4m6i","pgxcs-kftwbzqz",468801618,0.163,336516086,0.117,132285532,0.046,"PGX_AM_BS_GSM528968","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.229000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528968","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7aef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528993","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv07","pgxind-kftx4m6k","pgxcs-kftwc05f",1209459183,0.421,273152361,0.095,936306822,0.326,"PGX_AM_BS_GSM528993","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.230000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618809d374f2dc3b7af0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528970","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv08","pgxind-kftx4m6m","pgxcs-kftwbzry",1861573338,0.648,754558315,0.262,1107015023,0.385,"PGX_AM_BS_GSM528970","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.231000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7af1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528971","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0a","pgxind-kftx4m6o","pgxcs-kftwbzsg",1457744546,0.507,586873049,0.204,870871497,0.303,"PGX_AM_BS_GSM528971","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.233000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618809d374f2dc3b7af2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0c","pgxind-kftx4m6q","pgxcs-kftwbzsy",853463961,0.297,757190300,0.263,96273661,0.033,"PGX_AM_BS_GSM528972","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.234000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528972","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618809d374f2dc3b7af4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528974","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0f","pgxind-kftx4m6u","pgxcs-kftwbztx",1795577072,0.625,1309712400,0.456,485864672,0.169,"PGX_AM_BS_GSM528974","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.237000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL3720","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7af5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528975","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0h","pgxind-kftx4m6w","pgxcs-kftwbzue",1383575015,0.481,535546032,0.186,848028983,0.295,"PGX_AM_BS_GSM528975","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.239000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7af6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528976","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0i","pgxind-kftx4m6y","pgxcs-kftwbzuw",702466648,0.244,414945925,0.144,287520723,0.1,"PGX_AM_BS_GSM528976","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.240000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7af8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528978","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0m","pgxind-kftx4m72","pgxcs-kftwbzvv",557808388,0.194,460905682,0.16,96902706,0.034,"PGX_AM_BS_GSM528978","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.243000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7af9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0n","pgxind-kftx4m74","pgxcs-kftwbzwd",1732308033,0.603,635176287,0.221,1097131746,0.382,"PGX_AM_BS_GSM528979","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.245000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528979","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5c86618809d374f2dc3b7afb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528981","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0r","pgxind-kftx4m78","pgxcs-kftwbzxc",2186446171,0.761,970786114,0.338,1215660057,0.423,"PGX_AM_BS_GSM528981","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.248000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE21123","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7afe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528984","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0w","pgxind-kftx4m7e","pgxcs-kftwbzys",660765058,0.23,438506435,0.153,222258623,0.077,"PGX_AM_BS_GSM528984","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.252000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7aff","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0x","pgxind-kftx4m7g","pgxcs-kftwbzza",1691166097,0.588,771450025,0.268,919716072,0.32,"PGX_AM_BS_GSM528985","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.253000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528985","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b00","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528986","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0z","pgxind-kftx4m7i","pgxcs-kftwc01w",491689290,0.171,330087416,0.115,161601874,0.056,"PGX_AM_BS_GSM528986","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.255000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b01","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv11","pgxind-kftx4m7k","pgxcs-kftwc02f",1825292783,0.635,809964837,0.282,1015327946,0.353,"PGX_AM_BS_GSM528987","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.256000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528987","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b02","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv12","pgxind-kftx4m7n","pgxcs-kftwc03g",1196678462,0.416,549886545,0.191,646791917,0.225,"PGX_AM_BS_GSM528989","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.258000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528989","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b03","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv14","pgxind-kftx4m7p","pgxcs-kftwc03y",1789968933,0.623,875424292,0.304,914544641,0.318,"PGX_AM_BS_GSM528990","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.259000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528990","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b05","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv17","pgxind-kftx4m7t","pgxcs-kftwc04x",989110123,0.344,635347156,0.221,353762967,0.123,"PGX_AM_BS_GSM528992","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.262000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528992","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b06","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv19","pgxind-kftx4m7v","pgxcs-kftwbzrg",1355785207,0.472,618306950,0.215,737478257,0.257,"PGX_AM_BS_GSM528969","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.263000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528969","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b07","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528994","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1b","pgxind-kftx4m7x","pgxcs-kftwc05w",1750658560,0.609,856190758,0.298,894467802,0.311,"PGX_AM_BS_GSM528994","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.265000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1c","pgxind-kftx4m7z","pgxcs-kftwc06e",2306120958,0.802,886774093,0.308,1419346865,0.494,"PGX_AM_BS_GSM528995","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.266000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528995","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b09","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1e","pgxind-kftx4m81","pgxcs-kftwc06w",497948141,0.173,1557173,0.001,496390968,0.173,"PGX_AM_BS_GSM528996","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.268000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528996","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528997","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1f","pgxind-kftx4m83","pgxcs-kftwc07d",1867043815,0.649,976176364,0.34,890867451,0.31,"PGX_AM_BS_GSM528997","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.269000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1h","pgxind-kftx4m85","pgxcs-kftwc07v",2117571983,0.737,1080698475,0.376,1036873508,0.361,"PGX_AM_BS_GSM528998","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.271000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528998","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1k","pgxind-kftx4m89","pgxcs-kftwc08u",1095778207,0.381,540899245,0.188,554878962,0.193,"PGX_AM_BS_GSM529000","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.274000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529000","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529001","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1m","pgxind-kftx4m8b","pgxcs-kftwc09c",1220876441,0.425,613073042,0.213,607803399,0.211,"PGX_AM_BS_GSM529001","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.275000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529002","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1o","pgxind-kftx4m8d","pgxcs-kftwc09t",806234697,0.28,355561074,0.124,450673623,0.157,"PGX_AM_BS_GSM529002","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.277000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b10","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1p","pgxind-kftx4m8f","pgxcs-kftwc0aa",1727542646,0.601,903488830,0.314,824053816,0.287,"PGX_AM_BS_GSM529003","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.278000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529003","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b11","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1r","pgxind-kftx4m8h","pgxcs-kftwc0as",763078032,0.265,577236138,0.201,185841894,0.065,"PGX_AM_BS_GSM529004","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.280000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529004","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b12","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529005","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1s","pgxind-kftx4m8j","pgxcs-kftwc0b9",1420449301,0.494,809528213,0.282,610921088,0.212,"PGX_AM_BS_GSM529005","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.281000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b13","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1u","pgxind-kftx4m8l","pgxcs-kftwc0br",707076141,0.246,526240850,0.183,180835291,0.063,"PGX_AM_BS_GSM529006","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.283000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529006","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b14","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1w","pgxind-kftx4m8n","pgxcs-kftwc0c8",1504605533,0.523,865879366,0.301,638726167,0.222,"PGX_AM_BS_GSM529007","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.284000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529007","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0502","Vietnamese",0.76,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5c86618909d374f2dc3b7b15","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529008","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1y","pgxind-kftx4m8p","pgxcs-kftwc0cq",1102318230,0.383,550560076,0.191,551758154,0.192,"PGX_AM_BS_GSM529008","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.286000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b16","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529009","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1z","pgxind-kftx4m8s","pgxcs-kftwc0d7",380770712,0.132,194061548,0.067,186709164,0.065,"PGX_AM_BS_GSM529009","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.287000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b17","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529010","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv21","pgxind-kftx4m8u","pgxcs-kftwc0dp",1157896915,0.403,579817346,0.202,578079569,0.201,"PGX_AM_BS_GSM529010","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.288000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b18","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv23","pgxind-kftx4m8w","pgxcs-kftwc0e6",1576923678,0.548,889411666,0.309,687512012,0.239,"PGX_AM_BS_GSM529011","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.290000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529011","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b1a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv26","pgxind-kftx4m90","pgxcs-kftwc0f5",358235206,0.125,237422329,0.083,120812877,0.042,"PGX_AM_BS_GSM529013","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.293000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529013","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b1c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv29","pgxind-kftx4m94","pgxcs-kftwc0g5",1073073661,0.373,561027182,0.195,512046479,0.178,"PGX_AM_BS_GSM529015","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.296000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529015","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b1d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2b","pgxind-kftx4m96","pgxcs-kftwc0gm",185668549,0.065,101777999,0.035,83890550,0.029,"PGX_AM_BS_GSM529016","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.298000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529016","","arraymap import",0.24,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b1e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2d","pgxind-kftx4m98","pgxcs-kftwc0h3",1471986858,0.512,642194969,0.223,829791889,0.289,"PGX_AM_BS_GSM529017","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.299000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529017","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b1f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2e","pgxind-kftx4m9a","pgxcs-kftwc0hm",1054925764,0.367,593703640,0.207,461222124,0.16,"PGX_AM_BS_GSM529018","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.301000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529018","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b20","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529019","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2g","pgxind-kftx4m9c","pgxcs-kftwc0i3",1794934108,0.624,978942926,0.341,815991182,0.284,"PGX_AM_BS_GSM529019","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.302000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b22","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529021","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2j","pgxind-kftx4m9g","pgxcs-kftwc0j3",896382609,0.312,620451483,0.216,275931126,0.096,"PGX_AM_BS_GSM529021","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.305000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b23","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529022","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2l","pgxind-kftx4m9i","pgxcs-kftwc0jk",2044828919,0.711,1075418942,0.374,969409977,0.337,"PGX_AM_BS_GSM529022","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.307000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b25","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2o","pgxind-kftx4m9m","pgxcs-kftwc0kk",1312388937,0.456,692273985,0.241,620114952,0.216,"PGX_AM_BS_GSM529024","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.310000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529024","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b26","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2q","pgxind-kftx4m9o","pgxcs-kftwc0l2",785575096,0.273,355971277,0.124,429603819,0.149,"PGX_AM_BS_GSM529025","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.311000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529025","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2r","pgxind-kftx4m9q","pgxcs-kftwc0lj",979023009,0.341,464615561,0.162,514407448,0.179,"PGX_AM_BS_GSM529026","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.313000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529026","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b2a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2w","pgxind-kftx4m9w","pgxcs-kftwc0mz",791776126,0.275,230087262,0.08,561688864,0.195,"PGX_AM_BS_GSM529029","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.317000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529029","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b2f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv34","pgxind-kftx4ma6","pgxcs-kftwc0pd",172126426,0.06,130598697,0.045,41527729,0.014,"PGX_AM_BS_GSM529034","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.324000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529034","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b30","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv36","pgxind-kftx4ma8","pgxcs-kftwc0pv",486690960,0.169,348899174,0.121,137791786,0.048,"PGX_AM_BS_GSM529035","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.326000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529035","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b34","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","geo:GSM529039","","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3c","pgxind-kftx4mag","pgxcs-kftwc0rs",308372997,0.107,235456573,0.082,72916424,0.025,"PGX_AM_BS_GSM529039","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.331000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b3d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529048","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3r","pgxind-kftx4may","pgxcs-kftwc0w4",957599876,0.333,412481912,0.143,545117964,0.19,"PGX_AM_BS_GSM529048","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.344000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b3e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3t","pgxind-kftx4mb0","pgxcs-kftwc0wm",1257349209,0.437,528934984,0.184,728414225,0.253,"PGX_AM_BS_GSM529049","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.345000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529049","","arraymap import",0.58,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b3f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529050","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3v","pgxind-kftx4mb2","pgxcs-kftwc0x3",1864720773,0.649,956500278,0.333,908220495,0.316,"PGX_AM_BS_GSM529050","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.347000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b40","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3w","pgxind-kftx4mb4","pgxcs-kftwc0xl",1769689043,0.616,914620537,0.318,855068506,0.297,"PGX_AM_BS_GSM529051","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.348000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529051","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b41","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3y","pgxind-kftx4mb6","pgxcs-kftwc0y2",1544310096,0.537,694726706,0.242,849583390,0.296,"PGX_AM_BS_GSM529052","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.350000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529052","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b42","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3z","pgxind-kftx4mb9","pgxcs-kftwc0yk",1677421117,0.583,843284351,0.293,834136766,0.29,"PGX_AM_BS_GSM529053","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.351000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529053","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b43","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv41","pgxind-kftx4mbb","pgxcs-kftwc0z2",865325437,0.301,414715579,0.144,450609858,0.157,"PGX_AM_BS_GSM529054","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.353000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529054","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b44","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529055","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv43","pgxind-kftx4mbd","pgxcs-kftwc0zk",1483840337,0.516,710264537,0.247,773575800,0.269,"PGX_AM_BS_GSM529055","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.354000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b45","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv44","pgxind-kftx4mbf","pgxcs-kftwc102",948980411,0.33,426337091,0.148,522643320,0.182,"PGX_AM_BS_GSM529056","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.356000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529056","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b46","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv46","pgxind-kftx4mbh","pgxcs-kftwc10k",1806463114,0.628,960237666,0.334,846225448,0.294,"PGX_AM_BS_GSM529057","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.357000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529057","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.64,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b47","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529058","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv48","pgxind-kftx4mbj","pgxcs-kftwc112",1716942191,0.597,795488582,0.277,921453609,0.321,"PGX_AM_BS_GSM529058","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.359000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b48","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv49","pgxind-kftx4mbl","pgxcs-kftwc11k",1448360581,0.504,760231374,0.264,688129207,0.239,"PGX_AM_BS_GSM529059","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.360000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529059","","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b49","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4b","pgxind-kftx4mbn","pgxcs-kftwc121",1440426837,0.501,820282231,0.285,620144606,0.216,"PGX_AM_BS_GSM529060","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.361000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529060","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b4b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529062","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4e","pgxind-kftx4mbr","pgxcs-kftwc131",1857847184,0.646,845218192,0.294,1012628992,0.352,"PGX_AM_BS_GSM529062","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.364000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.7,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b4c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4g","pgxind-kftx4mbt","pgxcs-kftwc13i",1248462247,0.434,530071661,0.184,718390586,0.25,"PGX_AM_BS_GSM529063","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.366000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529063","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b4e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529065","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4j","pgxind-kftx4mbx","pgxcs-kftwc14h",81440312,0.028,81439502,0.028,810,0,"PGX_AM_BS_GSM529065","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.369000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b4f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4l","pgxind-kftx4mbz","pgxcs-kftwc14y",777998145,0.271,305368680,0.106,472629465,0.164,"PGX_AM_BS_GSM529066","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.370000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529066","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b50","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529067","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4m","pgxind-kftx4mc1","pgxcs-kftwc15g",1123131640,0.391,557475960,0.194,565655680,0.197,"PGX_AM_BS_GSM529067","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.371000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b51","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529068","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4o","pgxind-kftx4mc3","pgxcs-kftwc15z",594029668,0.207,472652016,0.164,121377652,0.042,"PGX_AM_BS_GSM529068","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.373000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b52","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4q","pgxind-kftx4mc5","pgxcs-kftwc16g",1684425282,0.586,821284465,0.286,863140817,0.3,"PGX_AM_BS_GSM529069","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.374000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529069","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b53","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529070","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4r","pgxind-kftx4mc7","pgxcs-kftwc16y",1919288457,0.668,1016722052,0.354,902566405,0.314,"PGX_AM_BS_GSM529070","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.376000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b54","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529071","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4t","pgxind-kftx4mc9","pgxcs-kftwc17g",742449237,0.258,695996398,0.242,46452839,0.016,"PGX_AM_BS_GSM529071","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.377000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b55","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529072","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4u","pgxind-kftx4mcb","pgxcs-kftwc19u",488142916,0.17,268090525,0.093,220052391,0.077,"PGX_AM_BS_GSM529072","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.379000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b57","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529074","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4y","pgxind-kftx4mcg","pgxcs-kftwc1au",1269612963,0.442,607640439,0.211,661972524,0.23,"PGX_AM_BS_GSM529074","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.382000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618b09d374f2dc3b7b5b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv54","pgxind-kftx4mco","pgxcs-kftwc1cs",198071462,0.069,66696661,0.023,131374801,0.046,"PGX_AM_BS_GSM529078","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.387000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529078","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618b09d374f2dc3b7b61","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, biphasic","geo:GSM529084","","pgxfus-0002","no followup status","NCIT:C4279","Biphasic synovial sarcoma","icdom-90433","Synovial sarcoma, biphasic","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv5e","pgxind-kftx4md0","pgxcs-kftwc1fn",32480918,0.011,25813489,0.009,6667429,0.002,"PGX_AM_BS_GSM529084","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.396000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.24,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618b09d374f2dc3b7b6c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv5x","pgxind-kftx4mdn","pgxcs-kftwc1ky",2293915996,0.798,820846179,0.286,1473069817,0.512,"PGX_AM_BS_GSM529095","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.411000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529095","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618f09d374f2dc3b7c3c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528988","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivfh","pgxind-kftx4mpd","pgxcs-kftwc02y",360502068,0.125,352864441,0.123,7637627,0.003,"PGX_AM_BS_GSM528988","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.700000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL3720","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8661b209d374f2dc3c3629","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSM537763","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivk9","pgxind-kftx4mv8","pgxcs-kftwc607",1452887708,0.505,635875243,0.221,817012465,0.284,"PGX_AM_BS_GSM537763","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.850000",,,,,,,"geo:GPL4091","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21530","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","arraymap import",,,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkc","pgxind-kftx4mvc","pgxcs-kftwc5z6",1593367841,0.554,877305721,0.305,716062120,0.249,"PGX_AM_BS_GSM537761","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.852000",,,,,,,"geo:GSE21530","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM537761","","arraymap import",,,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSE21530","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkf","pgxind-kftx4mvg","pgxcs-kftwc60o",1699450864,0.591,699503270,0.243,999947594,0.348,"PGX_AM_BS_GSM537764","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.855000",,,,,,,"geo:GPL4091","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM537764","","arraymap import",,,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkh","pgxind-kftx4mvi","pgxcs-kftwc616",1880479731,0.654,971680735,0.338,908798996,0.316,"PGX_AM_BS_GSM537765","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.857000",,,,,,,"geo:GPL4091","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21530","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM537765","","arraymap import",,,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c3630","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSM537767","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkk","pgxind-kftx4mvm","pgxcs-kftwc626",1667728431,0.58,1001873803,0.348,665854628,0.232,"PGX_AM_BS_GSM537767","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.860000",,,,,,,"geo:GSE21530","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4091","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","arraymap import",,,,,,,,,,,,,,,,
"5c86639c09d374f2dc42ed03","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677364","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1a6","pgxind-kftx4tkb","pgxcs-kftwdufu",2125696396,0.739,1233723893,0.429,891972503,0.31,"PGX_AM_BS_GSM677364","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.938000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed05","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677366","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1aa","pgxind-kftx4tkg","pgxcs-kftwdugu",1591269714,0.553,1103626877,0.384,487642837,0.17,"PGX_AM_BS_GSM677366","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.941000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1af","pgxind-kftx4tkm","pgxcs-kftwduib",1219957412,0.424,645592566,0.225,574364846,0.2,"PGX_AM_BS_GSM677369","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.946000",,,,,,,"geo:GSE27392","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,,"geo:gsm","geo:GSM677369","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed09","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677370","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ag","pgxind-kftx4tko","pgxcs-kftwduit",1521792964,0.529,912305832,0.317,609487132,0.212,"PGX_AM_BS_GSM677370","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.947000",,,,,,,"geo:GPL13190","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677371","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ai","pgxind-kftx4tkq","pgxcs-kftwduja",1229907143,0.428,666964591,0.232,562942552,0.196,"PGX_AM_BS_GSM677371","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.949000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed10","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1as","pgxind-kftx4tl2","pgxcs-kftwduma",1813778781,0.631,1101974797,0.383,711803984,0.248,"PGX_AM_BS_GSM677378","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.958000",,,,,,,"geo:GSE27392","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,,"geo:gsm","geo:GSM677378","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed12","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677380","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1av","pgxind-kftx4tl6","pgxcs-kftwdun9",1589724513,0.553,1020928430,0.355,568796083,0.198,"PGX_AM_BS_GSM677380","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.961000",,,,,,,"geo:GPL13190","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed14","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GPL13190","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ay","pgxind-kftx4tla","pgxcs-kftwduo9",1405962822,0.489,911325044,0.317,494637778,0.172,"PGX_AM_BS_GSM677382","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.964000",,,,,,,"geo:GSE27392","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"geo:gsm","geo:GSM677382","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed1a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677388","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b8","pgxind-kftx4tlm","pgxcs-kftwdut7",1590521397,0.553,1181046780,0.411,409474617,0.142,"PGX_AM_BS_GSM677388","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.973000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86647809d374f2dc47586c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma [p53mut, Li-Fraumeni syndrome]","PMID:22265402","Rausch T, Jones DT et al. (2012): Genome sequencing of pediatric medulloblastoma links...","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj37y","pgxind-kftx4vxz","pgxcs-kftwefjj",1175721932,0.409,857167544,0.298,318554388,0.111,"PGX_AM_BS_GSM847446","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:51.447000",,,,,,,"geo:GSE34323","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,,"geo:gsm","geo:GSM847446","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c86647809d374f2dc47586d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma [p53mut, Li-Fraumeni syndrome]","geo:GSM847447","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj380","pgxind-kftx4vy1","pgxcs-kftwefk1",1426916231,0.496,1020634935,0.355,406281296,0.141,"PGX_AM_BS_GSM847447","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:51.449000",,,,,,,"PMID:22265402","Rausch T, Jones DT et al. (2012): Genome sequencing of pediatric medulloblastoma links...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE34323","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86649c09d374f2dc478e08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-NEP-1]","cellosaurus:CVCL_0631","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj3hr","pgxind-kftx4wa4","pgxcs-kftwej6j",1623257343,0.565,961787230,0.335,661470113,0.23,"PGX_AM_BS_GSM827180","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:51.752000",,,,,,,"geo:GSM827180","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE20306","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,,,
"5c86649c09d374f2dc478e27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","uterine corpus sarcoma [cell line SKN]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvj3j6","pgxind-kftx4wbv","pgxcs-kftwejnv",981668300,0.341,757265608,0.263,224402692,0.078,"PGX_AM_BS_GSM827211","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:45:51.798000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_3167","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0502","Vietnamese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","geo:gsm","geo:GSM827211","",,,,,
"5c86649c09d374f2dc478e29","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","ovarian leiomyosarcoma [cell line RKN]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","ovary","pgxbs-kftvj3j9","pgxind-kftx4wbz","pgxcs-kftwejov",1029523749,0.358,531386605,0.185,498137144,0.173,"PGX_AM_BS_GSM827213","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000992","ovary","{}","2020-09-10 17:45:51.801000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827213","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","cellosaurus","cellosaurus:CVCL_3156","",,,,,
"5c86649e09d374f2dc478e67","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line NY]","cellosaurus:CVCL_1613","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3m4","pgxind-kftx4wqm","pgxcs-kftwekja",1301755987,0.453,616142736,0.214,685613251,0.238,"PGX_AM_BS_GSM827276","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.894000",,,,,,,"geo:GSM827276","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE20306","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.6,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c86649e09d374f2dc478e83","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line A-673]","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj3ne","pgxind-kftx4ws7","pgxcs-kftwekz9",306994337,0.107,162022146,0.056,144972191,0.05,"PGX_AM_BS_GSM827304","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:51.936000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827304","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0080","",,,,,
"5c86649f09d374f2dc478e90","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3o0","pgxind-kftx4wsx","pgxcs-kftwel5m",1573544754,0.547,878480668,0.306,695064086,0.242,"PGX_AM_BS_GSM827317","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.955000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE20306","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827317","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0426","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c86649f09d374f2dc478e92","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3o3","pgxind-kftx4wt1","pgxcs-kftwel6m",701159829,0.244,149451737,0.052,551708092,0.192,"PGX_AM_BS_GSM827319","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.958000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827319","","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.46,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0312","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c86649f09d374f2dc478ea9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line G-292 clone A141B1]","geo:GSM827342","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3p5","pgxind-kftx4wuc","pgxcs-kftwelhr",1094428347,0.381,414193396,0.144,680234951,0.237,"PGX_AM_BS_GSM827342","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.991000",,,,,,,"cellosaurus:CVCL_2909","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE20306","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8664a009d374f2dc478ebb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-312H]","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3pz","pgxind-kftx4wvd","pgxcs-kftwem3v",1152330212,0.401,541748330,0.188,610581882,0.212,"PGX_AM_BS_GSM827383","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.018000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827383","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_2545","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8664a009d374f2dc478ed0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-240S]","cellosaurus:CVCL_2544","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3qy","pgxind-kftx4wwk","pgxcs-kftwem2u",1088898562,0.379,543811560,0.189,545087002,0.19,"PGX_AM_BS_GSM827381","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.049000",,,,,,,"geo:GSM827381","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE20306","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gpl","geo:GPL3720","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8664a009d374f2dc478ed4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS/NP]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3r5","pgxind-kftx4wws","pgxcs-kftwem4u",1429204012,0.497,722386547,0.251,706817465,0.246,"PGX_AM_BS_GSM827385","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.055000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_2546","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827385","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8664a309d374f2dc478f43","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma [cell line GCT]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj3w9","pgxind-kftx4x32","pgxcs-kftwenpi",1222293365,0.425,658195520,0.229,564097845,0.196,"PGX_AM_BS_GSM827496","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:52.218000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_1229","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827496","",,,,,
"5c8664a509d374f2dc478f9f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj40j","pgxind-kftx4x8a","pgxcs-kftwep15",1009270471,0.351,324106722,0.113,685163749,0.238,"PGX_AM_BS_GSM827588","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.354000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_0548","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827588","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8665b209d374f2dc4c82e2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820994","","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6b1","pgxind-kftx501h","pgxcs-kftwfeh4",926026379,0.322,765505189,0.266,160521190,0.056,"PGX_AM_BS_GSM820994","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.914000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82e3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820995","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6b2","pgxind-kftx501j","pgxcs-kftwfehn",756995622,0.263,485437558,0.169,271558064,0.094,"PGX_AM_BS_GSM820995","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.916000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82e5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821019","","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6b6","pgxind-kftx501n","pgxcs-kftwfetq",987162929,0.343,578941164,0.201,408221765,0.142,"PGX_AM_BS_GSM821019","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.919000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82e6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820998","","pgxfus-0002","no followup status","NCIT:C3902","Telangiectatic Osteosarcoma","icdom-91833","Telangiectatic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6b7","pgxind-kftx501p","pgxcs-kftwfej5",1454098868,0.506,755225823,0.263,698873045,0.243,"PGX_AM_BS_GSM820998","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.920000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82e7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6b9","pgxind-kftx501r","pgxcs-kftwfejo",1275360835,0.444,383055586,0.133,892305249,0.31,"PGX_AM_BS_GSM820999","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.921000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM820999","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c8665b209d374f2dc4c82e8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6ba","pgxind-kftx501t","pgxcs-kftwfek5",1166836154,0.406,728889313,0.254,437946841,0.152,"PGX_AM_BS_GSM821000","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.923000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,,"geo:gsm","geo:GSM821000","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82e9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821001","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bc","pgxind-kftx501v","pgxcs-kftwfekn",861053227,0.299,353838660,0.123,507214567,0.176,"PGX_AM_BS_GSM821001","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.924000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82ea","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6be","pgxind-kftx501x","pgxcs-kftwfel5",2035764873,0.708,1134660545,0.395,901104328,0.313,"PGX_AM_BS_GSM821002","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.926000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33153","",,,,,"geo:gsm","geo:GSM821002","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82ec","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821004","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bh","pgxind-kftx5021","pgxcs-kftwfem5",1545453001,0.538,681388132,0.237,864064869,0.301,"PGX_AM_BS_GSM821004","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.929000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c8665b209d374f2dc4c82ed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GPL6801","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bj","pgxind-kftx5023","pgxcs-kftwfemn",1479507226,0.515,755430311,0.263,724076915,0.252,"PGX_AM_BS_GSM821005","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.931000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM821005","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82ee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821006","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bk","pgxind-kftx5025","pgxcs-kftwfen5",1369879591,0.476,702658518,0.244,667221073,0.232,"PGX_AM_BS_GSM821006","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.932000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821007","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bm","pgxind-kftx5027","pgxcs-kftwfenn",1700213083,0.591,1010095393,0.351,690117690,0.24,"PGX_AM_BS_GSM821007","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.934000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821008","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bo","pgxind-kftx5029","pgxcs-kftwfeo5",1079207660,0.375,747976584,0.26,331231076,0.115,"PGX_AM_BS_GSM821008","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.935000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c8665b209d374f2dc4c82f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6bp","pgxind-kftx502c","pgxcs-kftwfeon",1317597971,0.458,822576285,0.286,495021686,0.172,"PGX_AM_BS_GSM821009","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.937000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,,"geo:gsm","geo:GSM821009","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6br","pgxind-kftx502e","pgxcs-kftwfep5",1296956651,0.451,757060822,0.263,539895829,0.188,"PGX_AM_BS_GSM821010","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.938000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM821010","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bt","pgxind-kftx502g","pgxcs-kftwfepn",1551848177,0.54,1025768864,0.357,526079313,0.183,"PGX_AM_BS_GSM821011","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.940000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33153","",,,,,"geo:gsm","geo:GSM821011","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821014","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bw","pgxind-kftx502k","pgxcs-kftwfer6",1367169807,0.476,740326730,0.258,626843077,0.218,"PGX_AM_BS_GSM821014","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.943000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821013","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6by","pgxind-kftx502m","pgxcs-kftwfeqo",1453663675,0.506,792739413,0.276,660924262,0.23,"PGX_AM_BS_GSM821013","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.944000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821015","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bz","pgxind-kftx502o","pgxcs-kftwfero",1695513145,0.59,1062693124,0.37,632820021,0.22,"PGX_AM_BS_GSM821015","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.946000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c8665b209d374f2dc4c82f9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6c2","pgxind-kftx502s","pgxcs-kftwfeso",1231975786,0.429,859858366,0.299,372117420,0.129,"PGX_AM_BS_GSM821017","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.949000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM821017","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c8665b209d374f2dc4c82fa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821018","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6c4","pgxind-kftx502u","pgxcs-kftwfet8",1384166344,0.481,839545129,0.292,544621215,0.189,"PGX_AM_BS_GSM821018","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.950000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82fb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820997","","pgxfus-0002","no followup status","NCIT:C3902","Telangiectatic Osteosarcoma","icdom-91833","Telangiectatic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6c6","pgxind-kftx502w","pgxcs-kftwfein",1422511490,0.495,704680099,0.245,717831391,0.25,"PGX_AM_BS_GSM820997","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.951000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821021","","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6c9","pgxind-kftx5030","pgxcs-kftwfeus",2184453077,0.76,1151587048,0.401,1032866029,0.359,"PGX_AM_BS_GSM821021","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.954000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821022","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6cb","pgxind-kftx5032","pgxcs-kftwfevb",1412457634,0.491,911282170,0.317,501175464,0.174,"PGX_AM_BS_GSM821022","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.956000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c8300","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6ce","pgxind-kftx5036","pgxcs-kftwfewb",967043569,0.336,649518111,0.226,317525458,0.11,"PGX_AM_BS_GSM821024","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.959000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM821024","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86661909d374f2dc4e34a2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line 143B]","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cr","pgxind-kftx51bi","pgxcs-kftwfq2i",1402234302,0.488,681632469,0.237,720601833,0.251,"PGX_AM_BS_GSM879206","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.085000",,,,,,,"geo:GPL6801","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE36003","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_2270","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM879206","",,,,,
"5c86661909d374f2dc4e34a3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","cellosaurus:CVCL_0312","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7ct","pgxind-kftx51bk","pgxcs-kftwfq30",691578252,0.241,175555038,0.061,516023214,0.179,"PGX_AM_BS_GSM879208","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.087000",,,,,,,"geo:GSM879208","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gpl","geo:GPL6801","",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE36003","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...",,,,,
"5c86661909d374f2dc4e34a4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS10]","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cv","pgxind-kftx51bm","pgxcs-kftwfq3i",992044581,0.345,465939234,0.162,526105347,0.183,"PGX_AM_BS_GSM879210","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.088000",,,,,,,"geo:GSE36003","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_9989","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American","geo:gsm","geo:GSM879210","",,,,,
"5c86661909d374f2dc4e34a5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KPD]","geo:GSM879216","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cx","pgxind-kftx51bo","pgxcs-kftwfq40",1192511599,0.415,767492938,0.267,425018661,0.148,"PGX_AM_BS_GSM879216","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.090000",,,,,,,"cellosaurus:CVCL_B412","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE36003","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gpl","geo:GPL6801","",,,,,
"5c86661909d374f2dc4e34a6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line MNNG/HOS CI #5]","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cy","pgxind-kftx51bq","pgxcs-kftwfq4h",1065381362,0.371,625968078,0.218,439413284,0.153,"PGX_AM_BS_GSM879219","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.092000",,,,,,,"geo:GPL6801","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE36003","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_0439","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM879219","",,,,,
"5c86675409d374f2dc538641","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqe","pgxind-kftx554l","pgxcs-kftwgot0",623126720,0.217,409501098,0.142,213625622,0.074,"PGX_AM_BS_GSM1109929","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.558000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109929","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538643","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqh","pgxind-kftx554q","pgxcs-kftwgoty",615708632,0.214,375677617,0.131,240031015,0.083,"PGX_AM_BS_GSM1109931","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.561000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109931","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538646","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqm","pgxind-kftx554w","pgxcs-kftwgove",1472262854,0.512,917644303,0.319,554618551,0.193,"PGX_AM_BS_GSM1109934","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.565000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109934","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538648","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqp","pgxind-kftx5550","pgxcs-kftwgowe",267658509,0.093,207793566,0.072,59864943,0.021,"PGX_AM_BS_GSM1109936","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.567000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109936","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538649","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1109937","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqr","pgxind-kftx5552","pgxcs-kftwgowv",2235406600,0.778,1116267871,0.388,1119138729,0.389,"PGX_AM_BS_GSM1109937","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.569000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc53864a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1109938","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqs","pgxind-kftx5554","pgxcs-kftwgoxf",97493059,0.034,83234680,0.029,14258379,0.005,"PGX_AM_BS_GSM1109938","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.570000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE45573","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc53864b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE45573","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqu","pgxind-kftx5557","pgxcs-kftwgoxw",381160016,0.133,209195494,0.073,171964522,0.06,"PGX_AM_BS_GSM1109939","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.572000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109939","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc53864d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1109941","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqx","pgxind-kftx555b","pgxcs-kftwgoyx",1479362867,0.515,940304325,0.327,539058542,0.187,"PGX_AM_BS_GSM1109941","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.575000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc53864e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqz","pgxind-kftx555d","pgxcs-kftwgozf",605930155,0.211,524981586,0.183,80948569,0.028,"PGX_AM_BS_GSM1109942","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.576000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109942","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc53864f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar0","pgxind-kftx555f","pgxcs-kftwgozw",407404284,0.142,284489113,0.099,122915171,0.043,"PGX_AM_BS_GSM1109943","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.578000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109943","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538650","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE45573","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar2","pgxind-kftx555h","pgxcs-kftwgp0f",1509656304,0.525,937840710,0.326,571815594,0.199,"PGX_AM_BS_GSM1109944","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.579000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109944","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538651","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE45573","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar4","pgxind-kftx555j","pgxcs-kftwgp0w",349371247,0.122,209372056,0.073,139999191,0.049,"PGX_AM_BS_GSM1109945","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.580000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109945","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538653","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar7","pgxind-kftx555n","pgxcs-kftwgojl",1779638885,0.619,1341932077,0.467,437706808,0.152,"PGX_AM_BS_GSM1109910","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.583000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109910","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538655","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109912","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjara","pgxind-kftx555r","pgxcs-kftwgokl",999637834,0.348,561120227,0.195,438517607,0.153,"PGX_AM_BS_GSM1109912","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.586000",,,,,,,"PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL8841","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE45573","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538659","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109916","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarh","pgxind-kftx5560","pgxcs-kftwgomk",1770157322,0.616,1237782329,0.431,532374993,0.185,"PGX_AM_BS_GSM1109916","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.592000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE45573","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675509d374f2dc538660","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109923","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjars","pgxind-kftx556e","pgxcs-kftwgoq0",195145926,0.068,179890358,0.063,15255568,0.005,"PGX_AM_BS_GSM1109923","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.602000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675509d374f2dc538661","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109924","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaru","pgxind-kftx556g","pgxcs-kftwgoqh",1899622852,0.661,985887199,0.343,913735653,0.318,"PGX_AM_BS_GSM1109924","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.603000",,,,,,,"PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE45573","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL8841","","arraymap import",,,,,,,,,,,,,,,,
"5c86675509d374f2dc538664","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarz","pgxind-kftx556m","pgxcs-kftwgory",1537867147,0.535,870367630,0.303,667499517,0.232,"PGX_AM_BS_GSM1109927","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.608000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109927","","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d5d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197410","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjas3","pgxind-kftx556s","pgxcs-kftwgp1w",649456178,0.226,287091292,0.1,362364886,0.126,"PGX_AM_BS_GSM1197410","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.612000",,,,,,,"PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE49324","",,,,,"geo:gpl","geo:GPL9777","","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d5e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197411","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjas5","pgxind-kftx556u","pgxcs-kftwgp2d",1271015117,0.442,904887969,0.315,366127148,0.127,"PGX_AM_BS_GSM1197411","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.613000",,,,,,,"PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE49324","",,,,,"geo:gpl","geo:GPL9777","","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d65","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197421","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasg","pgxind-kftx5579","pgxcs-kftwgp7e",1729490435,0.602,1257902651,0.438,471587784,0.164,"PGX_AM_BS_GSM1197421","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.623000",,,,,,,"geo:GSE49324","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL9777","",,,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d66","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197415","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasi","pgxind-kftx557b","pgxcs-kftwgp4e",446851848,0.155,112683125,0.039,334168723,0.116,"PGX_AM_BS_GSM1197415","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.625000",,,,,,,"geo:GPL9777","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE49324","",,,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d67","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197419","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjask","pgxind-kftx557d","pgxcs-kftwgp6e",1654212713,0.575,1091514020,0.38,562698693,0.196,"PGX_AM_BS_GSM1197419","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.626000",,,,,,,"PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL9777","",,,,,"geo:gse","geo:GSE49324","","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d68","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197420","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasl","pgxind-kftx557f","pgxcs-kftwgp6v",1241237875,0.432,347069585,0.121,894168290,0.311,"PGX_AM_BS_GSM1197420","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.627000",,,,,,,"geo:GSE49324","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL9777","",,,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d6a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma [recurrence]","geo:GSM1197423","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasp","pgxind-kftx557j","pgxcs-kftwgp8e",730172350,0.254,372324919,0.13,357847431,0.124,"PGX_AM_BS_GSM1197423","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.630000",,,,,,,"geo:GPL9777","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE49324","",,,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,,
"5c86675c09d374f2dc53a00b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS]","geo:GSM1280502","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau3","pgxind-kftx559a","pgxcs-kftwgpt4",1699977149,0.591,950495654,0.331,749481495,0.261,"PGX_AM_BS_GSM1280502","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.675000",,,,,,,"PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE53021","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL3718","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a00c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS]","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau5","pgxind-kftx559c","pgxcs-kftwgpv4",1541090236,0.536,859765918,0.299,681324318,0.237,"PGX_AM_BS_GSM1280506","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.676000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE53021","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1280506","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a00e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau8","pgxind-kftx559g","pgxcs-kftwgptn",906535481,0.315,611361643,0.213,295173838,0.103,"PGX_AM_BS_GSM1280503","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.679000",,,,,,,"geo:GSE53021","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3718","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1280503","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a010","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1280505","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaub","pgxind-kftx559k","pgxcs-kftwgpum",1140237001,0.397,416848373,0.145,723388628,0.252,"PGX_AM_BS_GSM1280505","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.682000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE53021","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a019","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Gastrointestinal stromal tumor [cell line eRMS]","geo:GSM1280499","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjauq","pgxind-kftx55a2","pgxcs-kftwgprn",1925479044,0.67,1249812987,0.435,675666057,0.235,"PGX_AM_BS_GSM1280499","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.694000",,,,,,,"PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3718","",,,,,"geo:gse","geo:GSE53021","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a01a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Gastrointestinal stromal tumor [cell line eRMS]","geo:GSE53021","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaus","pgxind-kftx55a4","pgxcs-kftwgps5",711510898,0.247,401570603,0.14,309940295,0.108,"PGX_AM_BS_GSM1280500","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.696000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...",,,,,"geo:gsm","geo:GSM1280500","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a01b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaut","pgxind-kftx55a6","pgxcs-kftwgpr6",1385110960,0.482,1022498046,0.356,362612914,0.126,"PGX_AM_BS_GSM1280498","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.697000",,,,,,,"geo:GSE53021","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3718","",,,,,"geo:gsm","geo:GSM1280498","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a01c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma","geo:GSM1280497","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjauv","pgxind-kftx55a8","pgxcs-kftwgpqo",2237740332,0.778,1313488811,0.457,924251521,0.321,"PGX_AM_BS_GSM1280497","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.699000",,,,,,,"geo:GSE53021","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,"pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8668e809d374f2dc5998bc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509942","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeu3","pgxind-kftx5a6g","pgxcs-kftwhyd9",1695146944,0.59,1053183823,0.366,641963121,0.223,"PGX_AM_BS_GSM509942","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.549000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998be","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GPL8634","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeu6","pgxind-kftx5a6k","pgxcs-kftwhye8",1712354640,0.596,843815603,0.294,868539037,0.302,"PGX_AM_BS_GSM509944","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.551000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gpl","geo:gse","pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"geo:gsm","geo:GSM509944","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998c9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509955","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeup","pgxind-kftx5a75","pgxcs-kftwhyjq",420629194,0.146,66114701,0.023,354514493,0.123,"PGX_AM_BS_GSM509955","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.566000",,,,,,,"PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","pubmed","geo:gpl","geo:GPL8634","",,,,,"geo:gse","geo:GSE20355","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE20355","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeuq","pgxind-kftx5a77","pgxcs-kftwhyk7",1189060137,0.414,670929817,0.233,518130320,0.18,"PGX_AM_BS_GSM509956","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.568000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"geo:gsm","geo:GSM509956","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998cd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509959","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeuv","pgxind-kftx5a7d","pgxcs-kftwhyln",1966658940,0.684,1192975345,0.415,773683595,0.269,"PGX_AM_BS_GSM509959","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.572000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE20355","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998dd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509975","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjevn","pgxind-kftx5a8a","pgxcs-kftwhytn",2424088286,0.843,1502341088,0.523,921747198,0.321,"PGX_AM_BS_GSM509975","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.594000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998df","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509977","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjevq","pgxind-kftx5a8e","pgxcs-kftwhyum",1678159991,0.584,1075313524,0.374,602846467,0.21,"PGX_AM_BS_GSM509977","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.597000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE20355","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998e4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjevz","pgxind-kftx5a8o","pgxcs-kftwhyx2",163295409,0.057,87505762,0.03,75789647,0.026,"PGX_AM_BS_GSM509982","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.604000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"geo:gsm","geo:GSM509982","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998e8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509986","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjew6","pgxind-kftx5a8w","pgxcs-kftwhyz1",559122638,0.194,368121039,0.128,191001599,0.066,"PGX_AM_BS_GSM509986","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.610000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509993","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewi","pgxind-kftx5a9b","pgxcs-kftwhz2j",1547477920,0.538,1045848029,0.364,501629891,0.174,"PGX_AM_BS_GSM509993","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.620000",,,,,,,"PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","pubmed","geo:gse","geo:GSE20355","",,,,,"geo:gpl","geo:GPL8634","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509995","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewl","pgxind-kftx5a9f","pgxcs-kftwhz3h",202519645,0.07,202519645,0.07,0,0,"PGX_AM_BS_GSM509995","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.623000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line A4573]","geo:GPL8634","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewv","pgxind-kftx5a9r","pgxcs-kftwhz6d",1481607082,0.515,506250271,0.176,975356811,0.339,"PGX_AM_BS_GSM510001","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.631000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:gse","pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"geo:gsm","geo:GSM510001","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_6245","",,,,,
"5c8668e909d374f2dc5998fc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line RD-ES]","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjex4","pgxind-kftx5aa1","pgxcs-kftwhz8v",1487068603,0.517,721917933,0.251,765150670,0.266,"PGX_AM_BS_GSM510006","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.638000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"geo:gsm","geo:GSM510006","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_2169","",,,,,
"5c8668e909d374f2dc5998fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line RM-82]","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjex5","pgxind-kftx5aa3","pgxcs-kftwhz9d",1713906666,0.596,1223377249,0.426,490529417,0.171,"PGX_AM_BS_GSM510007","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.640000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"geo:gsm","geo:GSM510007","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_9714","",,,,,
"5c8668e909d374f2dc599900","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line STA-ET-1]","geo:GSM510010","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexa","pgxind-kftx5aa9","pgxcs-kftwhzau",513249148,0.179,59597094,0.021,453652054,0.158,"PGX_AM_BS_GSM510010","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.644000",,,,,,,"cellosaurus:CVCL_9681","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"geo:gpl","geo:GPL8634","","arraymap import",,,,,,,,,"geo:gse","geo:GSE20355","",,,,,
"5c8668e909d374f2dc599901","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line STA-ET-2.1]","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexc","pgxind-kftx5aab","pgxcs-kftwhzbb",1405392856,0.489,938298021,0.326,467094835,0.162,"PGX_AM_BS_GSM510011","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.645000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"cellosaurus","cellosaurus:CVCL_9686","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM510011","",,,,,
"5c8668e909d374f2dc599903","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line TTC-466]","geo:GSM510014","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexf","pgxind-kftx5aaf","pgxcs-kftwhzcu",1612282662,0.561,800165144,0.278,812117518,0.282,"PGX_AM_BS_GSM510014","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.648000",,,,,,,"cellosaurus:CVCL_A444","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","pubmed","PMID:21822310","Mackintosh C, Ordez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"geo:gse","geo:GSE20355","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL8634","",,,,,
"5c86690609d374f2dc59e8c3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf8z","pgxind-kftx5aoq","pgxcs-kftwi2yl",2629816976,0.915,0,0,2629816976,0.915,"PGX_AM_BS_GSM637930","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.011000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"geo:gsm","geo:GSM637930","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf90","pgxind-kftx5aos","pgxcs-kftwi2z2",2629095210,0.914,0,0,2629095210,0.914,"PGX_AM_BS_GSM637931","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.012000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,,"geo:gsm","geo:GSM637931","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf92","pgxind-kftx5aou","pgxcs-kftwi2zj",2629322510,0.915,0,0,2629322510,0.915,"PGX_AM_BS_GSM637932","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.014000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"geo:gsm","geo:GSM637932","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSM637933","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf94","pgxind-kftx5aow","pgxcs-kftwi301",2629701416,0.915,0,0,2629701416,0.915,"PGX_AM_BS_GSM637933","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.015000",,,,,,,"PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6985","",,,,,"geo:gse","geo:GSE25985","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf95","pgxind-kftx5aoy","pgxcs-kftwi30i",2629785586,0.915,0,0,2629785586,0.915,"PGX_AM_BS_GSM637935","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.017000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"geo:gsm","geo:GSM637935","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf97","pgxind-kftx5ap0","pgxcs-kftwi310",2629768603,0.915,0,0,2629768603,0.915,"PGX_AM_BS_GSM637936","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.018000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,,"geo:gsm","geo:GSM637936","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf98","pgxind-kftx5ap2","pgxcs-kftwi31i",2629768983,0.915,0,0,2629768983,0.915,"PGX_AM_BS_GSM637938","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.020000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,,"geo:gsm","geo:GSM637938","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSM637940","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf9a","pgxind-kftx5ap4","pgxcs-kftwi31z",2629502545,0.915,0,0,2629502545,0.915,"PGX_AM_BS_GSM637940","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.021000",,,,,,,"geo:GSE25985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6985","",,,,,"pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8cb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf9c","pgxind-kftx5ap7","pgxcs-kftwi32h",2628994443,0.914,0,0,2628994443,0.914,"PGX_AM_BS_GSM637942","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.023000",,,,,,,"geo:GSE25985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6985","",,,,,"geo:gsm","geo:GSM637942","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1h","pgxind-kftx5cx2","pgxcs-kftwin9h",964049514,0.335,720147239,0.25,243902275,0.085,"PGX_AM_BS_GSM816451","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.034000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE32964","",,,,,"geo:gsm","geo:GSM816451","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816439","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1i","pgxind-kftx5cx4","pgxcs-kftwin3j",933825434,0.325,642803057,0.224,291022377,0.101,"PGX_AM_BS_GSM816439","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.035000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE32964","",,,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1o","pgxind-kftx5cxa","pgxcs-kftwin50",714592224,0.249,530954318,0.185,183637906,0.064,"PGX_AM_BS_GSM816442","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.040000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE32964","",,,,,"geo:gsm","geo:GSM816442","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL6985","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1p","pgxind-kftx5cxc","pgxcs-kftwin5j",416413172,0.145,322220936,0.112,94192236,0.033,"PGX_AM_BS_GSM816443","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.041000",,,,,,,"geo:GSE32964","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...",,,,,"geo:gsm","geo:GSM816443","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816445","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1t","pgxind-kftx5cxg","pgxcs-kftwin6i",134396128,0.047,47873869,0.017,86522259,0.03,"PGX_AM_BS_GSM816445","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.044000",,,,,,,"PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6985","",,,,,"geo:gse","geo:GSE32964","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816446","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1u","pgxind-kftx5cxi","pgxcs-kftwin6z",1302846801,0.453,1128488115,0.393,174358686,0.061,"PGX_AM_BS_GSM816446","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.046000",,,,,,,"PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6985","",,,,,"geo:gse","geo:GSE32964","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816455","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh28","pgxind-kftx5cxz","pgxcs-kftwinbg",204707191,0.071,1704689,0.001,203002502,0.071,"PGX_AM_BS_GSM816455","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.058000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE32964","",,,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2a","pgxind-kftx5cy1","pgxcs-kftwinbx",719174518,0.25,511250169,0.178,207924349,0.072,"PGX_AM_BS_GSM816456","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.059000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE32964","",,,,,"geo:gsm","geo:GSM816456","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2d","pgxind-kftx5cy5","pgxcs-kftwincx",340763743,0.119,145029000,0.05,195734743,0.068,"PGX_AM_BS_GSM816458","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.062000",,,,,,,"geo:GSE32964","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6985","",,,,,"geo:gsm","geo:GSM816458","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816460","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2g","pgxind-kftx5cy9","pgxcs-kftwindy",508762398,0.177,189794558,0.066,318967840,0.111,"PGX_AM_BS_GSM816460","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.065000",,,,,,,"geo:GSE32964","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6985","",,,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,,
"5c86699e09d374f2dc5b8bbd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2s","pgxind-kftx5cyn","pgxcs-kftwinhe",196139922,0.068,71680741,0.025,124459181,0.043,"PGX_AM_BS_GSM816467","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.075000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE32964","",,,,,"geo:gsm","geo:GSM816467","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhth","pgxind-kftx5dvj","pgxcs-kftwivr7",1124565450,0.391,795966085,0.277,328599365,0.114,"PGX_AM_BS_GSM838289","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.903000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL5477","",,,,,"geo:gsm","geo:GSM838289","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhti","pgxind-kftx5dvl","pgxcs-kftwivrp",1156184322,0.402,738914787,0.257,417269535,0.145,"PGX_AM_BS_GSM838290","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.904000",,,,,,,"geo:GPL5477","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838290","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2a0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtm","pgxind-kftx5dvp","pgxcs-kftwivso",2207386370,0.768,855361762,0.298,1352024608,0.47,"PGX_AM_BS_GSM838292","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.907000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL5477","",,,,,"geo:gsm","geo:GSM838292","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2aa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhu2","pgxind-kftx5dwb","pgxcs-kftwivxh",2174141379,0.756,878621119,0.306,1295520260,0.451,"PGX_AM_BS_GSM838302","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.921000",,,,,,,"geo:GPL5477","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838302","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838308","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuc","pgxind-kftx5dwn","pgxcs-kftwiw0e",771406084,0.268,608421682,0.212,162984402,0.057,"PGX_AM_BS_GSM838308","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.929000",,,,,,,"PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838310","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuf","pgxind-kftx5dwr","pgxcs-kftwiw1d",1217255385,0.423,494446512,0.172,722808873,0.251,"PGX_AM_BS_GSM838310","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.932000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,,"pubmed","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838313","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuk","pgxind-kftx5dwx","pgxcs-kftwiw2t",1933037755,0.672,723038941,0.251,1209998814,0.421,"PGX_AM_BS_GSM838313","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.936000",,,,,,,"PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838314","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhum","pgxind-kftx5dwz","pgxcs-kftwiw3b",803491173,0.279,503139226,0.175,300351947,0.104,"PGX_AM_BS_GSM838314","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.938000",,,,,,,"geo:GPL5477","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33881","",,,,,"pubmed","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838315","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhun","pgxind-kftx5dx1","pgxcs-kftwiw3t",1949940043,0.678,829235467,0.288,1120704576,0.39,"PGX_AM_BS_GSM838315","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.939000",,,,,,,"PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33881","",,,,,"geo:gpl","geo:GPL5477","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838316","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhup","pgxind-kftx5dx3","pgxcs-kftwiw4b",2191537374,0.762,1482831148,0.516,708706226,0.247,"PGX_AM_BS_GSM838316","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.941000",,,,,,,"PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuq","pgxind-kftx5dx5","pgxcs-kftwiw4s",179815380,0.063,12333646,0.004,167481734,0.058,"PGX_AM_BS_GSM838317","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.942000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838317","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2bb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuu","pgxind-kftx5dx9","pgxcs-kftwiw5r",2171575610,0.755,1080120127,0.376,1091455483,0.38,"PGX_AM_BS_GSM838319","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.945000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838319","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2bf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838323","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv0","pgxind-kftx5dxh","pgxcs-kftwiw7p",915059292,0.318,634487174,0.221,280572118,0.098,"PGX_AM_BS_GSM838323","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.951000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,,"pubmed","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838324","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv2","pgxind-kftx5dxj","pgxcs-kftwiw87",2092793055,0.728,621405298,0.216,1471387757,0.512,"PGX_AM_BS_GSM838324","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.952000",,,,,,,"PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv5","pgxind-kftx5dxn","pgxcs-kftwiw96",1149236628,0.4,471284130,0.164,677952498,0.236,"PGX_AM_BS_GSM838326","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.955000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838326","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838327","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv7","pgxind-kftx5dxp","pgxcs-kftwiw9o",1406974910,0.489,1087086744,0.378,319888166,0.111,"PGX_AM_BS_GSM838327","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.957000",,,,,,,"PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838328","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv8","pgxind-kftx5dxs","pgxcs-kftwiwa6",1801923850,0.627,658414221,0.229,1143509629,0.398,"PGX_AM_BS_GSM838328","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.958000",,,,,,,"PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhvd","pgxind-kftx5dxy","pgxcs-kftwiwbm",1416736312,0.493,522630883,0.182,894105429,0.311,"PGX_AM_BS_GSM838331","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.963000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylip A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838331","","arraymap import",,,,,,,,,,,,,,,,
"5dc17b5f09d374f6dd77341c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","cellosaurus:CVCL_0042","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjtr5","pgxind-kftx5s7q","pgxcs-kftwmffm",1549575741,0.539,918057270,0.319,631518471,0.22,"PGX_AM_BS_GSM170250","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.183000",,,,,,,"geo:GSM170250","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gpl","geo:GPL2879","",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE7077","","arraymap import",,,,,,,,,"pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5dc17b5f09d374f6dd773585","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U-2 OS]","geo:GSM879223","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjtr6","pgxind-kftx5s7s","pgxcs-kftwmfg0",1356867660,0.472,720797339,0.251,636070321,0.221,"PGX_AM_BS_GSM879223","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.185000",,,,,,"P15Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0042","",,,"U-2 OS","cell line",
"5dc17be309d374f6dd79477f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","cellosaurus:CVCL_0312","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjude","pgxind-kftx5sz9","pgxcs-kftwmkea",722920466,0.251,116182894,0.04,606737572,0.211,"PGX_AM_BS_GSM170248","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.786000",,,,,,"P13Y","geo:GSM170248","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE7077","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL2879","",,,,,
"5dc17be709d374f6dd794833","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudl","pgxind-kftx5szi","pgxcs-kftwmkfk",1474530670,0.513,845233049,0.294,629297621,0.219,"PGX_AM_BS_GSM256076","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.791000",,,,,,,"geo:GPL6359","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_0317","",,,,,"geo:gsm","geo:GSM256076","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd794834","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudm","pgxind-kftx5szk","pgxcs-kftwmkfv",1321785373,0.46,739532302,0.257,582253071,0.203,"PGX_AM_BS_GSM256077","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.792000",,,,,,,"geo:GPL6359","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_0317","",,,,,"geo:gsm","geo:GSM256077","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd79483f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSM256088","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjue4","pgxind-kftx5t06","pgxcs-kftwmkjd",706015692,0.246,580210060,0.202,125805632,0.044,"PGX_AM_BS_GSM256088","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.803000",,,,,,,"cellosaurus:CVCL_0317","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","geo:gse","geo:GSE10132","",,,,,"geo:gpl","geo:GPL6359","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd794845","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSM256094","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuee","pgxind-kftx5t0i","pgxcs-kftwmkla",996046253,0.346,553408494,0.192,442637759,0.154,"PGX_AM_BS_GSM256094","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.810000",,,,,,,"cellosaurus:CVCL_0317","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","geo:gpl","geo:GPL6359","",,,,,"geo:gse","geo:GSE10132","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd79484d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","cellosaurus:CVCL_0317","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjues","pgxind-kftx5t0y","pgxcs-kftwmknt",524994351,0.183,173630114,0.06,351364237,0.122,"PGX_AM_BS_GSM256102","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.818000",,,,,,,"geo:GSM256102","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","geo:gpl","geo:GPL6359","",,,,,"geo:gse","geo:GSE10132","","arraymap import",,,,,,,,,,,,,,,,
"5dc17bf209d374f6dd796459","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","cellosaurus:CVCL_0426","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjugt","pgxind-kftx5t3g","pgxcs-kftwml3a",1729284741,0.601,1110759283,0.386,618525458,0.215,"PGX_AM_BS_GSM170251","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.870000",,,,,,,"geo:GSM170251","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE7077","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL2879","","arraymap import",,,,,,,,,"pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5dc17bf209d374f6dd796566","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line MG-63]","geo:GSM879217","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjugv","pgxind-kftx5t3i","pgxcs-kftwml3o",0,0,0,0,0,0,"PGX_AM_BS_GSM879217","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.871000",,,,,,"P14Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0426","",,,"MG-63","cell line",
"5dc17c0109d374f6dd797070","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-3]","geo:GSM393031","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjujv","pgxind-kftx5t76","pgxcs-kftwmm0e",626214146,0.218,489713123,0.17,136501023,0.047,"PGX_AM_BS_GSM393031","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.952000",,,,,,,"cellosaurus:CVCL_5170","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE15696","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3718","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.0800000000000001,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797077","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuk6","pgxind-kftx5t7k","pgxcs-kftwmlxf",951438749,0.331,803594307,0.28,147844442,0.051,"PGX_AM_BS_GSM393023","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.960000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393023","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd797078","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuk8","pgxind-kftx5t7m","pgxcs-kftwmlxq",2575077376,0.896,1351409861,0.47,1223667515,0.426,"PGX_AM_BS_GSM393024","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.961000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393024","",,,,,,,,"arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd79707a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SCMS-ES1]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukb","pgxind-kftx5t7r","pgxcs-kftwmlye",986003667,0.343,176946065,0.062,809057602,0.281,"PGX_AM_BS_GSM393026","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.963000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_7123","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393026","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.56,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd79707b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-ES-1]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukd","pgxind-kftx5t7t","pgxcs-kftwmlys",881818415,0.307,201062203,0.07,680756212,0.237,"PGX_AM_BS_GSM393027","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.964000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_0627","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393027","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17c0109d374f6dd79707c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line ES-1-OT]","geo:GSM393028","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukf","pgxind-kftx5t7v","pgxcs-kftwmlz7",1350344004,0.47,884383305,0.308,465960699,0.162,"PGX_AM_BS_GSM393028","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.966000",,,,,,,"cellosaurus:CVCL_5122","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE15696","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3718","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0019","Japanese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd79707e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-2]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuki","pgxind-kftx5t7z","pgxcs-kftwmm00",1437160405,0.5,17510813,0.006,1419649592,0.494,"PGX_AM_BS_GSM393030","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.968000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393030","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5169","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.0800000000000001,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd79707f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-5]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukk","pgxind-kftx5t81","pgxcs-kftwmm0t",1306982442,0.455,805612779,0.28,501369663,0.174,"PGX_AM_BS_GSM393032","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.969000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_5171","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393032","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797080","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-6]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukm","pgxind-kftx5t83","pgxcs-kftwmm18",963224119,0.335,479778139,0.167,483445980,0.168,"PGX_AM_BS_GSM393033","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.971000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_5172","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393033","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797081","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-7]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuko","pgxind-kftx5t85","pgxcs-kftwmm1n",475944807,0.166,122300287,0.043,353644520,0.123,"PGX_AM_BS_GSM393034","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.972000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393034","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5173","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797082","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-8]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukp","pgxind-kftx5t87","pgxcs-kftwmm21",769415114,0.268,280959333,0.098,488455781,0.17,"PGX_AM_BS_GSM393035","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.973000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393035","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5174","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797083","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-N-PI]","geo:GSM393036","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukr","pgxind-kftx5t89","pgxcs-kftwmm2g",658585294,0.229,307150604,0.107,351434690,0.122,"PGX_AM_BS_GSM393036","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.975000",,,,,,,"cellosaurus:CVCL_S664","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL3718","",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE15696","","arraymap import",0.48,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797087","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line KP-PN-TTBm2]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukx","pgxind-kftx5t8h","pgxcs-kftwmm3z",611637757,0.213,284270731,0.099,327367026,0.114,"PGX_AM_BS_GSM393040","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.979000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393040","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5147","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd797089","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line RD-ES]","geo:GPL2004","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjul1","pgxind-kftx5t8l","pgxcs-kftwmm4q",1152168769,0.401,440996405,0.153,711172364,0.247,"PGX_AM_BS_GSM393042","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.982000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393042","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_2169","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.62,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd79708a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line UTP-ES1]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjul2","pgxind-kftx5t8n","pgxcs-kftwmm54",1395484188,0.485,754856400,0.263,640627788,0.223,"PGX_AM_BS_GSM393043","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.983000",,,,,,,"geo:GPL2004","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_DH85","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393043","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.6,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0509d374f6dd7977cb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjulk","pgxind-kftx5t99","pgxcs-kftwmm7m",1646421781,0.573,223144957,0.078,1423276824,0.495,"PGX_AM_BS_GSM170249","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.997000",,,,,,"P11Y","geo:GPL2879","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE7077","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM170249","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0548","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5dc17c0509d374f6dd797881","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","geo:GSM879222","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjull","pgxind-kftx5t9b","pgxcs-kftwmm82",1797249074,0.625,913787260,0.318,883461814,0.307,"PGX_AM_BS_GSM879222","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.998000",,,,,,,"geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0548","",,,"Saos-2","cell line",
"5dc17c3f09d374f6dd79dc81","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma [cell line SW872]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuxh","pgxind-kftx5tnu","pgxcs-kftwmp5u",1006134071,0.35,474415118,0.165,531718953,0.185,"PGX_AM_BS_GSM482514","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.327000",,,,,,,"geo:GSE19399","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_1730","","arraymap import",0.5,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.46,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM482514","",,,,,
"5dc17c7b09d374f6dd7a432e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Monophasic synovial sarcoma [cell line HS-SY-2]","geo:GSM482569","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjva7","pgxind-kftx5u3c","pgxcs-kftwms1o",1300272173,0.452,175824597,0.061,1124447576,0.391,"PGX_AM_BS_GSM482569","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.667000",,,,,,,"cellosaurus:CVCL_8719","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE19399","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,,,,
"5dc17c8109d374f6dd7a50cd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line LM5]","geo:GSM1639706","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbi","pgxind-kftx5u4z","pgxcs-kftwms45",0,0,0,0,0,0,"PGX_AM_BS_GSM1639706","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.708000",,,,,,,"geo:GSE67125","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","cellosaurus","cellosaurus:CVCL_9567","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,"LM5","cell line",
"5dc17c8109d374f6dd7a5327","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line SAOS]","geo:GSM1639703","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbk","pgxind-kftx5u51","pgxcs-kftwms4n",0,0,0,0,0,0,"PGX_AM_BS_GSM1639703","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.709000",,,,,,,"geo:GSE67125","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"cell line",
"5dc17c8109d374f6dd7a5328","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line SAOS]","geo:GSM1639704","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbm","pgxind-kftx5u53","pgxcs-kftwms55",0,0,0,0,0,0,"PGX_AM_BS_GSM1639704","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.711000",,,,,,,"geo:GSE67125","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"cell line",
"5dc17c8209d374f6dd7a5509","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line ZK-58]","geo:GSM879224","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbn","pgxind-kftx5u55","pgxcs-kftwms5n",0,0,0,0,0,0,"PGX_AM_BS_GSM879224","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.712000",,,,,,"P21Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9920","",,,"ZK-58","cell line",
"5dc17c8209d374f6dd7a5650","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS9]","geo:GSM879209","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbr","pgxind-kftx5u59","pgxcs-kftwms6k",0,0,0,0,0,0,"PGX_AM_BS_GSM879209","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.715000",,,,,,"P15Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",5.55111512312578e-17,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American","cellosaurus","cellosaurus:CVCL_9988","",,,"IOR/OS9","metastasis",
"5dc17c8309d374f6dd7a5b5e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS14]","geo:GSM879211","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbs","pgxind-kftx5u5b","pgxcs-kftwms72",0,0,0,0,0,0,"PGX_AM_BS_GSM879211","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.717000",,,,,,"P13Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American","cellosaurus","cellosaurus:CVCL_9990","",,,"IOR/OS14","cell line",
"5dc17c8409d374f6dd7a5d31","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS15]","geo:GSM879212","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbu","pgxind-kftx5u5d","pgxcs-kftwms7k",0,0,0,0,0,0,"PGX_AM_BS_GSM879212","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.718000",,,,,,,"geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9991","",,,"IOR/OS15","cell line",
"5dc17c8409d374f6dd7a5e46","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS18]","geo:GSM879213","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbw","pgxind-kftx5u5f","pgxcs-kftwms82",2113352049,0.735,951924865,0.331,1161427184,0.404,"PGX_AM_BS_GSM879213","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.720000",,,,,,"P33Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9993","",,,"IOR/OS18","metastasis",
"5dc17c8409d374f6dd7a61bc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/SARG]","geo:GSM879215","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbx","pgxind-kftx5u5h","pgxcs-kftwms8k",0,0,0,0,0,0,"PGX_AM_BS_GSM879215","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.721000",,,,,,,"geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9995","",,,"IOR/SARG","cell line",
"5dc17c9109d374f6dd7a711c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line OHS]","geo:GSM879220","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvf2","pgxind-kftx5u9d","pgxcs-kftwmsru",0,0,0,0,0,0,"PGX_AM_BS_GSM879220","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.804000",,,,,,"P14Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_B450","",,,"OHS","cell line",
"5dc17c9209d374f6dd7a741f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line HAL]","geo:GSM879207","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvfa","pgxind-kftx5u9n","pgxcs-kftwmstx",1669041877,0.581,757383055,0.263,911658822,0.317,"PGX_AM_BS_GSM879207","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.811000",,,,,,"P15Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_D788","",,,"HAL","cell line",
"5dc17ca709d374f6dd7a97c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pleomorphic liposarcoma [cell line LiSa-2]","geo:GSE19399","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvjp","pgxind-kftx5uf1","pgxcs-kftwmu3j",903906771,0.314,451447221,0.157,452459550,0.157,"PGX_AM_BS_GSM482515","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.943000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_M821","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM482515","",,,,,
"5dc17cab09d374f6dd7aa40b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkc","pgxind-kftx5uft","pgxcs-kftwmuaa",1581196569,0.55,652082017,0.227,929114552,0.323,"PGX_AM_BS_GSM1012753","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.964000",,,,,,,"geo:GPL2004","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_W527","",,,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM1012753","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.82,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cab09d374f6dd7aa40c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GPL2004","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvke","pgxind-kftx5ufv","pgxcs-kftwmu9v",1519445948,0.529,633843365,0.22,885602583,0.308,"PGX_AM_BS_GSM1012752","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.965000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012752","",,,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_W527","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cab09d374f6dd7aa40e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSM1012755","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkh","pgxind-kftx5ufz","pgxcs-kftwmub3",1675555505,0.583,957514844,0.333,718040661,0.25,"PGX_AM_BS_GSM1012755","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.967000",,,,,,,"cellosaurus:CVCL_W527","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL2004","",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE41263","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cab09d374f6dd7aa40f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSM1012756","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkj","pgxind-kftx5ug1","pgxcs-kftwmubh",1137546644,0.396,531096468,0.185,606450176,0.211,"PGX_AM_BS_GSM1012756","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.969000",,,,,,,"cellosaurus:CVCL_W527","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE41263","",,,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL2004","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.76,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cab09d374f6dd7aa410","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSM1012757","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkk","pgxind-kftx5ug3","pgxcs-kftwmubw",1726870012,0.601,843776113,0.293,883093899,0.307,"PGX_AM_BS_GSM1012757","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.970000",,,,,,,"cellosaurus:CVCL_W527","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL2004","",,,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE41263","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cb009d374f6dd7aa59c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkm","pgxind-kftx5ug5","pgxcs-kftwmurp",939920384,0.327,441476206,0.154,498444178,0.173,"PGX_AM_BS_GSM1012758","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.971000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012758","",,,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17cb009d374f6dd7aa59e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkp","pgxind-kftx5ug9","pgxcs-kftwmucm",588552243,0.205,246543151,0.086,342009092,0.119,"PGX_AM_BS_GSM1012714","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.973000",,,,,,,"geo:GPL2004","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM1012714","",,,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cb009d374f6dd7aa5a2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkw","pgxind-kftx5ugh","pgxcs-kftwmudv",1507400129,0.524,713119926,0.248,794280203,0.276,"PGX_AM_BS_GSM1012718","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.978000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE41263","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5ad","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012729","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvle","pgxind-kftx5uh3","pgxcs-kftwmuhd",446167129,0.155,3163250,0.001,443003879,0.154,"PGX_AM_BS_GSM1012729","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.990000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5b6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012738","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvlt","pgxind-kftx5uhl","pgxcs-kftwmun9",362231105,0.126,37442556,0.013,324788549,0.113,"PGX_AM_BS_GSM1012738","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.999000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5c1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvmb","pgxind-kftx5ui7","pgxcs-kftwmuqr",123513675,0.043,25983279,0.009,97530396,0.034,"PGX_AM_BS_GSM1012749","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.011000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM1012749","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5c2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012750","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvmd","pgxind-kftx5ui9","pgxcs-kftwmur2",1634918613,0.569,956575905,0.333,678342708,0.236,"PGX_AM_BS_GSM1012750","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.012000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5c3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvmf","pgxind-kftx5uib","pgxcs-kftwmurd",286339626,0.1,122692689,0.043,163646937,0.057,"PGX_AM_BS_GSM1012751","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.013000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012751","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5c5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528055","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmi","pgxind-kftx5uif","pgxcs-kftwmusi",1489799079,0.518,911176883,0.317,578622196,0.201,"PGX_AM_BS_GSM1528055","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.016000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17cb009d374f6dd7aa5cb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528061","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvms","pgxind-kftx5uis","pgxcs-kftwmuvg",1843936398,0.641,1299154444,0.452,544781954,0.189,"PGX_AM_BS_GSM1528061","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.025000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17cb009d374f6dd7aa5cc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1530028","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmu","pgxind-kftx5uiu","pgxcs-kftwmuvx",1847510121,0.643,1323358464,0.46,524151657,0.182,"PGX_AM_BS_GSM1530028","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.026000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17d2609d374f6dd7c37bf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma","geo:GSM2087503","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvjw9v","pgxind-kftx5vbh","pgxcs-kftwrys3",1057650576,0.368,638475163,0.222,419175413,0.146,"PGX_AM_BS_GSM2087503","{}",16.37,48.21,"Point","AUT","Vienna","Austria","Vienna, Austria",48.21,16.37,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:23.638000",,,,,,,"geo:GSE79187","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,,"arraymap import",0.48,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.5,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary","23000"
"5dc17dcb09d374f6dd7ce3ea","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559547","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxe1","pgxind-kftx5woi","pgxcs-kftwn9rr",233235772,0.081,13598191,0.005,219637581,0.076,"PGX_AM_BS_GSM1559547","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.865000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3ee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559551","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxe8","pgxind-kftx5woq","pgxcs-kftwn9tp",1436214339,0.5,1129135551,0.393,307078788,0.107,"PGX_AM_BS_GSM1559551","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.871000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559552","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxe9","pgxind-kftx5wos","pgxcs-kftwn9u7",2174000976,0.756,1272532144,0.443,901468832,0.314,"PGX_AM_BS_GSM1559552","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.873000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3f3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559556","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxeg","pgxind-kftx5wp1","pgxcs-kftwn9w6",989120112,0.344,434524931,0.151,554595181,0.193,"PGX_AM_BS_GSM1559556","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.879000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559559","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxel","pgxind-kftx5wp7","pgxcs-kftwn9xn",435718785,0.152,155522425,0.054,280196360,0.097,"PGX_AM_BS_GSM1559559","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.883000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3f8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559561","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxeo","pgxind-kftx5wpb","pgxcs-kftwn9yn",1170766846,0.407,165135062,0.057,1005631784,0.35,"PGX_AM_BS_GSM1559561","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.886000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559567","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxey","pgxind-kftx5wpn","pgxcs-kftwna1l",0,0,0,0,0,0,"PGX_AM_BS_GSM1559567","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.894000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17eda09d374f6dd7e598e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzdw","pgxind-kftx5yq9","pgxcs-kftwnoe2",1783807328,0.62,599786745,0.209,1184020583,0.412,"PGX_AM_BS_GSM608959","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.502000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608959","",,,,,,,,"arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e598f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608960","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzdy","pgxind-kftx5yqb","pgxcs-kftwnoee",1195435624,0.416,406243304,0.141,789192320,0.275,"PGX_AM_BS_GSM608960","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.503000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE24715","",,,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e5992","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze3","pgxind-kftx5yqh","pgxcs-kftwnofc",1935794411,0.673,884834173,0.308,1050960238,0.366,"PGX_AM_BS_GSM608963","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.506000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608963","",,,,,,,,"arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e5995","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608966","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze8","pgxind-kftx5yqn","pgxcs-kftwnogb",1604494403,0.558,792098610,0.276,812395793,0.283,"PGX_AM_BS_GSM608966","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.510000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE24715","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e5996","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608967","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze9","pgxind-kftx5yqp","pgxcs-kftwnogn",1918270231,0.667,700571035,0.244,1217699196,0.424,"PGX_AM_BS_GSM608967","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.511000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0567","Afro-Caribbean",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e5998","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzed","pgxind-kftx5yqt","pgxcs-kftwnoh9",1559601901,0.542,813233208,0.283,746368693,0.26,"PGX_AM_BS_GSM608969","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.513000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608969","",,,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e5999","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzef","pgxind-kftx5yqv","pgxcs-kftwnohl",1339383050,0.466,880786230,0.306,458596820,0.16,"PGX_AM_BS_GSM608970","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.514000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608970","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e599c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzek","pgxind-kftx5yr1","pgxcs-kftwnoij",1759834960,0.612,598991883,0.208,1160843077,0.404,"PGX_AM_BS_GSM608973","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.518000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608973","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e599d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzem","pgxind-kftx5yr3","pgxcs-kftwnoiu",1790941184,0.623,676384805,0.235,1114556379,0.388,"PGX_AM_BS_GSM608974","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.519000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608974","",,,,,,,,"arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e599f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzep","pgxind-kftx5yr7","pgxcs-kftwnojh",181804918,0.063,69846641,0.024,111958277,0.039,"PGX_AM_BS_GSM608976","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.521000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608976","",,,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59a0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzer","pgxind-kftx5yra","pgxcs-kftwnojs",1109201625,0.386,463889212,0.161,645312413,0.224,"PGX_AM_BS_GSM608977","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.522000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608977","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59a7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzf2","pgxind-kftx5yro","pgxcs-kftwnom3",753070838,0.262,393080578,0.137,359990260,0.125,"PGX_AM_BS_GSM608984","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.530000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608984","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e59a8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608985","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzf4","pgxind-kftx5yrt","pgxcs-kftwnomf",1674322512,0.582,897573908,0.312,776748604,0.27,"PGX_AM_BS_GSM608985","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.531000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.58,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e59a9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608986","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzf5","pgxind-kftx5yrv","pgxcs-kftwnomr",672308124,0.234,395935376,0.138,276372748,0.096,"PGX_AM_BS_GSM608986","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.532000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e59ac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfa","pgxind-kftx5ys1","pgxcs-kftwnonp",2261001252,0.786,1467837725,0.511,793163527,0.276,"PGX_AM_BS_GSM608989","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.535000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608989","",,,,,,,,"arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.54,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59b4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608997","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfn","pgxind-kftx5ysi","pgxcs-kftwnoq9",1112901848,0.387,222443980,0.077,890457868,0.31,"PGX_AM_BS_GSM608997","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.545000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.78,"SNP2pop 1000 Genomes population","HANCESTRO:0485","Bangladesh",0.9,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0006","South Asian",,,,,,,,
"5dc17eda09d374f6dd7e59bb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfy","pgxind-kftx5ysw","pgxcs-kftwnosh",1028129069,0.358,522461419,0.182,505667650,0.176,"PGX_AM_BS_GSM609004","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.552000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM609004","",,,,,,,,"arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e59bf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzg5","pgxind-kftx5yt4","pgxcs-kftwnotq",1488233682,0.518,615794708,0.214,872438974,0.303,"PGX_AM_BS_GSM609008","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.557000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM609008","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM609017","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzgi","pgxind-kftx5ytl","pgxcs-kftwnowl",1461377903,0.508,852389186,0.296,608988717,0.212,"PGX_AM_BS_GSM609017","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.565000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE24715","",,,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.86,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e59cd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM609009","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzgs","pgxind-kftx5ytx","pgxcs-kftwnou2",852235381,0.296,312794509,0.109,539440872,0.188,"PGX_AM_BS_GSM609009","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.572000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73ee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhd","pgxind-kftx5yuo","pgxcs-kftwnp28",921802483,0.321,331205643,0.115,590596840,0.205,"PGX_AM_BS_GSM218577","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.585000",,,,,,,"geo:GPL5750","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:gpl","geo:gsm","geo:GSM218577","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218578","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhf","pgxind-kftx5yuq","pgxcs-kftwnp2j",876140936,0.305,249713331,0.087,626427605,0.218,"PGX_AM_BS_GSM218578","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.586000",,,,,,,"geo:GSE8798","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL5750","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218657","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhq","pgxind-kftx5yv3","pgxcs-kftwnp4r",1809939295,0.63,736652836,0.256,1073286459,0.373,"PGX_AM_BS_GSM218657","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.594000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE8798","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17ee409d374f6dd7e73f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhs","pgxind-kftx5yv5","pgxcs-kftwnp52",2028442631,0.706,907661240,0.316,1120781391,0.39,"PGX_AM_BS_GSM218658","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.595000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM218658","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73f8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhu","pgxind-kftx5yv7","pgxcs-kftwnp5e",59995956,0.021,3191667,0.001,56804289,0.02,"PGX_AM_BS_GSM218659","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.596000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","geo:gsm","geo:GSM218659","",,,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73fa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218661","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhx","pgxind-kftx5yvb","pgxcs-kftwnp61",82340753,0.029,7114491,0.002,75226262,0.026,"PGX_AM_BS_GSM218661","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.598000",,,,,,,"geo:GSE8798","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73fb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSM218662","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzhz","pgxind-kftx5yvd","pgxcs-kftwnp6c",405823694,0.141,178083526,0.062,227740168,0.079,"PGX_AM_BS_GSM218662","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.599000",,,,,,,"geo:GSE8798","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73fc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzi0","pgxind-kftx5yvf","pgxcs-kftwnp6n",1633794853,0.568,962321481,0.335,671473372,0.234,"PGX_AM_BS_GSM218663","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.600000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM218663","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.72,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSM218664","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzi2","pgxind-kftx5yvh","pgxcs-kftwnp92",1803714502,0.627,995367446,0.346,808347056,0.281,"PGX_AM_BS_GSM218664","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.602000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE8798","",,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17fe909d374f6dd7eea9e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM244057","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvk168","pgxind-kftx60xt","pgxcs-kftwo40r",248528812,0.086,0,0,248528812,0.086,"PGX_AM_BS_GSM244057","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:28.205000",,,,,,,"geo:GPL2879","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE9654","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc17fe909d374f6dd7eeaa3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL2879","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvk16h","pgxind-kftx60y4","pgxcs-kftwo42b",202728574,0.071,0,0,202728574,0.071,"PGX_AM_BS_GSM244062","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:28.210000",,,,,,,"geo:GSE9654","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gpl","geo:gse","geo:gsm","geo:GSM244062","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSM108568","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82j","pgxind-kftx69du","pgxcs-kftwpo9l",2670545460,0.929,1855508262,0.645,815037198,0.283,"PGX_AM_BS_GSM108568","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.167000",,,,,,,"geo:GSE4838","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3749","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GPL3749","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82n","pgxind-kftx69dy","pgxcs-kftwpoae",2525485061,0.878,2166551894,0.754,358933167,0.125,"PGX_AM_BS_GSM108972","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.170000",,,,,,,"geo:GSE4838","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM108972","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GPL3749","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82o","pgxind-kftx69e0","pgxcs-kftwpoat",1077208590,0.375,575979661,0.2,501228929,0.174,"PGX_AM_BS_GSM108973","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.171000",,,,,,,"geo:GSE4838","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM108973","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSM108975","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82q","pgxind-kftx69e2","pgxcs-kftwpobk",1948950785,0.678,1706491972,0.594,242458813,0.084,"PGX_AM_BS_GSM108975","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.172000",,,,,,,"geo:GPL3749","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE4838","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd837950","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSE4838","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82r","pgxind-kftx69e4","pgxcs-kftwpobz",1664430584,0.579,1411035072,0.491,253395512,0.088,"PGX_AM_BS_GSM109004","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.173000",,,,,,,"geo:GPL3749","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM109004","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd837951","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSE4838","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82t","pgxind-kftx69e6","pgxcs-kftwpob8",2659098403,0.925,2077115970,0.722,581982433,0.202,"PGX_AM_BS_GSM108974","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.175000",,,,,,,"geo:GPL3749","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM108974","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1878d09d374f6dd89798c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567059","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7b","pgxind-kftx6gvq","pgxcs-kftwqrvj",1307532229,0.455,131958056,0.046,1175574173,0.409,"PGX_AM_BS_GSM567059","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.669000",,,,,,"P15Y","geo:GSE22965","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,"primary",
"5dc1878d09d374f6dd897997","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567338","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7t","pgxind-kftx6gwd","pgxcs-kftwqs76",1717566648,0.597,983636526,0.342,733930122,0.255,"PGX_AM_BS_GSM567338","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.685000",,,,,,"P68Y","geo:GSE22965","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.0399999999999999,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary",
"5dc1890909d374660e5075e3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell lineI OR/MOS]","geo:GSM879214","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvkg3y","pgxind-kftx6j8a","pgxcs-kftwrczu",0,0,0,0,0,0,"PGX_AM_BS_GSM879214","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:42.791000",,,,,,"P13Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"cell line",
"5f5a354582925370d25adf94","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1638950",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkij3","pgxind-kftx6m7t","pgxcs-kftwsi4p",2061338509,0.717,1254446105,0.436,806892404,0.281,"PGX_AM_BS_GSM1638950",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.382000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","P39Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Mllerian...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adf9e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1638961",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijj","pgxind-kftx6m8e","pgxcs-kftwsi9j",882254608,0.307,420888536,0.146,461366072,0.16,"PGX_AM_BS_GSM1638961",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.396000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","P77Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Mllerian...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adf9f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1917699",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijl","pgxind-kftx6m8g","pgxcs-kftwsia1",793272664,0.276,654852486,0.228,138420178,0.048,"PGX_AM_BS_GSM1917699",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.398000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","P64Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Mllerian...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adfa0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1917700",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijn","pgxind-kftx6m8i","pgxcs-kftwsiai",1081760010,0.376,770934553,0.268,310825457,0.108,"PGX_AM_BS_GSM1917700",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.399000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","P38Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Mllerian...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a354782925370d25ae29b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma lung metastasis [Li-Fraumeni Syndrome]","geo:GSM1568172",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkji0","pgxind-kftx6nfr","pgxcs-kftwst5m",1523549432,0.53,623982340,0.217,899567092,0.313,"PGX_AM_BS_GSM1568172","{}",-111.89,40.76,"Point","USA","Salt Lake City","United States of America","Salt Lake City, United States of America",40.76,-111.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:46.480000",,,,,,,"geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:25762628","Ribi S, Baumhoer D et al. (2015): TP53 intron 1 hotspot rearrangements are...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a354782925370d25ae29c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma lung metastasis [Li-Fraumeni Syndrome]","geo:GSM1568173",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkji2","pgxind-kftx6nft","pgxcs-kftwst63",1928017089,0.671,1114829333,0.388,813187756,0.283,"PGX_AM_BS_GSM1568173","{}",-111.89,40.76,"Point","USA","Salt Lake City","United States of America","Salt Lake City, United States of America",40.76,-111.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:46.481000",,,,,,,"geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:25762628","Ribi S, Baumhoer D et al. (2015): TP53 intron 1 hotspot rearrangements are...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a354782925370d25ae30e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ovarian adenosarcoma","geo:GSM1638955",,"pgxfus-0002","no followup status","NCIT:C7317","Ovarian adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C56.9","Ovary","pgxbs-kftvkjn8","pgxind-kftx6nm8","pgxcs-kftwsus6",1230421522,0.428,702165748,0.244,528255774,0.184,"PGX_AM_BS_GSM1638955",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000992","ovary","{}","2020-09-10 17:46:46.642000","T2","NCITstage-C28054","Stage II","TNM-C48724","T2 Stage Finding","P51Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Mllerian...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvklhu","pgxind-kftx6pxp","pgxcs-kftwyfkl",1225293726,0.426,521578076,0.181,703715650,0.245,"PGX_AM_BS_AE-MTAB_3034-OS011-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.761000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2d7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvklig","pgxind-kftx6pyf","pgxcs-kftwyfzg",874278313,0.304,456749646,0.159,417528667,0.145,"PGX_AM_BS_AE-MTAB_3034-OS049-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.779000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2e3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkliz","pgxind-kftx6pz4","pgxcs-kftwygb1",1370586535,0.477,476472299,0.166,894114236,0.311,"PGX_AM_BS_AE-MTAB_3034-OS088-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.797000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2ed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkljf","pgxind-kftx6pzo","pgxcs-kftwygkr",1244469140,0.433,1087970187,0.378,156498953,0.054,"PGX_AM_BS_AE-MTAB_3034-OS124-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.811000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2f3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkljp","pgxind-kftx6q00","pgxcs-kftwygqk",798349155,0.278,513304984,0.179,285044171,0.099,"PGX_AM_BS_AE-MTAB_3034-OS157-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.820000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36305667b527f2dbe7e4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4q","pgxind-kftx6rzp","pgxcs-kftwzgwe",1250648244,0.435,892496897,0.31,358151347,0.125,"PGX_AM_BS_AE-MTAB_3998-OS001-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.614000",,,,,,"P4Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7e6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4t","pgxind-kftx6rzt","pgxcs-kftwzgyc",1452430035,0.505,856295894,0.298,596134141,0.207,"PGX_AM_BS_AE-MTAB_3998-OS007-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.617000",,,,,,"P74Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7e7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4v","pgxind-kftx6rzv","pgxcs-kftwzgzb",437179447,0.152,91921522,0.032,345257925,0.12,"PGX_AM_BS_AE-MTAB_3998-OS011-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.619000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7e8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4x","pgxind-kftx6rzx","pgxcs-kftwzh0a",1358598297,0.473,1055160392,0.367,303437905,0.106,"PGX_AM_BS_AE-MTAB_3998-OS012-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.620000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7eb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn51","pgxind-kftx6s03","pgxcs-kftwzh36",464194359,0.161,300599113,0.105,163595246,0.057,"PGX_AM_BS_AE-MTAB_3998-OS024-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.624000",,,,,,"P11Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7ec","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn53","pgxind-kftx6s05","pgxcs-kftwzh44",1383170091,0.481,851550193,0.296,531619898,0.185,"PGX_AM_BS_AE-MTAB_3998-OS026-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.626000",,,,,,"P13Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn58","pgxind-kftx6s0b","pgxcs-kftwzh72",837088546,0.291,650253171,0.226,186835375,0.065,"PGX_AM_BS_AE-MTAB_3998-OS033-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.630000",,,,,,"P6Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5b","pgxind-kftx6s0f","pgxcs-kftwzh90",676842587,0.235,177525987,0.062,499316600,0.174,"PGX_AM_BS_AE-MTAB_3998-OS038-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.633000",,,,,,"P23Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5g","pgxind-kftx6s0l","pgxcs-kftwzhbv",1288999674,0.448,694324366,0.242,594675308,0.207,"PGX_AM_BS_AE-MTAB_3998-OS045-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.637000",,,,,,"P12Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5i","pgxind-kftx6s0n","pgxcs-kftwzhct",1827789424,0.636,815583556,0.284,1012205868,0.352,"PGX_AM_BS_AE-MTAB_3998-OS046-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.638000",,,,,,"P10Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5j","pgxind-kftx6s0p","pgxcs-kftwzhds",572880192,0.199,258236054,0.09,314644138,0.109,"PGX_AM_BS_AE-MTAB_3998-OS048-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.640000",,,,,,"P9Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5l","pgxind-kftx6s0r","pgxcs-kftwzher",683417459,0.238,432914511,0.151,250502948,0.087,"PGX_AM_BS_AE-MTAB_3998-OS049-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.641000",,,,,,"P4Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5o","pgxind-kftx6s0v","pgxcs-kftwzhgp",1340392621,0.466,657940678,0.229,682451943,0.237,"PGX_AM_BS_AE-MTAB_3998-OS053-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.644000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5v","pgxind-kftx6s13","pgxcs-kftwzhkk",1581969383,0.55,841797975,0.293,740171408,0.257,"PGX_AM_BS_AE-MTAB_3998-OS061-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.650000",,,,,,"P12Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5x","pgxind-kftx6s16","pgxcs-kftwzhlk",1641404150,0.571,924063518,0.321,717340632,0.25,"PGX_AM_BS_AE-MTAB_3998-OS062-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.651000",,,,,,"P10Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe800","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn60","pgxind-kftx6s1a","pgxcs-kftwzhni",1117857699,0.389,405731127,0.141,712126572,0.248,"PGX_AM_BS_AE-MTAB_3998-OS065-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.654000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe801","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn62","pgxind-kftx6s1c","pgxcs-kftwzhog",1157675713,0.403,877837968,0.305,279837745,0.097,"PGX_AM_BS_AE-MTAB_3998-OS072-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.656000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe802","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn64","pgxind-kftx6s1e","pgxcs-kftwzhpg",1226447390,0.427,797286869,0.277,429160521,0.149,"PGX_AM_BS_AE-MTAB_3998-OS073-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.657000",,,,,,"P6Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe806","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6a","pgxind-kftx6s1m","pgxcs-kftwzhtc",1006395413,0.35,741026008,0.258,265369405,0.092,"PGX_AM_BS_AE-MTAB_3998-OS081-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.663000",,,,,,"P8Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe807","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6c","pgxind-kftx6s1o","pgxcs-kftwzhub",1273978166,0.443,862027184,0.3,411950982,0.143,"PGX_AM_BS_AE-MTAB_3998-OS083-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.664000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6i","pgxind-kftx6s1w","pgxcs-kftwzhy7",1377670451,0.479,516215991,0.18,861454460,0.3,"PGX_AM_BS_AE-MTAB_3998-OS088-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.670000",,,,,,"P58Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6n","pgxind-kftx6s22","pgxcs-kftwzi14",1225136346,0.426,924501509,0.322,300634837,0.105,"PGX_AM_BS_AE-MTAB_3998-OS099-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.675000",,,,,,"P9Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe810","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6q","pgxind-kftx6s26","pgxcs-kftwzi5h",1723982010,0.6,996068054,0.346,727913956,0.253,"PGX_AM_BS_AE-MTAB_3998-OS102-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.677000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe817","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn72","pgxind-kftx6s2l","pgxcs-kftwzict",1884057497,0.655,1014909523,0.353,869147974,0.302,"PGX_AM_BS_AE-MTAB_3998-OS114-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.688000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe818","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn73","pgxind-kftx6s2n","pgxcs-kftwzids",1790600121,0.623,1022849220,0.356,767750901,0.267,"PGX_AM_BS_AE-MTAB_3998-OS115-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.689000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe819","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn75","pgxind-kftx6s2p","pgxcs-kftwzies",1599312819,0.556,872720982,0.304,726591837,0.253,"PGX_AM_BS_AE-MTAB_3998-OS117-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.691000",,,,,,"P8Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe81a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn77","pgxind-kftx6s2r","pgxcs-kftwzifr",445057080,0.155,248019207,0.086,197037873,0.069,"PGX_AM_BS_AE-MTAB_3998-OS120-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.692000",,,,,,"P18Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe81c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7a","pgxind-kftx6s2v","pgxcs-kftwzihp",556818101,0.194,397105440,0.138,159712661,0.056,"PGX_AM_BS_AE-MTAB_3998-OS122-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.695000",,,,,,"P6Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe81d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7b","pgxind-kftx6s2x","pgxcs-kftwziio",1550568944,0.539,314733539,0.109,1235835405,0.43,"PGX_AM_BS_AE-MTAB_3998-OS123-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.696000",,,,,,"P21Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe81e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7d","pgxind-kftx6s2z","pgxcs-kftwzijn",905650500,0.315,798020445,0.278,107630055,0.037,"PGX_AM_BS_AE-MTAB_3998-OS124-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.698000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe81f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7f","pgxind-kftx6s31","pgxcs-kftwzikm",1473870396,0.513,879764858,0.306,594105538,0.207,"PGX_AM_BS_AE-MTAB_3998-OS125-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.699000",,,,,,"P29Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe820","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7g","pgxind-kftx6s33","pgxcs-kftwzilm",1679115161,0.584,705619778,0.245,973495383,0.339,"PGX_AM_BS_AE-MTAB_3998-OS126-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.701000",,,,,,"P6Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe822","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7k","pgxind-kftx6s37","pgxcs-kftwzink",941771617,0.328,748845196,0.26,192926421,0.067,"PGX_AM_BS_AE-MTAB_3998-OS128-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.704000",,,,,,"P17Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe824","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7n","pgxind-kftx6s3b","pgxcs-kftwzipk",1359643815,0.473,937314940,0.326,422328875,0.147,"PGX_AM_BS_AE-MTAB_3998-OS130-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.707000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe825","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7o","pgxind-kftx6s3d","pgxcs-kftwziqj",2022437717,0.703,1058790381,0.368,963647336,0.335,"PGX_AM_BS_AE-MTAB_3998-OS131-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.708000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe827","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7s","pgxind-kftx6s3h","pgxcs-kftwzisi",1108635122,0.386,270301716,0.094,838333406,0.292,"PGX_AM_BS_AE-MTAB_3998-OS135-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.711000",,,,,,"P20Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe828","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7t","pgxind-kftx6s3j","pgxcs-kftwziti",1095968672,0.381,220797229,0.077,875171443,0.304,"PGX_AM_BS_AE-MTAB_3998-OS136-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.713000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe82a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7w","pgxind-kftx6s3n","pgxcs-kftwzivh",975392020,0.339,719134148,0.25,256257872,0.089,"PGX_AM_BS_AE-MTAB_3998-OS139-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.715000",,,,,,"P23Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe82b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7y","pgxind-kftx6s3p","pgxcs-kftwziwf",1337902104,0.465,960417652,0.334,377484452,0.131,"PGX_AM_BS_AE-MTAB_3998-OS140-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.717000",,,,,,"P39Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe82e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn83","pgxind-kftx6s3w","pgxcs-kftwzizc",1454466084,0.506,543160549,0.189,911305535,0.317,"PGX_AM_BS_AE-MTAB_3998-OS145-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.721000",,,,,,"P24Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe830","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn86","pgxind-kftx6s40","pgxcs-kftwzj1a",1086491150,0.378,857499508,0.298,228991642,0.08,"PGX_AM_BS_AE-MTAB_3998-OS148-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.724000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe831","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn88","pgxind-kftx6s42","pgxcs-kftwzj29",1468541077,0.511,836241903,0.291,632299174,0.22,"PGX_AM_BS_AE-MTAB_3998-OS149-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.725000",,,,,,"P26Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe832","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8a","pgxind-kftx6s44","pgxcs-kftwzj39",1145000304,0.398,526242887,0.183,618757417,0.215,"PGX_AM_BS_AE-MTAB_3998-OS151-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.726000",,,,,,"P19Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe835","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8e","pgxind-kftx6s4a","pgxcs-kftwzj65",1837891540,0.639,675193397,0.235,1162698143,0.404,"PGX_AM_BS_AE-MTAB_3998-OS156-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.731000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe836","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8g","pgxind-kftx6s4c","pgxcs-kftwzj74",869484234,0.302,560187689,0.195,309296545,0.108,"PGX_AM_BS_AE-MTAB_3998-OS157-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.732000",,,,,,"P10Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe838","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8j","pgxind-kftx6s4g","pgxcs-kftwzj93",1221524598,0.425,756731002,0.263,464793596,0.162,"PGX_AM_BS_AE-MTAB_3998-OS160-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.735000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe839","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8l","pgxind-kftx6s4i","pgxcs-kftwzjc5",1236004048,0.43,854953693,0.297,381050355,0.133,"PGX_AM_BS_AE-MTAB_3998-OS161-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.736000",,,,,,"P19Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8n","pgxind-kftx6s4k","pgxcs-kftwzjd6",1839278122,0.64,708389104,0.246,1130889018,0.393,"PGX_AM_BS_AE-MTAB_3998-OS162-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.738000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8q","pgxind-kftx6s4o","pgxcs-kftwzjf4",751852613,0.262,529067762,0.184,222784851,0.077,"PGX_AM_BS_AE-MTAB_3998-OS170-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.741000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8t","pgxind-kftx6s4s","pgxcs-kftwzjh3",1375148182,0.478,766441824,0.267,608706358,0.212,"PGX_AM_BS_AE-MTAB_3998-OS178-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.743000",,,,,,"P19Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe840","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8w","pgxind-kftx6s4w","pgxcs-kftwzjj2",1391415576,0.484,802841414,0.279,588574162,0.205,"PGX_AM_BS_AE-MTAB_3998-OS183-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.746000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe841","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8y","pgxind-kftx6s4y","pgxcs-kftwzjk1",1608416961,0.559,1136879676,0.395,471537285,0.164,"PGX_AM_BS_AE-MTAB_3998-OS186-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.748000",,,,,,"P13Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe842","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8z","pgxind-kftx6s50","pgxcs-kftwzjl0",1341753245,0.467,571535930,0.199,770217315,0.268,"PGX_AM_BS_AE-MTAB_3998-OS188-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.749000",,,,,,"P8Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe845","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn94","pgxind-kftx6s57","pgxcs-kftwzjny",1961075673,0.682,1021983408,0.355,939092265,0.327,"PGX_AM_BS_AE-MTAB_3998-OS224-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.753000",,,,,,"P11Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe846","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn96","pgxind-kftx6s59","pgxcs-kftwzjox",732485759,0.255,535161882,0.186,197323877,0.069,"PGX_AM_BS_AE-MTAB_3998-OS225-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.755000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9e","pgxind-kftx6s5j","pgxcs-kftwzjts",965879557,0.336,791017957,0.275,174861600,0.061,"PGX_AM_BS_AE-MTAB_3998-OS231-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.762000",,,,,,"P13Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9g","pgxind-kftx6s5l","pgxcs-kftwzjur",524335102,0.182,215466198,0.075,308868904,0.107,"PGX_AM_BS_AE-MTAB_3998-OS232-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.763000",,,,,,"P21Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9h","pgxind-kftx6s5n","pgxcs-kftwzjvq",1369076948,0.476,549061263,0.191,820015685,0.285,"PGX_AM_BS_AE-MTAB_3998-OS234-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.765000",,,,,,"P17Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9j","pgxind-kftx6s5p","pgxcs-kftwzjwp",1129082316,0.393,168440656,0.059,960641660,0.334,"PGX_AM_BS_AE-MTAB_3998-OS235-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.766000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9k","pgxind-kftx6s5r","pgxcs-kftwzjxo",1820158210,0.633,947832897,0.33,872325313,0.303,"PGX_AM_BS_AE-MTAB_3998-OS236-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.767000",,,,,,"P19Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe850","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9m","pgxind-kftx6s5t","pgxcs-kftwzjyn",1111398034,0.387,741346099,0.258,370051935,0.129,"PGX_AM_BS_AE-MTAB_3998-OS237-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.769000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe851","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9o","pgxind-kftx6s5v","pgxcs-kftwzjzl",453224802,0.158,364141795,0.127,89083007,0.031,"PGX_AM_BS_AE-MTAB_3998-OS238-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.770000",,,,,,"P17Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe852","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9p","pgxind-kftx6s5x","pgxcs-kftwzk0k",490106163,0.17,359888622,0.125,130217541,0.045,"PGX_AM_BS_AE-MTAB_3998-OS250-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.772000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a366e6b8c1d6d377c1937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvks8i","pgxind-kftx6xzf","pgxcs-kftwtx28",2143458545,0.746,1205494141,0.419,937964404,0.326,"PGX_AM_BS_CELLLINE_CCLE_BROAD-143B_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.053000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2270",,,,,,,,,,,,,,,,"143B",,
"5f5a366e6b8c1d6d377c19f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksgx","pgxind-kftx6y9z","pgxcs-kftwtzpx",1891990954,0.658,883389188,0.307,1008601766,0.351,"PGX_AM_BS_CELLLINE_CCLE_BROAD-EWS502_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.330000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_S740",,,,,,,,,,,,,,,,"EWS-502",,
"5f5a366e6b8c1d6d377c19f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksha","pgxind-kftx6yaf","pgxcs-kftwtztv",1634468367,0.569,750845233,0.261,883623134,0.307,"PGX_AM_BS_CELLLINE_CCLE_BROAD-G292CLONEA141B1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.342000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2909",,,,,,,,,,,,,,,,"G-292 clone A141B1",,
"5f5a366e6b8c1d6d377c1a01","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated pleomorphic sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvkshn","pgxind-kftx6yaw","pgxcs-kftwtzxs",1526516299,0.531,895209219,0.311,631307080,0.22,"PGX_AM_BS_CELLLINE_CCLE_BROAD-GCT_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:56.354000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1229",,,,,,,,,,,,,,,,"GCT",,
"5f5a366e6b8c1d6d377c1a4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkskz","pgxind-kftx6yf1","pgxcs-kftwu10d",979150070,0.341,265264663,0.092,713885407,0.248,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HOS_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.466000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0312",,,,,,,,,,,,,,,,"HOS",,
"5f5a366e6b8c1d6d377c1a64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.4","Skeletal muscle","pgxbs-kftvksm5","pgxind-kftx6ygg","pgxcs-kftwu1ci",2110019958,0.734,1082596507,0.377,1027423451,0.357,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HS729_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:46:56.502000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0871",,,,,,,,,,,,,,,,"Hs 729.T",,
"5f5a366e6b8c1d6d377c1a6c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4304","Malignancy in giant cell tumor of bone","icdom-92503","Giant cell tumor of bone, malignant","icdot-C41.9","Bone, NOS","pgxbs-kftvksmi","pgxind-kftx6ygw","pgxcs-kftwu1ip",135353388,0.047,99322957,0.035,36030431,0.013,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HS821T_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.513000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0932",,,,,,,,,,,,,,,,"Hs 821.T",,
"5f5a366e6b8c1d6d377c1a85","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksnm","pgxind-kftx6yib","pgxcs-kftwu1ux",1584253550,0.551,760341633,0.264,823911917,0.287,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HTK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.549000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2522",,,,,,,,,,,,,,,,"HTK-",,
"5f5a366f6b8c1d6d377c1b36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksvm","pgxind-kftx6ysd","pgxcs-kftwu4ex",1690368393,0.588,788482463,0.274,901885930,0.314,"PGX_AM_BS_CELLLINE_CCLE_BROAD-MG63_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.822000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0426",,,,,,,,,,,,,,,,"MG-63",,
"5f5a366f6b8c1d6d377c1be8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C7155","Primary central chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkt3o","pgxind-kftx6z2f","pgxcs-kftwu6zn",1462636362,0.509,692769954,0.241,769866408,0.268,"PGX_AM_BS_CELLLINE_CCLE_BROAD-OUMS27_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.089000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_3090",,,,,,,,,,,,,,,,"OUMS-27",,
"5f5a366f6b8c1d6d377c1c1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvkt5y","pgxind-kftx6z59","pgxcs-kftwu7r9",1565857138,0.545,798980444,0.278,766876694,0.267,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RDES_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.164000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2169",,,,,,,,,,,,,,,,"RD-ES",,
"5f5a366f6b8c1d6d377c1c25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt6e","pgxind-kftx6z5t","pgxcs-kftwu7w7",1860803474,0.647,888995865,0.309,971807609,0.338,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RH30_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.179000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0041",,,,,,,,,,,,,,,,"Rh30",,
"5f5a366f6b8c1d6d377c1c26","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt6g","pgxind-kftx6z5v","pgxcs-kftwu7wo",1658654654,0.577,549769474,0.191,1108885180,0.386,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RH41_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.181000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2176",,,,,,,,,,,,,,,,"Rh41",,
"5f5a366f6b8c1d6d377c1c28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","Ovary","pgxbs-kftvkt6j","pgxind-kftx6z5z","pgxcs-kftwu7xo",1530041480,0.532,737601161,0.257,792440319,0.276,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RKN_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000992","ovary","{}","2020-09-10 17:46:57.184000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_3156",,,,,,,,,,,,,,,,"RKN",,
"5f5a366f6b8c1d6d377c1c36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C6041","Thyroid gland sarcoma","icdom-88003","Sarcoma, NOS","icdot-C73.9","Thyroid gland","pgxbs-kftvkt76","pgxind-kftx6z6s","pgxcs-kftwu84h",1761557134,0.613,823388269,0.286,938168865,0.326,"PGX_AM_BS_CELLLINE_CCLE_BROAD-S117_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002046","thyroid gland","{}","2020-09-10 17:46:57.204000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1674",,,,,,,,,,,,,,,,"S-117",,
"5f5a366f6b8c1d6d377c1c4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt82","pgxind-kftx6z7x","pgxcs-kftwu8e9",1939688127,0.675,973563105,0.339,966125022,0.336,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SJRH30_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.234000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0041",,,,,,,,,,,,,,,,"Rh30",,
"5f5a366f6b8c1d6d377c1c50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C40318","Vulvar leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS","icdot-C51.9","Vulva","pgxbs-kftvkt8c","pgxind-kftx6z8a","pgxcs-kftwu8h7",1913263435,0.665,867342681,0.302,1045920754,0.364,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SKLMS1_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0011387","constrictor vulvae muscle","{}","2020-09-10 17:46:57.243000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0628",,,,,,,,,,,,,,,,"SK-LMS-1",,
"5f5a366f6b8c1d6d377c1cce","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvkte0","pgxind-kftx6zff","pgxcs-kftwuabg",1295110436,0.45,674157989,0.234,620952447,0.216,"PGX_AM_BS_CELLLINE_CCLE_BROAD-TC71_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.432000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2213",,,,,,,,,,,,,,,,"TC-71",,
"5f5a366f6b8c1d6d377c1cf5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvktfq","pgxind-kftx6zhn","pgxcs-kftwuauf",1555060673,0.541,741101488,0.258,813959185,0.283,"PGX_AM_BS_CELLLINE_CCLE_BROAD-U2OS_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.491000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0042",,,,,,,,,,,,,,,,"U2OS",,
"5f5a36736b8c1d6d377c26d9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkwk7","pgxind-kftx73gj","pgxcs-kftwvabg",1070976211,0.373,683586722,0.238,387389489,0.135,"PGX_AM_BS_MSK_IMPACT_2017-P_0000092_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.055000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2773","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkwr5","pgxind-kftx73pa","pgxcs-kftwvcfp",1842109576,0.641,1347610038,0.469,494499538,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0000257_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:01.270000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c277e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkwrn","pgxind-kftx73pw","pgxcs-kftwvcky",990912319,0.345,647290873,0.225,343621446,0.12,"PGX_AM_BS_MSK_IMPACT_2017-P_0000271_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.286000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c27ce","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkwv9","pgxind-kftx73ue","pgxcs-kftwvdpf",671780075,0.234,417303979,0.145,254476096,0.089,"PGX_AM_BS_MSK_IMPACT_2017-P_0000355_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.398000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2833","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkwzs","pgxind-kftx7404","pgxcs-kftwvf5s",1883428320,0.655,923571581,0.321,959856739,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0000451_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.918000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2852","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkx16","pgxind-kftx741v","pgxcs-kftwvfko",626703604,0.218,438259469,0.152,188444135,0.066,"PGX_AM_BS_MSK_IMPACT_2017-P_0000482_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.961000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c285f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkx1s","pgxind-kftx742m","pgxcs-kftwvfqv",587129504,0.204,371259619,0.129,215869885,0.075,"PGX_AM_BS_MSK_IMPACT_2017-P_0000499_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.979000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c28a5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkx4z","pgxind-kftx746l","pgxcs-kftwvgqq",1835690915,0.639,713051364,0.248,1122639551,0.39,"PGX_AM_BS_MSK_IMPACT_2017-P_0000576_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.076000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c290b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkx9l","pgxind-kftx74cc","pgxcs-kftwvi7k",1956935000,0.681,1245911521,0.433,711023479,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0000673_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.219000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2935","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkxbh","pgxind-kftx74eq","pgxcs-kftwvitn",1639024541,0.57,807986700,0.281,831037841,0.289,"PGX_AM_BS_MSK_IMPACT_2017-P_0000711_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.278000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2996","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondroblastic Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkxft","pgxind-kftx74k7","pgxcs-kftwvk6g",2244284503,0.781,951329041,0.331,1292955462,0.45,"PGX_AM_BS_MSK_IMPACT_2017-P_0000815_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.414000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29b3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkxh3","pgxind-kftx74lu","pgxcs-kftwvkkc",2351408247,0.818,1228344608,0.427,1123063639,0.391,"PGX_AM_BS_MSK_IMPACT_2017-P_0000845_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:02.455000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29b9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Alveolar Soft Part Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxhd","pgxind-kftx74m6","pgxcs-kftwvkn6",130915372,0.046,51413,0,130863959,0.046,"PGX_AM_BS_MSK_IMPACT_2017-P_0000851_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.463000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29bd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxhk","pgxind-kftx74me","pgxcs-kftwvkp2",790655643,0.275,389129813,0.135,401525830,0.14,"PGX_AM_BS_MSK_IMPACT_2017-P_0000855_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.468000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a37","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4303","Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkxn0","pgxind-kftx74tb","pgxcs-kftwvmdq",1826663761,0.635,867344061,0.302,959319700,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0000972_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.641000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxoy","pgxind-kftx74vr","pgxcs-kftwvn0i",1614701731,0.562,874062447,0.304,740639284,0.258,"PGX_AM_BS_MSK_IMPACT_2017-P_0001016_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.702000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a7c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkxq3","pgxind-kftx74x8","pgxcs-kftwvncy",724982695,0.252,261222548,0.091,463760147,0.161,"PGX_AM_BS_MSK_IMPACT_2017-P_0001046_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.738000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a9b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Epithelioid Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3714","Epithelioid Sarcoma","icdom-88043","Epithelioid sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxrj","pgxind-kftx74yz","pgxcs-kftwvntw",611227334,0.213,282008678,0.098,329218656,0.115,"PGX_AM_BS_MSK_IMPACT_2017-P_0001083_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.781000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a9f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxrp","pgxind-kftx74z7","pgxcs-kftwvnvt",1547408929,0.538,909092070,0.316,638316859,0.222,"PGX_AM_BS_MSK_IMPACT_2017-P_0001087_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.787000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2aae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkxsd","pgxind-kftx7501","pgxcs-kftwvo30",300488315,0.105,171495817,0.06,128992498,0.045,"PGX_AM_BS_MSK_IMPACT_2017-P_0001101_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:02.808000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2aeb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxv6","pgxind-kftx753i","pgxcs-kftwvoyw",1650395188,0.574,1041742335,0.362,608652853,0.212,"PGX_AM_BS_MSK_IMPACT_2017-P_0001173_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.894000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b17","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxx5","pgxind-kftx7560","pgxcs-kftwvpk1",988167851,0.344,687425175,0.239,300742676,0.105,"PGX_AM_BS_MSK_IMPACT_2017-P_0001217_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.958000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b97","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky2w","pgxind-kftx75d7","pgxcs-kftwvrds",2662660842,0.926,1571680810,0.547,1090980032,0.379,"PGX_AM_BS_MSK_IMPACT_2017-P_0001343_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:03.138000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2bf6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvky76","pgxind-kftx75ik","pgxcs-kftwvspo",2219447370,0.772,1171196058,0.407,1048251312,0.365,"PGX_AM_BS_MSK_IMPACT_2017-P_0001439_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.272000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c00","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky7m","pgxind-kftx75j4","pgxcs-kftwvsuj",1765639897,0.614,1144803350,0.398,620836547,0.216,"PGX_AM_BS_MSK_IMPACT_2017-P_0001448_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.286000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c11","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvky8d","pgxind-kftx75k2","pgxcs-kftwvt2r",881994222,0.307,497080527,0.173,384913695,0.134,"PGX_AM_BS_MSK_IMPACT_2017-P_0001464_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.310000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c1f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky90","pgxind-kftx75kv","pgxcs-kftwvt9i",883913624,0.307,529617474,0.184,354296150,0.123,"PGX_AM_BS_MSK_IMPACT_2017-P_0001482_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.330000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c3f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyag","pgxind-kftx75mo","pgxcs-kftwvtow",1109989470,0.386,888138005,0.309,221851465,0.077,"PGX_AM_BS_MSK_IMPACT_2017-P_0001513_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.375000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyb7","pgxind-kftx75nn","pgxcs-kftwvtzc",1039500909,0.362,404453761,0.141,635047148,0.221,"PGX_AM_BS_MSK_IMPACT_2017-P_0001527_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.399000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c5e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkybt","pgxind-kftx75og","pgxcs-kftwvu63",514869615,0.179,271792890,0.095,243076725,0.085,"PGX_AM_BS_MSK_IMPACT_2017-P_0001540_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:03.418000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkyc0","pgxind-kftx75oo","pgxcs-kftwvu81",398909680,0.139,54551003,0.019,344358677,0.12,"PGX_AM_BS_MSK_IMPACT_2017-P_0001544_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:03.424000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c78","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkycz","pgxind-kftx75px","pgxcs-kftwvuin",514327464,0.179,316451380,0.11,197876084,0.069,"PGX_AM_BS_MSK_IMPACT_2017-P_0001564_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.456000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c7f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkydb","pgxind-kftx75qb","pgxcs-kftwvum3",1971605805,0.686,861247457,0.3,1110358348,0.386,"PGX_AM_BS_MSK_IMPACT_2017-P_0001572_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.466000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c91","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkye3","pgxind-kftx75rc","pgxcs-kftwvuus",872011022,0.303,553238004,0.192,318773018,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0001596_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.491000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2ca2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyev","pgxind-kftx75sa","pgxcs-kftwvv55",2056552603,0.715,1392860870,0.484,663691733,0.231,"PGX_AM_BS_MSK_IMPACT_2017-P_0001612_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.514000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2cca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sclerosing Epithelioid Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C49027","Sclerosing Epithelioid Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkygn","pgxind-kftx75uk","pgxcs-kftwvvoe",1204118760,0.419,900681765,0.313,303436995,0.106,"PGX_AM_BS_MSK_IMPACT_2017-P_0001652_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.570000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d14","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkyjz","pgxind-kftx75yr","pgxcs-kftwvwqd",1875053770,0.652,1226334481,0.427,648719289,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0001725_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:03.674000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkymf","pgxind-kftx761v","pgxcs-kftwvxis",1875049386,0.652,1170841945,0.407,704207441,0.245,"PGX_AM_BS_MSK_IMPACT_2017-P_0001781_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.752000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e14","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkyvl","pgxind-kftx76d8","pgxcs-kftww0bj",2222309090,0.773,639592211,0.222,1582716879,0.551,"PGX_AM_BS_MSK_IMPACT_2017-P_0001982_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.036000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e15","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyvn","pgxind-kftx76da","pgxcs-kftww0c1",1068617821,0.372,306060009,0.106,762557812,0.265,"PGX_AM_BS_MSK_IMPACT_2017-P_0001983_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.037000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyvw","pgxind-kftx76dm","pgxcs-kftww0ex",1559064860,0.542,848055290,0.295,711009570,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0001989_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.046000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e24","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkywb","pgxind-kftx76e4","pgxcs-kftww0j8",502592681,0.175,282698316,0.098,219894365,0.076,"PGX_AM_BS_MSK_IMPACT_2017-P_0001998_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:04.059000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkywt","pgxind-kftx76eq","pgxcs-kftww0oh",1884098681,0.655,1149095090,0.4,735003591,0.256,"PGX_AM_BS_MSK_IMPACT_2017-P_0002008_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.075000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e3d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyxg","pgxind-kftx76fj","pgxcs-kftww0v8",2017618406,0.702,840379847,0.292,1177238559,0.409,"PGX_AM_BS_MSK_IMPACT_2017-P_0002020_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.095000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkyy0","pgxind-kftx76g9","pgxcs-kftww13i",2446428671,0.851,1498163839,0.521,948264832,0.33,"PGX_AM_BS_MSK_IMPACT_2017-P_0002034_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:04.113000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e68","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4258","Pleomorphic Rhabdomyosarcoma","icdom-89013","Pleomorphic rhabdomyosarcoma, adult type ","icdot-C49.4","Connective, subcutaneous and other soft tissues of abdomen","pgxbs-kftvkyzd","pgxind-kftx76hy","pgxcs-kftww1hx",1665399234,0.579,919344898,0.32,746054336,0.259,"PGX_AM_BS_MSK_IMPACT_2017-P_0002066_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:47:04.155000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e72","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyzt","pgxind-kftx76ij","pgxcs-kftww1mr",1248501047,0.434,749066940,0.261,499434107,0.174,"PGX_AM_BS_MSK_IMPACT_2017-P_0002077_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.169000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e94","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz1e","pgxind-kftx76kg","pgxcs-kftww231",1655841016,0.576,1117856279,0.389,537984737,0.187,"PGX_AM_BS_MSK_IMPACT_2017-P_0002111_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.217000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2ea6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz28","pgxind-kftx76lh","pgxcs-kftww2dt",723173484,0.252,206773982,0.072,516399502,0.18,"PGX_AM_BS_MSK_IMPACT_2017-P_0002130_T02_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.241000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2eab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkz2h","pgxind-kftx76lr","pgxcs-kftww2g7",1618761304,0.563,1015319262,0.353,603442042,0.21,"PGX_AM_BS_MSK_IMPACT_2017-P_0002134_T02_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:04.249000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2ed7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz4i","pgxind-kftx76o9","pgxcs-kftww319",2026595829,0.705,1336535102,0.465,690060727,0.24,"PGX_AM_BS_MSK_IMPACT_2017-P_0002179_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.310000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2ee4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkz53","pgxind-kftx76oz","pgxcs-kftww37j",608871844,0.212,538579597,0.187,70292247,0.024,"PGX_AM_BS_MSK_IMPACT_2017-P_0002191_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:04.329000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2ee8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz59","pgxind-kftx76p7","pgxcs-kftww39g",1929906878,0.671,933893425,0.325,996013453,0.346,"PGX_AM_BS_MSK_IMPACT_2017-P_0002195_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.334000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f0e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvkz6z","pgxind-kftx76rd","pgxcs-kftww3tu",617184290,0.215,152913935,0.053,464270355,0.161,"PGX_AM_BS_MSK_IMPACT_2017-P_0002226_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:04.387000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f0f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvkz71","pgxind-kftx76rf","pgxcs-kftww3ub",580578108,0.202,123518989,0.043,457059119,0.159,"PGX_AM_BS_MSK_IMPACT_2017-P_0002226_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:04.388000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f14","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz79","pgxind-kftx76rp","pgxcs-kftww3wq",346756688,0.121,284352478,0.099,62404210,0.022,"PGX_AM_BS_MSK_IMPACT_2017-P_0002231_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.395000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvkz8e","pgxind-kftx76t4","pgxcs-kftww48s",1273894921,0.443,647566473,0.225,626328448,0.218,"PGX_AM_BS_MSK_IMPACT_2017-P_0002256_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:04.431000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f39","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondroblastic Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkz8y","pgxind-kftx76ts","pgxcs-kftww4en",1448846621,0.504,965816864,0.336,483029757,0.168,"PGX_AM_BS_MSK_IMPACT_2017-P_0002269_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.448000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f3b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkz91","pgxind-kftx76tw","pgxcs-kftww4fm",1313620580,0.457,664611949,0.231,649008631,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0002272_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.451000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f8e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzct","pgxind-kftx76yl","pgxcs-kftww5ly",806483716,0.281,454274769,0.158,352208947,0.123,"PGX_AM_BS_MSK_IMPACT_2017-P_0002356_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.568000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2fd7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzg4","pgxind-kftx772p","pgxcs-kftww6n7",75757423,0.026,31534898,0.011,44222525,0.015,"PGX_AM_BS_MSK_IMPACT_2017-P_0002430_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.670000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2fe8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzgw","pgxind-kftx773o","pgxcs-kftww6vf",1895290519,0.659,892776171,0.311,1002514348,0.349,"PGX_AM_BS_MSK_IMPACT_2017-P_0002448_T02_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.694000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c301d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzjb","pgxind-kftx776o","pgxcs-kftww7n2",1557964145,0.542,1238043222,0.431,319920923,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0002501_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.769000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c302a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzjw","pgxind-kftx777e","pgxcs-kftww7ta",1996932370,0.695,1454273325,0.506,542659045,0.189,"PGX_AM_BS_MSK_IMPACT_2017-P_0002513_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.787000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c306f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzn1","pgxind-kftx77bb","pgxcs-kftww8sp",1233230956,0.429,524267569,0.182,708963387,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0002588_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.884000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c30a3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzpe","pgxind-kftx77e9","pgxcs-kftww9hn",2224200502,0.774,985355971,0.343,1238844531,0.431,"PGX_AM_BS_MSK_IMPACT_2017-P_0002641_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.957000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c30ca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzr6","pgxind-kftx77gf","pgxcs-kftwwa2s",471936789,0.164,439692647,0.153,32244142,0.011,"PGX_AM_BS_MSK_IMPACT_2017-P_0002679_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.011000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3119","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzup","pgxind-kftx77kx","pgxcs-kftwwb6t",2684117091,0.934,1653522360,0.575,1030594731,0.358,"PGX_AM_BS_MSK_IMPACT_2017-P_0002764_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.122000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3142","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvkzwk","pgxind-kftx77n8","pgxcs-kftwwbqh",631418734,0.22,458238641,0.159,173180093,0.06,"PGX_AM_BS_MSK_IMPACT_2017-P_0002807_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.180000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3147","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvkzws","pgxind-kftx77ni","pgxcs-kftwwbsx",1522280977,0.529,795447995,0.277,726832982,0.253,"PGX_AM_BS_MSK_IMPACT_2017-P_0002812_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.187000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c314c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzx0","pgxind-kftx77ns","pgxcs-kftwwbvc",956090515,0.333,563284599,0.196,392805916,0.137,"PGX_AM_BS_MSK_IMPACT_2017-P_0002817_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.194000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c314e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzx3","pgxind-kftx77nw","pgxcs-kftwwbwb",509338167,0.177,479396752,0.167,29941415,0.01,"PGX_AM_BS_MSK_IMPACT_2017-P_0002819_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.196000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3192","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl005","pgxind-kftx77rs","pgxcs-kftwwcvo",2052767870,0.714,1021740416,0.355,1031027454,0.359,"PGX_AM_BS_MSK_IMPACT_2017-P_0002885_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.291000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c31b7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl01t","pgxind-kftx77tu","pgxcs-kftwwdfq",2015357457,0.701,1229184873,0.428,786172584,0.273,"PGX_AM_BS_MSK_IMPACT_2017-P_0002919_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.344000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c31e2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl03q","pgxind-kftx77w9","pgxcs-kftwwe0j",2638130232,0.918,1803423896,0.627,834706336,0.29,"PGX_AM_BS_MSK_IMPACT_2017-P_0002972_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.405000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3225","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl06q","pgxind-kftx7802","pgxcs-kftwwez8",114578086,0.04,56910780,0.02,57667306,0.02,"PGX_AM_BS_MSK_IMPACT_2017-P_0003032_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.499000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3231","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl079","pgxind-kftx780r","pgxcs-kftwwf51",1788474263,0.622,788870087,0.274,999604176,0.348,"PGX_AM_BS_MSK_IMPACT_2017-P_0003043_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.516000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3267","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl09n","pgxind-kftx783t","pgxcs-kftwwfx7",1346952356,0.469,731849024,0.255,615103332,0.214,"PGX_AM_BS_MSK_IMPACT_2017-P_0003109_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.603000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3282","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl0av","pgxind-kftx785c","pgxcs-kftwwga5",882935091,0.307,541956831,0.189,340978260,0.119,"PGX_AM_BS_MSK_IMPACT_2017-P_0003138_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:05.641000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c329b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl0bz","pgxind-kftx786q","pgxcs-kftwwgm2",1728201994,0.601,960142288,0.334,768059706,0.267,"PGX_AM_BS_MSK_IMPACT_2017-P_0003164_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.676000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32ac","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0cr","pgxind-kftx787n","pgxcs-kftwwgu8",2121237127,0.738,969988431,0.337,1151248696,0.4,"PGX_AM_BS_MSK_IMPACT_2017-P_0003180_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.699000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32d1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0ee","pgxind-kftx789r","pgxcs-kftwwhe6",909250245,0.316,582206685,0.203,327043560,0.114,"PGX_AM_BS_MSK_IMPACT_2017-P_0003217_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.751000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32e1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Spindle Cell Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6519","Spindle Cell Rhabdomyosarcoma","icdom-89123","Spindle cell rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0f5","pgxind-kftx78an","pgxcs-kftwwhlu",2083081650,0.725,1276410978,0.444,806670672,0.281,"PGX_AM_BS_MSK_IMPACT_2017-P_0003232_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.773000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c331c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl0hs","pgxind-kftx78e0","pgxcs-kftwwigg",2106785816,0.733,1368624467,0.476,738161349,0.257,"PGX_AM_BS_MSK_IMPACT_2017-P_0003290_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.855000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3322","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0i2","pgxind-kftx78ec","pgxcs-kftwwijd",34734348,0.012,10009735,0.003,24724613,0.009,"PGX_AM_BS_MSK_IMPACT_2017-P_0003295_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.864000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3398","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0nf","pgxind-kftx78l1","pgxcs-kftwwk60",1335372849,0.464,811040291,0.282,524332558,0.182,"PGX_AM_BS_MSK_IMPACT_2017-P_0003430_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.028000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c339d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0nn","pgxind-kftx78lb","pgxcs-kftwwk8f",85843847,0.03,3273091,0.001,82570756,0.029,"PGX_AM_BS_MSK_IMPACT_2017-P_0003435_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.035000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33a2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl0nv","pgxind-kftx78ll","pgxcs-kftwwkat",2813191820,0.979,1549776365,0.539,1263415455,0.439,"PGX_AM_BS_MSK_IMPACT_2017-P_0003440_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:06.042000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33c3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl0pd","pgxind-kftx78nh","pgxcs-kftwwkt5",895456871,0.311,476563085,0.166,418893786,0.146,"PGX_AM_BS_MSK_IMPACT_2017-P_0003476_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.088000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33cb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0pq","pgxind-kftx78nx","pgxcs-kftwwkx1",2233495212,0.777,871405812,0.303,1362089400,0.474,"PGX_AM_BS_MSK_IMPACT_2017-P_0003484_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.099000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0qc","pgxind-kftx78on","pgxcs-kftwwl3b",1152779656,0.401,721547528,0.251,431232128,0.15,"PGX_AM_BS_MSK_IMPACT_2017-P_0003496_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.117000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33d9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0qe","pgxind-kftx78op","pgxcs-kftwwl3s",1521971130,0.529,721019820,0.251,800951310,0.279,"PGX_AM_BS_MSK_IMPACT_2017-P_0003498_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.119000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33ea","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl0r6","pgxind-kftx78pp","pgxcs-kftwwlby",599945461,0.209,445277599,0.155,154667862,0.054,"PGX_AM_BS_MSK_IMPACT_2017-P_0003512_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:06.142000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3490","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0yn","pgxind-kftx78z6","pgxcs-kftwwno5",2179318611,0.758,803015448,0.279,1376303163,0.479,"PGX_AM_BS_MSK_IMPACT_2017-P_0003668_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.379000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c349f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0zb","pgxind-kftx7901","pgxcs-kftwwnvd",1514672409,0.527,867515173,0.302,647157236,0.225,"PGX_AM_BS_MSK_IMPACT_2017-P_0003686_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.400000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c34cc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl11b","pgxind-kftx792k","pgxcs-kftwwoj7",694109182,0.241,241276588,0.084,452832594,0.158,"PGX_AM_BS_MSK_IMPACT_2017-P_0003731_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.465000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c34db","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl11z","pgxind-kftx793e","pgxcs-kftwwoqg",414204698,0.144,341517620,0.119,72687078,0.025,"PGX_AM_BS_MSK_IMPACT_2017-P_0003746_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.486000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c34e4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl12d","pgxind-kftx793x","pgxcs-kftwwour",2252801853,0.784,968165868,0.337,1284635985,0.447,"PGX_AM_BS_MSK_IMPACT_2017-P_0003754_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.498000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c351b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl14w","pgxind-kftx7970","pgxcs-kftwwpnm",2198803409,0.765,1087056751,0.378,1111746658,0.387,"PGX_AM_BS_MSK_IMPACT_2017-P_0003806_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.575000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3537","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl166","pgxind-kftx798l","pgxcs-kftwwq12",1757056470,0.611,967506755,0.337,789549715,0.275,"PGX_AM_BS_MSK_IMPACT_2017-P_0003835_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.614000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c35a0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1ax","pgxind-kftx79ed","pgxcs-kftwwrhj",1776713986,0.618,1136657600,0.395,640056386,0.223,"PGX_AM_BS_MSK_IMPACT_2017-P_0003948_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.760000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c35aa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1bd","pgxind-kftx79ey","pgxcs-kftwwrmc",1490236792,0.518,727880693,0.253,762356099,0.265,"PGX_AM_BS_MSK_IMPACT_2017-P_0003959_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.775000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c35ee","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl1ej","pgxind-kftx79iq","pgxcs-kftwwslu",511126045,0.178,306939124,0.107,204186921,0.071,"PGX_AM_BS_MSK_IMPACT_2017-P_0004041_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:06.870000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c360b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1ft","pgxind-kftx79kd","pgxcs-kftwwszt",1521727730,0.529,918019578,0.319,603708152,0.21,"PGX_AM_BS_MSK_IMPACT_2017-P_0004070_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.911000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3614","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1g8","pgxind-kftx79kv","pgxcs-kftwwt66",594557650,0.207,193050286,0.067,401507364,0.14,"PGX_AM_BS_MSK_IMPACT_2017-P_0004079_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.923000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3617","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1gd","pgxind-kftx79l1","pgxcs-kftwwt7o",2398601856,0.834,1472230885,0.512,926370971,0.322,"PGX_AM_BS_MSK_IMPACT_2017-P_0004082_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.927000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c362f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1hg","pgxind-kftx79md","pgxcs-kftwwtja",1408509098,0.49,911482895,0.317,497026203,0.173,"PGX_AM_BS_MSK_IMPACT_2017-P_0004107_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.961000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3634","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1ho","pgxind-kftx79mn","pgxcs-kftwwtlp",902624426,0.314,616041664,0.214,286582762,0.1,"PGX_AM_BS_MSK_IMPACT_2017-P_0004112_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.968000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3658","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl1ja","pgxind-kftx79oo","pgxcs-kftwwu2z",976812541,0.34,840986147,0.293,135826394,0.047,"PGX_AM_BS_MSK_IMPACT_2017-P_0004145_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.018000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3664","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl1jt","pgxind-kftx79pc","pgxcs-kftwwu8s",1422984600,0.495,622700815,0.217,800283785,0.278,"PGX_AM_BS_MSK_IMPACT_2017-P_0004157_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:07.035000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3690","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1lr","pgxind-kftx79ru","pgxcs-kftwwuw6",1610496875,0.56,639239338,0.222,971257537,0.338,"PGX_AM_BS_MSK_IMPACT_2017-P_0004198_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.096000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36bc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1nq","pgxind-kftx79ub","pgxcs-kftwwvhd",1227784147,0.427,717104919,0.249,510679228,0.178,"PGX_AM_BS_MSK_IMPACT_2017-P_0004241_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.158000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1oz","pgxind-kftx79vw","pgxcs-kftwwvwx",1579890071,0.55,684049311,0.238,895840760,0.312,"PGX_AM_BS_MSK_IMPACT_2017-P_0004267_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.197000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36da","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1p3","pgxind-kftx79w0","pgxcs-kftwwvxw",1216049407,0.423,551432220,0.192,664617187,0.231,"PGX_AM_BS_MSK_IMPACT_2017-P_0004269_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.199000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1qp","pgxind-kftx79y1","pgxcs-kftwwwfa",905339565,0.315,673577421,0.234,231762144,0.081,"PGX_AM_BS_MSK_IMPACT_2017-P_0004306_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.250000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c372f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1sw","pgxind-kftx7a0s","pgxcs-kftwwx54",2019223117,0.702,1262914924,0.439,756308193,0.263,"PGX_AM_BS_MSK_IMPACT_2017-P_0004357_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.318000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3769","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1vi","pgxind-kftx7a42","pgxcs-kftwwxx7",89381810,0.031,63340013,0.022,26041797,0.009,"PGX_AM_BS_MSK_IMPACT_2017-P_0004411_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.399000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c379e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1xw","pgxind-kftx7a73","pgxcs-kftwwyp5",474536863,0.165,452900597,0.158,21636266,0.008,"PGX_AM_BS_MSK_IMPACT_2017-P_0004467_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.474000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37b6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1yz","pgxind-kftx7a8g","pgxcs-kftwwz0r",2083785420,0.725,1332142628,0.463,751642792,0.261,"PGX_AM_BS_MSK_IMPACT_2017-P_0004499_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.507000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37bc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl1z8","pgxind-kftx7a8s","pgxcs-kftwwz3n",1576603670,0.548,610936958,0.212,965666712,0.336,"PGX_AM_BS_MSK_IMPACT_2017-P_0004505_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.516000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37c3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1zk","pgxind-kftx7a96","pgxcs-kftwwz71",1736077259,0.604,679424955,0.236,1056652304,0.368,"PGX_AM_BS_MSK_IMPACT_2017-P_0004512_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.525000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3862","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl26p","pgxind-kftx7ai8","pgxcs-kftwx1g0",239822095,0.083,209637025,0.073,30185070,0.01,"PGX_AM_BS_MSK_IMPACT_2017-P_0004671_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.749000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3871","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl27d","pgxind-kftx7aj3","pgxcs-kftwx1n7",560478792,0.195,364348863,0.127,196129929,0.068,"PGX_AM_BS_MSK_IMPACT_2017-P_0004685_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.770000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c38e9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2cr","pgxind-kftx7apx","pgxcs-kftwx3cy",1086440479,0.378,769962873,0.268,316477606,0.11,"PGX_AM_BS_MSK_IMPACT_2017-P_0004804_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.937000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c38fa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2dj","pgxind-kftx7aqv","pgxcs-kftwx3l4",1125454002,0.391,722641284,0.251,402812718,0.14,"PGX_AM_BS_MSK_IMPACT_2017-P_0004819_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.961000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3966","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2ie","pgxind-kftx7awz","pgxcs-kftwx52z",1775275501,0.617,710629719,0.247,1064645782,0.37,"PGX_AM_BS_MSK_IMPACT_2017-P_0004922_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.112000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c399a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2kp","pgxind-kftx7azx","pgxcs-kftwx5u2",1656348827,0.576,637480869,0.222,1018867958,0.354,"PGX_AM_BS_MSK_IMPACT_2017-P_0004973_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:08.185000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3a2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2ra","pgxind-kftx7b87","pgxcs-kftwx7ws",2321405162,0.807,1381658925,0.481,939746237,0.327,"PGX_AM_BS_MSK_IMPACT_2017-P_0005126_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.389000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3a46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2se","pgxind-kftx7b9m","pgxcs-kftwx88s",1999651700,0.696,1022845434,0.356,976806266,0.34,"PGX_AM_BS_MSK_IMPACT_2017-P_0005149_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:08.423000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3ad5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl2yv","pgxind-kftx7bhk","pgxcs-kftwxa7o",355511921,0.124,4927221,0.002,350584700,0.122,"PGX_AM_BS_MSK_IMPACT_2017-P_0005297_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:08.623000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3ad9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2z1","pgxind-kftx7bhs","pgxcs-kftwxabq",1789943867,0.623,870810893,0.303,919132974,0.32,"PGX_AM_BS_MSK_IMPACT_2017-P_0005301_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.628000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3b89","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl370","pgxind-kftx7brp","pgxcs-kftwxe8l",1777622629,0.618,513564718,0.179,1264057911,0.44,"PGX_AM_BS_MSK_IMPACT_2017-P_0005484_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.873000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3ba9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Secondary Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53704","Secondary Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl38f","pgxind-kftx7bti","pgxcs-kftwxf3f",1599942498,0.557,865273345,0.301,734669153,0.256,"PGX_AM_BS_MSK_IMPACT_2017-P_0005517_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:08.918000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bb0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl38q","pgxind-kftx7btv","pgxcs-kftwxfce",968317131,0.337,737075133,0.256,231241998,0.08,"PGX_AM_BS_MSK_IMPACT_2017-P_0005524_T03_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.928000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3be6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3b5","pgxind-kftx7bwx","pgxcs-kftwxgut",861661718,0.3,421553739,0.147,440107979,0.153,"PGX_AM_BS_MSK_IMPACT_2017-P_0005578_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.003000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bea","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl3bc","pgxind-kftx7bx5","pgxcs-kftwxgy8",661862463,0.23,306898253,0.107,354964210,0.123,"PGX_AM_BS_MSK_IMPACT_2017-P_0005582_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:09.009000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bec","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3bf","pgxind-kftx7bx9","pgxcs-kftwxh05",2523720085,0.878,1526452909,0.531,997267176,0.347,"PGX_AM_BS_MSK_IMPACT_2017-P_0005584_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.012000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bf0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3bl","pgxind-kftx7bxh","pgxcs-kftwxh43",1658334841,0.577,844053474,0.294,814281367,0.283,"PGX_AM_BS_MSK_IMPACT_2017-P_0005588_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.017000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3c30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3eh","pgxind-kftx7c14","pgxcs-kftwxiyj",904424859,0.315,537086684,0.187,367338175,0.128,"PGX_AM_BS_MSK_IMPACT_2017-P_0005648_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.107000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3c80","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3i2","pgxind-kftx7c5q","pgxcs-kftwxl6p",1716057347,0.597,1006662736,0.35,709394611,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0005740_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.225000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3cd0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3lp","pgxind-kftx7ca9","pgxcs-kftwxngf",2441400607,0.849,1258571182,0.438,1182829425,0.411,"PGX_AM_BS_MSK_IMPACT_2017-P_0005820_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.340000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3cd8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl3m2","pgxind-kftx7cap","pgxcs-kftwxnqg",368382561,0.128,367597378,0.128,785183,0,"PGX_AM_BS_MSK_IMPACT_2017-P_0005828_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:09.352000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3cf5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3ne","pgxind-kftx7ccc","pgxcs-kftwxohy",1182939973,0.411,613491922,0.213,569448051,0.198,"PGX_AM_BS_MSK_IMPACT_2017-P_0005856_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.394000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d77","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Clear Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3745","Clear Cell Sarcoma of Soft Tissue","icdom-90443","Clearcellsarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3ta","pgxind-kftx7cjr","pgxcs-kftwxs6q",565857884,0.197,315562980,0.11,250294904,0.087,"PGX_AM_BS_MSK_IMPACT_2017-P_0005989_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.585000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d83","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl3tt","pgxind-kftx7ckg","pgxcs-kftwxsi7",1173391758,0.408,602450171,0.21,570941587,0.199,"PGX_AM_BS_MSK_IMPACT_2017-P_0006001_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:09.602000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d98","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3ur","pgxind-kftx7clm","pgxcs-kftwxt4e",1384861489,0.482,890352537,0.31,494508952,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0006024_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.633000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3da1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3v6","pgxind-kftx7cm5","pgxcs-kftwxtcj",1452504538,0.505,956817158,0.333,495687380,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0006033_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.646000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3da7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3vf","pgxind-kftx7cmh","pgxcs-kftwxtia",27361305,0.01,23522261,0.008,3839044,0.001,"PGX_AM_BS_MSK_IMPACT_2017-P_0006040_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.655000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3da8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl3vh","pgxind-kftx7cmj","pgxcs-kftwxtj9",1962708243,0.683,1107700608,0.385,855007635,0.297,"PGX_AM_BS_MSK_IMPACT_2017-P_0006042_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:09.656000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3def","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Alveolar Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3yo","pgxind-kftx7cqj","pgxcs-kftwxvjt",605307450,0.211,291121285,0.101,314186165,0.109,"PGX_AM_BS_MSK_IMPACT_2017-P_0006113_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.759000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e1c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl40q","pgxind-kftx7ct3","pgxcs-kftwxwtg",405133037,0.141,158261716,0.055,246871321,0.086,"PGX_AM_BS_MSK_IMPACT_2017-P_0006159_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.824000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e1d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl40s","pgxind-kftx7ct5","pgxcs-kftwxwuv",1532381479,0.533,1073158437,0.373,459223042,0.16,"PGX_AM_BS_MSK_IMPACT_2017-P_0006160_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.825000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e66","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl443","pgxind-kftx7cx9","pgxcs-kftwxyx3",577633126,0.201,386818818,0.135,190814308,0.066,"PGX_AM_BS_MSK_IMPACT_2017-P_0006232_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.928000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e81","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl45a","pgxind-kftx7cys","pgxcs-kftwxzmc",1100310636,0.383,645719043,0.225,454591593,0.158,"PGX_AM_BS_MSK_IMPACT_2017-P_0006258_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.966000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3ea9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl475","pgxind-kftx7d12","pgxcs-kftwy0rf",845660124,0.294,814278150,0.283,31381974,0.011,"PGX_AM_BS_MSK_IMPACT_2017-P_0006303_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.022000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3f64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4fp","pgxind-kftx7dbo","pgxcs-kftwy60c",1861022232,0.647,1225373402,0.426,635648830,0.221,"PGX_AM_BS_MSK_IMPACT_2017-P_0006490_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.282000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3f79","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4gn","pgxind-kftx7dcu","pgxcs-kftwy6n1",112045430,0.039,3821565,0.001,108223865,0.038,"PGX_AM_BS_MSK_IMPACT_2017-P_0006507_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.312000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3fbd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4jp","pgxind-kftx7dgo","pgxcs-kftwy8ii",1436150960,0.5,1377303077,0.479,58847883,0.02,"PGX_AM_BS_MSK_IMPACT_2017-P_0006577_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.409000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4067","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Soft Tissue Myoepithelial Carcinoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4re","pgxind-kftx7dq9","pgxcs-kftwydb7",93359462,0.032,26195322,0.009,67164140,0.023,"PGX_AM_BS_MSK_IMPACT_2017-P_0006745_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.651000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c408a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4sz","pgxind-kftx7ds7","pgxcs-kftwyebb",1122990276,0.391,586063736,0.204,536926540,0.187,"PGX_AM_BS_MSK_IMPACT_2017-P_0006781_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.700000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c408e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4t5","pgxind-kftx7dsf","pgxcs-kftwyef8",1190729261,0.414,922511033,0.321,268218228,0.093,"PGX_AM_BS_MSK_IMPACT_2017-P_0006784_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:10.706000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4097","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4tk","pgxind-kftx7dsx","pgxcs-kftwyeq8",598043022,0.208,416243996,0.145,181799026,0.063,"PGX_AM_BS_MSK_IMPACT_2017-P_0006792_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.719000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c409e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4tw","pgxind-kftx7dta","pgxcs-kftwyewz",1005727064,0.35,867132124,0.302,138594940,0.048,"PGX_AM_BS_MSK_IMPACT_2017-P_0006799_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.728000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40d2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4w7","pgxind-kftx7dw9","pgxcs-kftwygdg",1124511246,0.391,720364813,0.251,404146433,0.141,"PGX_AM_BS_MSK_IMPACT_2017-P_0006851_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.800000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4xl","pgxind-kftx7dy0","pgxcs-kftwyh98",1966368148,0.684,1266881592,0.441,699486556,0.243,"PGX_AM_BS_MSK_IMPACT_2017-P_0006882_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.843000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40f3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4xo","pgxind-kftx7dy4","pgxcs-kftwyhb5",1335102639,0.464,845265660,0.294,489836979,0.17,"PGX_AM_BS_MSK_IMPACT_2017-P_0006884_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.846000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c414a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl51m","pgxind-kftx7e31","pgxcs-kftwyjrg",1673398953,0.582,985325960,0.343,688072993,0.239,"PGX_AM_BS_MSK_IMPACT_2017-P_0006975_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.967000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4154","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl522","pgxind-kftx7e3l","pgxcs-kftwyk18",1290952034,0.449,802391700,0.279,488560334,0.17,"PGX_AM_BS_MSK_IMPACT_2017-P_0006985_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:10.981000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4176","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl53l","pgxind-kftx7e5i","pgxcs-kftwyl0x",1025471291,0.357,503540205,0.175,521931086,0.182,"PGX_AM_BS_MSK_IMPACT_2017-P_0007021_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.029000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c417d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl53w","pgxind-kftx7e5x","pgxcs-kftwyl7o",95084730,0.033,32568078,0.011,62516652,0.022,"PGX_AM_BS_MSK_IMPACT_2017-P_0007028_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.039000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c41cf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl57l","pgxind-kftx7eal","pgxcs-kftwynk0",1149237655,0.4,866407454,0.301,282830201,0.098,"PGX_AM_BS_MSK_IMPACT_2017-P_0007111_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.155000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4212","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5an","pgxind-kftx7eeg","pgxcs-kftwypel",843024823,0.293,466267608,0.162,376757215,0.131,"PGX_AM_BS_MSK_IMPACT_2017-P_0007176_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.248000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4282","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5fo","pgxind-kftx7ekt","pgxcs-kftwysly",14711053,0.005,9245309,0.003,5465744,0.002,"PGX_AM_BS_MSK_IMPACT_2017-P_0007324_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.405000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4295","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5gk","pgxind-kftx7elv","pgxcs-kftwyt4j",1900689466,0.661,970173437,0.337,930516029,0.324,"PGX_AM_BS_MSK_IMPACT_2017-P_0007344_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.431000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c42b4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5hx","pgxind-kftx7enm","pgxcs-kftwyu0c",1371207245,0.477,746343877,0.26,624863368,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0007376_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.474000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c430e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl5lz","pgxind-kftx7esq","pgxcs-kftwywkr",1064063448,0.37,302684730,0.105,761378718,0.265,"PGX_AM_BS_MSK_IMPACT_2017-P_0007516_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:11.599000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4314","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl5m9","pgxind-kftx7et3","pgxcs-kftwywqm",1097321686,0.382,384896662,0.134,712425024,0.248,"PGX_AM_BS_MSK_IMPACT_2017-P_0007522_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:11.608000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c431c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5mm","pgxind-kftx7etj","pgxcs-kftwywyf",1760024173,0.612,1200829466,0.418,559194707,0.195,"PGX_AM_BS_MSK_IMPACT_2017-P_0007530_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:11.619000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4332","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl5nl","pgxind-kftx7eur","pgxcs-kftwyxm3",1445797744,0.503,796746352,0.277,649051392,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0007552_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:11.649000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c433b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5nz","pgxind-kftx7eva","pgxcs-kftwyxux",1250885598,0.435,731750454,0.255,519135144,0.181,"PGX_AM_BS_MSK_IMPACT_2017-P_0007562_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:11.662000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c437d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sclerosing Epithelioid Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C49027","Sclerosing Epithelioid Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5qx","pgxind-kftx7ez0","pgxcs-kftwyzrk",726646974,0.253,237477409,0.083,489169565,0.17,"PGX_AM_BS_MSK_IMPACT_2017-P_0007641_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.753000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4389","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5rh","pgxind-kftx7ezo","pgxcs-kftwz036",1027600795,0.357,447075062,0.156,580525733,0.202,"PGX_AM_BS_MSK_IMPACT_2017-P_0007651_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.769000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4391","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl5ru","pgxind-kftx7f04","pgxcs-kftwz0ax",1279351440,0.445,529088737,0.184,750262703,0.261,"PGX_AM_BS_MSK_IMPACT_2017-P_0007660_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:11.781000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4398","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5s5","pgxind-kftx7f0i","pgxcs-kftwz0hp",661646715,0.23,551039418,0.192,110607297,0.038,"PGX_AM_BS_MSK_IMPACT_2017-P_0007667_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.791000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c43bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5tw","pgxind-kftx7f2r","pgxcs-kftwz1lh",1543680658,0.537,777148534,0.27,766532124,0.267,"PGX_AM_BS_MSK_IMPACT_2017-P_0007735_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.847000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c43fb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5wl","pgxind-kftx7f66","pgxcs-kftwz3c0",2391020577,0.832,1376453906,0.479,1014566671,0.353,"PGX_AM_BS_MSK_IMPACT_2017-P_0007815_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.931000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c443a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl5zf","pgxind-kftx7f9x","pgxcs-kftwz53q",1203313018,0.419,688215448,0.239,515097570,0.179,"PGX_AM_BS_MSK_IMPACT_2017-P_0007891_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:12.018000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4496","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl63i","pgxind-kftx7ffb","pgxcs-kftwz7pj",1139666634,0.396,574240315,0.2,565426319,0.197,"PGX_AM_BS_MSK_IMPACT_2017-P_0008008_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.146000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c44bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl65c","pgxind-kftx7fhm","pgxcs-kftwz8vr",1871715756,0.651,1320605792,0.459,551109964,0.192,"PGX_AM_BS_MSK_IMPACT_2017-P_0008051_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.203000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c44f2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl67o","pgxind-kftx7fkj","pgxcs-kftwzab2",1748628177,0.608,1209853468,0.421,538774709,0.187,"PGX_AM_BS_MSK_IMPACT_2017-P_0008125_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.274000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4568","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6476","Dedifferentiated Chondrosarcoma","icdom-92433","Dedifferentiated chondrosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6cy","pgxind-kftx7fr7","pgxcs-kftwzdnz",710207144,0.247,365715950,0.127,344491194,0.12,"PGX_AM_BS_MSK_IMPACT_2017-P_0008266_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.438000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4596","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ez","pgxind-kftx7ftt","pgxcs-kftwzeza",495490035,0.172,0,0,495490035,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0008325_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.501000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c460d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ka","pgxind-kftx7g0k","pgxcs-kftwzidb",1958905869,0.681,971059418,0.338,987846451,0.344,"PGX_AM_BS_MSK_IMPACT_2017-P_0008455_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.667000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4614","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6kl","pgxind-kftx7g0z","pgxcs-kftwzik5",1659507912,0.577,1335621197,0.465,323886715,0.113,"PGX_AM_BS_MSK_IMPACT_2017-P_0008462_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.677000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4641","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6mn","pgxind-kftx7g3j","pgxcs-kftwzjua",111217258,0.039,64703624,0.023,46513634,0.016,"PGX_AM_BS_MSK_IMPACT_2017-P_0008526_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.739000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4665","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6oa","pgxind-kftx7g5j","pgxcs-kftwzkvn",109112882,0.038,66949766,0.023,42163116,0.015,"PGX_AM_BS_MSK_IMPACT_2017-P_0008561_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.791000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c468d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6q3","pgxind-kftx7g7u","pgxcs-kftwzm0n",1532103850,0.533,858213114,0.299,673890736,0.234,"PGX_AM_BS_MSK_IMPACT_2017-P_0008596_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.846000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c46ca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6sv","pgxind-kftx7gbb","pgxcs-kftwznps",1669658879,0.581,1040988381,0.362,628670498,0.219,"PGX_AM_BS_MSK_IMPACT_2017-P_0008695_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.930000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c46f5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ut","pgxind-kftx7gds","pgxcs-kftwzoy2",1291095751,0.449,739153980,0.257,551941771,0.192,"PGX_AM_BS_MSK_IMPACT_2017-P_0008752_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.990000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c471c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Spindle Cell Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6519","Spindle Cell Rhabdomyosarcoma","icdom-89123","Spindle cell rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6wl","pgxind-kftx7gg0","pgxcs-kftwzq25",2146345769,0.747,1114313676,0.388,1032032093,0.359,"PGX_AM_BS_MSK_IMPACT_2017-P_0008791_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.043000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4761","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6zp","pgxind-kftx7gjx","pgxcs-kftwzs17",486203973,0.169,275878927,0.096,210325046,0.073,"PGX_AM_BS_MSK_IMPACT_2017-P_0008877_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.139000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c477a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl70u","pgxind-kftx7glc","pgxcs-kftwzsuj",588403543,0.205,465586615,0.162,122816928,0.043,"PGX_AM_BS_MSK_IMPACT_2017-P_0008918_T03_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.173000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c47af","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl738","pgxind-kftx7goc","pgxcs-kftwzubx",504844714,0.176,343806570,0.12,161038144,0.056,"PGX_AM_BS_MSK_IMPACT_2017-P_0008971_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.246000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c47d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl752","pgxind-kftx7gqn","pgxcs-kftwzvi3",1724987773,0.6,872579728,0.304,852408045,0.296,"PGX_AM_BS_MSK_IMPACT_2017-P_0009027_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.304000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4819","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl77z","pgxind-kftx7gub","pgxcs-kftwzxd6",804596401,0.28,385773724,0.134,418822677,0.146,"PGX_AM_BS_MSK_IMPACT_2017-P_0009103_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.395000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4834","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl798","pgxind-kftx7gvt","pgxcs-kftwzy39",1446744946,0.503,475748298,0.165,970996648,0.338,"PGX_AM_BS_MSK_IMPACT_2017-P_0009144_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:13.432000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c486e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7bv","pgxind-kftx7gz4","pgxcs-kftwzzs0",1095710552,0.381,613329111,0.213,482381441,0.168,"PGX_AM_BS_MSK_IMPACT_2017-P_0009204_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.513000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl7fk","pgxind-kftx7h3p","pgxcs-kftx0233",2292727719,0.797,799472301,0.278,1493255418,0.519,"PGX_AM_BS_MSK_IMPACT_2017-P_0009314_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:13.625000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48e9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7hg","pgxind-kftx7h63","pgxcs-kftx03a6",109456212,0.038,11128721,0.004,98327491,0.034,"PGX_AM_BS_MSK_IMPACT_2017-P_0009359_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.685000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48ea","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7hi","pgxind-kftx7h65","pgxcs-kftx03b5",505281842,0.176,104631780,0.036,400650062,0.139,"PGX_AM_BS_MSK_IMPACT_2017-P_0009360_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.686000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48f8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7i5","pgxind-kftx7h6y","pgxcs-kftx03of",569078141,0.198,501702750,0.175,67375391,0.023,"PGX_AM_BS_MSK_IMPACT_2017-P_0009373_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.706000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7kz","pgxind-kftx7hbs","pgxcs-kftx05g5",1859051703,0.647,1146956370,0.399,712095333,0.248,"PGX_AM_BS_MSK_IMPACT_2017-P_0009452_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.793000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4939","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7l2","pgxind-kftx7hbw","pgxcs-kftx05i4",1568934998,0.546,782257709,0.272,786677289,0.274,"PGX_AM_BS_MSK_IMPACT_2017-P_0009454_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.796000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c493a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7l4","pgxind-kftx7hby","pgxcs-kftx05j3",1595366628,0.555,977258039,0.34,618108589,0.215,"PGX_AM_BS_MSK_IMPACT_2017-P_0009455_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.798000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4976","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7ns","pgxind-kftx7hf6","pgxcs-kftx078z",2150229386,0.748,1133896489,0.394,1016332897,0.354,"PGX_AM_BS_MSK_IMPACT_2017-P_0009525_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.881000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c497c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7o1","pgxind-kftx7hfi","pgxcs-kftx07es",1556662730,0.541,979281861,0.341,577380869,0.201,"PGX_AM_BS_MSK_IMPACT_2017-P_0009531_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.890000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4a46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7x6","pgxind-kftx7hqs","pgxcs-kftx0d5w",88950371,0.031,33707932,0.012,55242439,0.019,"PGX_AM_BS_MSK_IMPACT_2017-P_0009799_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.182000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4ad8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl83s","pgxind-kftx7hz2","pgxcs-kftx0fqr",699950379,0.243,559821889,0.195,140128490,0.049,"PGX_AM_BS_MSK_IMPACT_2017-P_0009968_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.384000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b07","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl85x","pgxind-kftx7i1q","pgxcs-kftx0gd7",1701681014,0.592,836864262,0.291,864816752,0.301,"PGX_AM_BS_MSK_IMPACT_2017-P_0010023_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.450000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b0c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl865","pgxind-kftx7i20","pgxcs-kftx0gfl",1069688916,0.372,402461971,0.14,667226945,0.232,"PGX_AM_BS_MSK_IMPACT_2017-P_0010028_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.457000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b19","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl86p","pgxind-kftx7i2q","pgxcs-kftx0gnx",1738942169,0.605,756329710,0.263,982612459,0.342,"PGX_AM_BS_MSK_IMPACT_2017-P_0010048_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:14.475000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b9f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl8cp","pgxind-kftx7iad","pgxcs-kftx0ihw",745386976,0.259,297555474,0.103,447831502,0.156,"PGX_AM_BS_MSK_IMPACT_2017-P_0010205_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:14.662000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4ba0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl8cq","pgxind-kftx7iaf","pgxcs-kftx0iid",1222576190,0.425,817203160,0.284,405373030,0.141,"PGX_AM_BS_MSK_IMPACT_2017-P_0010206_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:14.664000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4bb4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8dm","pgxind-kftx7ibk","pgxcs-kftx0is0",440610373,0.153,162986959,0.057,277623414,0.097,"PGX_AM_BS_MSK_IMPACT_2017-P_0010224_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.692000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4bee","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl8g8","pgxind-kftx7iev","pgxcs-kftx0jlv",1996879912,0.695,938015703,0.326,1058864209,0.368,"PGX_AM_BS_MSK_IMPACT_2017-P_0010301_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:14.773000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c1e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl8ie","pgxind-kftx7ihl","pgxcs-kftx0kaz",1797065484,0.625,936115214,0.326,860950270,0.299,"PGX_AM_BS_MSK_IMPACT_2017-P_0010353_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:14.841000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c21","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl8ij","pgxind-kftx7ihs","pgxcs-kftx0kcg",178512315,0.062,25233980,0.009,153278335,0.053,"PGX_AM_BS_MSK_IMPACT_2017-P_0010356_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:14.845000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c8c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl8nc","pgxind-kftx7inv","pgxcs-kftx0lui",195507368,0.068,69470582,0.024,126036786,0.044,"PGX_AM_BS_MSK_IMPACT_2017-P_0010515_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:14.994000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c92","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8nm","pgxind-kftx7io7","pgxcs-kftx0lxe",2714082960,0.944,1603381371,0.558,1110701589,0.386,"PGX_AM_BS_MSK_IMPACT_2017-P_0010521_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.003000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4d11","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8vm","pgxind-kftx7ivf","pgxcs-kftx0not",667577568,0.232,419136755,0.146,248440813,0.086,"PGX_AM_BS_MSK_IMPACT_2017-P_0010676_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.181000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4d34","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8x6","pgxind-kftx7ixf","pgxcs-kftx0o7v",1671402956,0.581,813363023,0.283,858039933,0.298,"PGX_AM_BS_MSK_IMPACT_2017-P_0010718_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.230000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4d96","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl91m","pgxind-kftx7j30","pgxcs-kftx0pl4",243482764,0.085,82995716,0.029,160487048,0.056,"PGX_AM_BS_MSK_IMPACT_2017-P_0010829_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.366000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4de4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl954","pgxind-kftx7j7e","pgxcs-kftx0qpe",1514193704,0.527,1098798452,0.382,415395252,0.144,"PGX_AM_BS_MSK_IMPACT_2017-P_0010931_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.475000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e1f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl97r","pgxind-kftx7jas","pgxcs-kftx0rj1",1496661762,0.521,830574755,0.289,666087007,0.232,"PGX_AM_BS_MSK_IMPACT_2017-P_0010991_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.557000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e5b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9ag","pgxind-kftx7je6","pgxcs-kftx0sed",546303895,0.19,219675184,0.076,326628711,0.114,"PGX_AM_BS_MSK_IMPACT_2017-P_0011067_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.640000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e77","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9bp","pgxind-kftx7jfr","pgxcs-kftx0ss1",168283613,0.059,116393746,0.04,51889867,0.018,"PGX_AM_BS_MSK_IMPACT_2017-P_0011094_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.680000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e8a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl9ck","pgxind-kftx7jgu","pgxcs-kftx0t3j",878830692,0.306,362947974,0.126,515882718,0.179,"PGX_AM_BS_MSK_IMPACT_2017-P_0011112_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:15.707000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4eab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9e2","pgxind-kftx7jip","pgxcs-kftx0tjl",1060382897,0.369,816333451,0.284,244049446,0.085,"PGX_AM_BS_MSK_IMPACT_2017-P_0011148_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.754000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4ed2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9ft","pgxind-kftx7jky","pgxcs-kftx0u4l",776677455,0.27,246112436,0.086,530565019,0.185,"PGX_AM_BS_MSK_IMPACT_2017-P_0011196_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:15.810000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4ee9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9gu","pgxind-kftx7jm9","pgxcs-kftx0ufr",1486850347,0.517,899147294,0.313,587703053,0.204,"PGX_AM_BS_MSK_IMPACT_2017-P_0011220_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:15.842000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4f04","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9i2","pgxind-kftx7jns","pgxcs-kftx0usp",1537361748,0.535,811132272,0.282,726229476,0.253,"PGX_AM_BS_MSK_IMPACT_2017-P_0011252_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:15.881000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4f30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9k2","pgxind-kftx7jqa","pgxcs-kftx0vg0",1520194886,0.529,1041562753,0.362,478632133,0.166,"PGX_AM_BS_MSK_IMPACT_2017-P_0011304_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.943000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c4f9a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Clear Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3745","Clear Cell Sarcoma of Soft Tissue","icdom-90443","Clearcellsarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9ot","pgxind-kftx7jwb","pgxcs-kftx0wxd",519945192,0.181,156214300,0.054,363730892,0.127,"PGX_AM_BS_MSK_IMPACT_2017-P_0011423_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.091000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c4fef","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9so","pgxind-kftx7k14","pgxcs-kftx0y4n",2098078168,0.73,1163969729,0.405,934108439,0.325,"PGX_AM_BS_MSK_IMPACT_2017-P_0011526_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.209000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c4ffc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9t9","pgxind-kftx7k1v","pgxcs-kftx0yay",1544387866,0.537,1029103055,0.358,515284811,0.179,"PGX_AM_BS_MSK_IMPACT_2017-P_0011539_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.227000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5006","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9tp","pgxind-kftx7k2f","pgxcs-kftx0yg2",941649297,0.328,621278961,0.216,320370336,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0011549_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.241000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5007","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9tq","pgxind-kftx7k2h","pgxcs-kftx0ygk",1508994186,0.525,1253443270,0.436,255550916,0.089,"PGX_AM_BS_MSK_IMPACT_2017-P_0011550_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.242000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5015","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvl9ud","pgxind-kftx7k3a","pgxcs-kftx0yn8",1751426112,0.609,1030743979,0.359,720682133,0.251,"PGX_AM_BS_MSK_IMPACT_2017-P_0011562_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:16.262000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c501f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9ut","pgxind-kftx7k3u","pgxcs-kftx0ys1",1514397398,0.527,890997100,0.31,623400298,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0011575_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.275000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c50e0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvla3h","pgxind-kftx7kev","pgxcs-kftx11jm",1545144252,0.537,371274553,0.129,1173869699,0.408,"PGX_AM_BS_MSK_IMPACT_2017-P_0012225_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.547000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5149","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvla88","pgxind-kftx7kks","pgxcs-kftx130a",860581543,0.299,608786949,0.212,251794594,0.088,"PGX_AM_BS_MSK_IMPACT_2017-P_0012377_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.692000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c514d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvla8e","pgxind-kftx7kl0","pgxcs-kftx1327",1202395087,0.418,591030150,0.206,611364937,0.213,"PGX_AM_BS_MSK_IMPACT_2017-P_0012381_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.698000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5156","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvla8t","pgxind-kftx7klj","pgxcs-kftx136l",1753252958,0.61,1090584933,0.379,662668025,0.23,"PGX_AM_BS_MSK_IMPACT_2017-P_0012401_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:16.711000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5162","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvla9c","pgxind-kftx7km7","pgxcs-kftx13cc",747790250,0.26,239865225,0.083,507925025,0.177,"PGX_AM_BS_MSK_IMPACT_2017-P_0012622_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.728000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58d5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnh","pgxind-kftx7nmc","pgxcs-kftx1u0l",1032288296,0.359,561587035,0.195,470701261,0.164,"PGX_AM_BS_SARC_MSKCC-PT100MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.389000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58d6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcni","pgxind-kftx7nme","pgxcs-kftx1u12",1994035923,0.694,128517148,0.045,1865518775,0.649,"PGX_AM_BS_SARC_MSKCC-PT101MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.390000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnm","pgxind-kftx7nmi","pgxcs-kftx1u21",1042743783,0.363,735480608,0.256,307263175,0.107,"PGX_AM_BS_SARC_MSKCC-PT103MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.393000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58db","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnq","pgxind-kftx7nmo","pgxcs-kftx1u3i",1327500275,0.462,1062107237,0.369,265393038,0.092,"PGX_AM_BS_SARC_MSKCC-PT106MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.397000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58dd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnu","pgxind-kftx7nms","pgxcs-kftx1u4h",1928631150,0.671,172128740,0.06,1756502410,0.611,"PGX_AM_BS_SARC_MSKCC-PT108MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.400000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58de","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnv","pgxind-kftx7nmu","pgxcs-kftx1u4z",1558111642,0.542,4100367,0.001,1554011275,0.541,"PGX_AM_BS_SARC_MSKCC-PT109MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.402000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcny","pgxind-kftx7nmz","pgxcs-kftx1u5y",688610869,0.24,304330161,0.106,384280708,0.134,"PGX_AM_BS_SARC_MSKCC-PT110MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.405000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlco2","pgxind-kftx7nn3","pgxcs-kftx1u6x",1282389657,0.446,879645175,0.306,402744482,0.14,"PGX_AM_BS_SARC_MSKCC-PT112MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.408000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlco5","pgxind-kftx7nn7","pgxcs-kftx1u7w",1551378913,0.54,347760368,0.121,1203618545,0.419,"PGX_AM_BS_SARC_MSKCC-PT114MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.411000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoa","pgxind-kftx7nnd","pgxcs-kftx1u9e",896377697,0.312,736442260,0.256,159935437,0.056,"PGX_AM_BS_SARC_MSKCC-PT117MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.415000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcob","pgxind-kftx7nnf","pgxcs-kftx1u9w",1080965967,0.376,883860554,0.307,197105413,0.069,"PGX_AM_BS_SARC_MSKCC-PT118MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.417000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcod","pgxind-kftx7nnh","pgxcs-kftx1uad",886390227,0.308,412682446,0.144,473707781,0.165,"PGX_AM_BS_SARC_MSKCC-PT119MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.418000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ec","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoi","pgxind-kftx7nnn","pgxcs-kftx1ubt",1498059946,0.521,528828934,0.184,969231012,0.337,"PGX_AM_BS_SARC_MSKCC-PT121MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.422000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ed","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoj","pgxind-kftx7nnp","pgxcs-kftx1ucb",1258463343,0.438,102334885,0.036,1156128458,0.402,"PGX_AM_BS_SARC_MSKCC-PT122MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.424000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ef","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcom","pgxind-kftx7nnt","pgxcs-kftx1uda",611706024,0.213,531300461,0.185,80405563,0.028,"PGX_AM_BS_SARC_MSKCC-PT124MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.427000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoq","pgxind-kftx7nnx","pgxcs-kftx1ue9",1338945939,0.466,513157582,0.178,825788357,0.287,"PGX_AM_BS_SARC_MSKCC-PT126MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.430000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcor","pgxind-kftx7nnz","pgxcs-kftx1ueq",313304110,0.109,75772032,0.026,237532078,0.083,"PGX_AM_BS_SARC_MSKCC-PT127MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.431000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcot","pgxind-kftx7no1","pgxcs-kftx1uf8",1726280986,0.6,348460099,0.121,1377820887,0.479,"PGX_AM_BS_SARC_MSKCC-PT128MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.432000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoy","pgxind-kftx7no7","pgxcs-kftx1ugo",1836209093,0.639,124699378,0.043,1711509715,0.595,"PGX_AM_BS_SARC_MSKCC-PT130MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.437000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp1","pgxind-kftx7nob","pgxcs-kftx1uhn",920603955,0.32,673814364,0.234,246789591,0.086,"PGX_AM_BS_SARC_MSKCC-PT132MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.440000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp3","pgxind-kftx7nod","pgxcs-kftx1ui5",1740314218,0.605,60585046,0.021,1679729172,0.584,"PGX_AM_BS_SARC_MSKCC-PT133MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.441000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp5","pgxind-kftx7nof","pgxcs-kftx1uim",1117301730,0.389,842784719,0.293,274517011,0.095,"PGX_AM_BS_SARC_MSKCC-PT134MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.443000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp6","pgxind-kftx7noi","pgxcs-kftx1uj4",1314013727,0.457,809160895,0.281,504852832,0.176,"PGX_AM_BS_SARC_MSKCC-PT135MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.444000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpa","pgxind-kftx7nom","pgxcs-kftx1uk3",1132045013,0.394,348227590,0.121,783817423,0.273,"PGX_AM_BS_SARC_MSKCC-PT137MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.447000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5900","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpf","pgxind-kftx7nos","pgxcs-kftx1ulk",1203403287,0.419,701119919,0.244,502283368,0.175,"PGX_AM_BS_SARC_MSKCC-PT13DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.452000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5901","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpg","pgxind-kftx7nou","pgxcs-kftx1um1",891888879,0.31,353752332,0.123,538136547,0.187,"PGX_AM_BS_SARC_MSKCC-PT140MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.453000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5904","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpl","pgxind-kftx7np0","pgxcs-kftx1unh",484798038,0.169,329380336,0.115,155417702,0.054,"PGX_AM_BS_SARC_MSKCC-PT143MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.457000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5906","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpo","pgxind-kftx7np4","pgxcs-kftx1uqk",546608046,0.19,539139324,0.188,7468722,0.003,"PGX_AM_BS_SARC_MSKCC-PT145MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.460000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5907","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpq","pgxind-kftx7np6","pgxcs-kftx1ur3",706950578,0.246,529336225,0.184,177614353,0.062,"PGX_AM_BS_SARC_MSKCC-PT146MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.462000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5908","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcps","pgxind-kftx7np8","pgxcs-kftx1url",480681618,0.167,346215851,0.12,134465767,0.047,"PGX_AM_BS_SARC_MSKCC-PT147MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.463000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c590c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpy","pgxind-kftx7npg","pgxcs-kftx1utj",829263832,0.288,829090997,0.288,172835,0,"PGX_AM_BS_SARC_MSKCC-PT150MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.469000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5915","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqd","pgxind-kftx7npy","pgxcs-kftx1uxv",1013423183,0.352,505196746,0.176,508226437,0.177,"PGX_AM_BS_SARC_MSKCC-PT159PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.481000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5918","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqi","pgxind-kftx7nq5","pgxcs-kftx1uzc",1894826820,0.659,156577473,0.054,1738249347,0.605,"PGX_AM_BS_SARC_MSKCC-PT161PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.486000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5919","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqj","pgxind-kftx7nq7","pgxcs-kftx1uzu",1550098832,0.539,1340634236,0.466,209464596,0.073,"PGX_AM_BS_SARC_MSKCC-PT162PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.487000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcql","pgxind-kftx7nq9","pgxcs-kftx1v0b",1448527219,0.504,676546404,0.235,771980815,0.269,"PGX_AM_BS_SARC_MSKCC-PT163PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.489000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqo","pgxind-kftx7nqd","pgxcs-kftx1v1b",888008249,0.309,518326066,0.18,369682183,0.129,"PGX_AM_BS_SARC_MSKCC-PT165PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.492000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqq","pgxind-kftx7nqf","pgxcs-kftx1v1s",1211990425,0.422,751544159,0.261,460446266,0.16,"PGX_AM_BS_SARC_MSKCC-PT166PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.493000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqr","pgxind-kftx7nqh","pgxcs-kftx1v2a",1013817425,0.353,395789831,0.138,618027594,0.215,"PGX_AM_BS_SARC_MSKCC-PT167PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.495000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqt","pgxind-kftx7nqj","pgxcs-kftx1v2s",1864069264,0.648,138844482,0.048,1725224782,0.6,"PGX_AM_BS_SARC_MSKCC-PT168PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.496000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5920","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqv","pgxind-kftx7nql","pgxcs-kftx1v3a",1651666232,0.574,821343952,0.286,830322280,0.289,"PGX_AM_BS_SARC_MSKCC-PT169PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.498000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5921","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqw","pgxind-kftx7nqn","pgxcs-kftx1v3r",762617291,0.265,593801500,0.207,168815791,0.059,"PGX_AM_BS_SARC_MSKCC-PT16DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.499000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5922","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqy","pgxind-kftx7nqp","pgxcs-kftx1v49",1618081079,0.563,80538943,0.028,1537542136,0.535,"PGX_AM_BS_SARC_MSKCC-PT170PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.501000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5923","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcr0","pgxind-kftx7nqr","pgxcs-kftx1v4q",1281036972,0.446,882523842,0.307,398513130,0.139,"PGX_AM_BS_SARC_MSKCC-PT171PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.502000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5926","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcr5","pgxind-kftx7nqx","pgxcs-kftx1v68",1315233979,0.457,1309754634,0.456,5479345,0.002,"PGX_AM_BS_SARC_MSKCC-PT174PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.506000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5928","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcr8","pgxind-kftx7nr2","pgxcs-kftx1v77",85990215,0.03,84642800,0.029,1347415,0,"PGX_AM_BS_SARC_MSKCC-PT176PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.509000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrb","pgxind-kftx7nr6","pgxcs-kftx1v86",1194942540,0.416,647115083,0.225,547827457,0.191,"PGX_AM_BS_SARC_MSKCC-PT178PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.512000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrd","pgxind-kftx7nr8","pgxcs-kftx1v8o",804413137,0.28,529536539,0.184,274876598,0.096,"PGX_AM_BS_SARC_MSKCC-PT179PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.514000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrg","pgxind-kftx7nrc","pgxcs-kftx1v9o",1855256692,0.645,243092224,0.085,1612164468,0.561,"PGX_AM_BS_SARC_MSKCC-PT180PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.517000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcri","pgxind-kftx7nre","pgxcs-kftx1va6",1478969699,0.514,1311086900,0.456,167882799,0.058,"PGX_AM_BS_SARC_MSKCC-PT181PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.518000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrj","pgxind-kftx7nrg","pgxcs-kftx1vao",745876360,0.259,745362880,0.259,513480,0,"PGX_AM_BS_SARC_MSKCC-PT182PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.520000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5930","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrl","pgxind-kftx7nri","pgxcs-kftx1vb6",558789728,0.194,385880963,0.134,172908765,0.06,"PGX_AM_BS_SARC_MSKCC-PT183SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.521000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5932","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcro","pgxind-kftx7nrm","pgxcs-kftx1vc4",1178877813,0.41,176382235,0.061,1002495578,0.349,"PGX_AM_BS_SARC_MSKCC-PT185SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.524000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrw","pgxind-kftx7nrw","pgxcs-kftx1vei",842077309,0.293,662574981,0.23,179502328,0.062,"PGX_AM_BS_SARC_MSKCC-PT18DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.531000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c593d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcs6","pgxind-kftx7ns8","pgxcs-kftx1vhf",138194558,0.048,29772387,0.01,108422171,0.038,"PGX_AM_BS_SARC_MSKCC-PT195SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.540000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5942","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcse","pgxind-kftx7nsi","pgxcs-kftx1vjv",611058267,0.213,575484361,0.2,35573906,0.012,"PGX_AM_BS_SARC_MSKCC-PT19DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.547000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c594d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcsw","pgxind-kftx7nt5","pgxcs-kftx1vp7",622098338,0.216,441355689,0.154,180742649,0.063,"PGX_AM_BS_SARC_MSKCC-PT21DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.563000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c594e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcsy","pgxind-kftx7nt7","pgxcs-kftx1vpp",874225029,0.304,274550429,0.095,599674600,0.209,"PGX_AM_BS_SARC_MSKCC-PT22DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.564000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5950","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct1","pgxind-kftx7ntb","pgxcs-kftx1vqo",1478225081,0.514,30991039,0.011,1447234042,0.503,"PGX_AM_BS_SARC_MSKCC-PT24DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.567000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5951","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct2","pgxind-kftx7ntd","pgxcs-kftx1vr7",1062769553,0.37,820632975,0.285,242136578,0.084,"PGX_AM_BS_SARC_MSKCC-PT25DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.569000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5952","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct4","pgxind-kftx7ntg","pgxcs-kftx1vro",715417625,0.249,535508385,0.186,179909240,0.063,"PGX_AM_BS_SARC_MSKCC-PT26DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.571000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5954","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct7","pgxind-kftx7ntk","pgxcs-kftx1vso",1438336829,0.5,1136327362,0.395,302009467,0.105,"PGX_AM_BS_SARC_MSKCC-PT28DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.574000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5957","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctc","pgxind-kftx7ntq","pgxcs-kftx1vu5",154487984,0.054,75500135,0.026,78987849,0.027,"PGX_AM_BS_SARC_MSKCC-PT30DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.578000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c595b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctj","pgxind-kftx7nty","pgxcs-kftx1vw2",691470242,0.241,454166849,0.158,237303393,0.083,"PGX_AM_BS_SARC_MSKCC-PT34DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.584000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5964","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctx","pgxind-kftx7nug","pgxcs-kftx1w2m",1279773299,0.445,981108953,0.341,298664346,0.104,"PGX_AM_BS_SARC_MSKCC-PT42DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.598000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5966","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu0","pgxind-kftx7nuk","pgxcs-kftx1w3v",470891057,0.164,427279577,0.149,43611480,0.015,"PGX_AM_BS_SARC_MSKCC-PT44DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.600000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5968","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu4","pgxind-kftx7nuo","pgxcs-kftx1w4v",1319949881,0.459,720621204,0.251,599328677,0.208,"PGX_AM_BS_SARC_MSKCC-PT46DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.603000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5969","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu5","pgxind-kftx7nuq","pgxcs-kftx1w5d",1183421140,0.412,754066948,0.262,429354192,0.149,"PGX_AM_BS_SARC_MSKCC-PT47DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.605000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c596a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu7","pgxind-kftx7nus","pgxcs-kftx1w5u",518859964,0.18,294672913,0.102,224187051,0.078,"PGX_AM_BS_SARC_MSKCC-PT48DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.606000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c596b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu9","pgxind-kftx7nuu","pgxcs-kftx1w6c",925542233,0.322,514300460,0.179,411241773,0.143,"PGX_AM_BS_SARC_MSKCC-PT49DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.608000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c596c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcua","pgxind-kftx7nux","pgxcs-kftx1w6u",895497403,0.311,700816099,0.244,194681304,0.068,"PGX_AM_BS_SARC_MSKCC-PT4DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.609000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5970","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcuh","pgxind-kftx7nv5","pgxcs-kftx1w8s",620028502,0.216,11471824,0.004,608556678,0.212,"PGX_AM_BS_SARC_MSKCC-PT53GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.615000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5974","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcun","pgxind-kftx7nvd","pgxcs-kftx1war",873573947,0.304,765822169,0.266,107751778,0.037,"PGX_AM_BS_SARC_MSKCC-PT57GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.621000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5977","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcus","pgxind-kftx7nvj","pgxcs-kftx1wc8",729677270,0.254,569079380,0.198,160597890,0.056,"PGX_AM_BS_SARC_MSKCC-PT5DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.626000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c597a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcux","pgxind-kftx7nvp","pgxcs-kftx1wdo",1344205673,0.468,1177539106,0.41,166666567,0.058,"PGX_AM_BS_SARC_MSKCC-PT62GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.630000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5983","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvc","pgxind-kftx7nw8","pgxcs-kftx1wi1",1811335874,0.63,11930080,0.004,1799405794,0.626,"PGX_AM_BS_SARC_MSKCC-PT70GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.644000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5986","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvh","pgxind-kftx7nwe","pgxcs-kftx1wjh",569288606,0.198,409286516,0.142,160002090,0.056,"PGX_AM_BS_SARC_MSKCC-PT73LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.648000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5987","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvi","pgxind-kftx7nwg","pgxcs-kftx1wjz",907469322,0.316,647752757,0.225,259716565,0.09,"PGX_AM_BS_SARC_MSKCC-PT74LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.649000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5988","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvk","pgxind-kftx7nwi","pgxcs-kftx1wkg",467731040,0.163,292937123,0.102,174793917,0.061,"PGX_AM_BS_SARC_MSKCC-PT75LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.651000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5989","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvm","pgxind-kftx7nwk","pgxcs-kftx1wky",546403828,0.19,527780836,0.184,18622992,0.006,"PGX_AM_BS_SARC_MSKCC-PT76LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.652000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvn","pgxind-kftx7nwm","pgxcs-kftx1wlf",1156612388,0.402,907582242,0.316,249030146,0.087,"PGX_AM_BS_SARC_MSKCC-PT77LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.654000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvp","pgxind-kftx7nwo","pgxcs-kftx1wlx",608895230,0.212,552140549,0.192,56754681,0.02,"PGX_AM_BS_SARC_MSKCC-PT78LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.655000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvq","pgxind-kftx7nwq","pgxcs-kftx1wmf",484642294,0.169,393232180,0.137,91410114,0.032,"PGX_AM_BS_SARC_MSKCC-PT79LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.657000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvs","pgxind-kftx7nws","pgxcs-kftx1wmx",994506594,0.346,926042242,0.322,68464352,0.024,"PGX_AM_BS_SARC_MSKCC-PT7DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.658000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvu","pgxind-kftx7nwu","pgxcs-kftx1wne",1127927450,0.392,940682261,0.327,187245189,0.065,"PGX_AM_BS_SARC_MSKCC-PT80LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.660000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvv","pgxind-kftx7nww","pgxcs-kftx1wnw",1579153643,0.549,1455312330,0.506,123841313,0.043,"PGX_AM_BS_SARC_MSKCC-PT81LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.662000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5990","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvx","pgxind-kftx7nwy","pgxcs-kftx1wod",1373227406,0.478,1174712929,0.409,198514477,0.069,"PGX_AM_BS_SARC_MSKCC-PT82LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.663000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5991","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvz","pgxind-kftx7nx0","pgxcs-kftx1wow",817930783,0.284,720734166,0.251,97196617,0.034,"PGX_AM_BS_SARC_MSKCC-PT83LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.665000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5993","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcw2","pgxind-kftx7nx4","pgxcs-kftx1wpv",1570118446,0.546,94066421,0.033,1476052025,0.513,"PGX_AM_BS_SARC_MSKCC-PT85LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.668000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5994","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcw4","pgxind-kftx7nx6","pgxcs-kftx1wqc",1331133679,0.463,548956068,0.191,782177611,0.272,"PGX_AM_BS_SARC_MSKCC-PT86LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.669000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5995","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcw5","pgxind-kftx7nx8","pgxcs-kftx1wqu",1026996458,0.357,404046878,0.141,622949580,0.217,"PGX_AM_BS_SARC_MSKCC-PT87LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.671000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5996","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcw7","pgxind-kftx7nxa","pgxcs-kftx1wrb",613729805,0.213,486480274,0.169,127249531,0.044,"PGX_AM_BS_SARC_MSKCC-PT88LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.672000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5997","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcw9","pgxind-kftx7nxc","pgxcs-kftx1wrt",751836565,0.262,513057456,0.178,238779109,0.083,"PGX_AM_BS_SARC_MSKCC-PT89LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.673000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5998","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwa","pgxind-kftx7nxe","pgxcs-kftx1wsb",1093427206,0.38,847781360,0.295,245645846,0.085,"PGX_AM_BS_SARC_MSKCC-PT8DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.675000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5999","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwc","pgxind-kftx7nxg","pgxcs-kftx1wss",1504414680,0.523,1389378967,0.483,115035713,0.04,"PGX_AM_BS_SARC_MSKCC-PT90LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.677000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c599b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwf","pgxind-kftx7nxk","pgxcs-kftx1wts",1305459590,0.454,1136047985,0.395,169411605,0.059,"PGX_AM_BS_SARC_MSKCC-PT92LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.680000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c599d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwi","pgxind-kftx7nxp","pgxcs-kftx1wus",338415170,0.118,332840863,0.116,5574307,0.002,"PGX_AM_BS_SARC_MSKCC-PT94LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.682000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c599e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwk","pgxind-kftx7nxr","pgxcs-kftx1wva",788179046,0.274,426798624,0.148,361380422,0.126,"PGX_AM_BS_SARC_MSKCC-PT95LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.684000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c599f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwm","pgxind-kftx7nxt","pgxcs-kftx1wvs",1269547370,0.442,1157499326,0.403,112048044,0.039,"PGX_AM_BS_SARC_MSKCC-PT96LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.685000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c59a1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwp","pgxind-kftx7nxx","pgxcs-kftx1wws",1249031678,0.434,1099376978,0.382,149654700,0.052,"PGX_AM_BS_SARC_MSKCC-PT98LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.688000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c59a2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwq","pgxind-kftx7nxz","pgxcs-kftx1wx9",383192673,0.133,367024444,0.128,16168229,0.006,"PGX_AM_BS_SARC_MSKCC-PT99LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.689000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b05","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcp","pgxind-kftx7oi4","pgxcs-kftx21ya",1070976211,0.373,683586722,0.238,387389489,0.135,"PGX_AM_BS_USARC_MSK_2020-P_0000092_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.207000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b07","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcs","pgxind-kftx7oi8","pgxcs-kftx21z8",990912319,0.345,647290873,0.225,343621446,0.12,"PGX_AM_BS_USARC_MSK_2020-P_0000271_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.210000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b08","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcu","pgxind-kftx7oia","pgxcs-kftx21zq",671780075,0.234,417303979,0.145,254476096,0.089,"PGX_AM_BS_USARC_MSK_2020-P_0000355_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.211000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcx","pgxind-kftx7oie","pgxcs-kftx220o",1883428320,0.655,923571581,0.321,959856739,0.334,"PGX_AM_BS_USARC_MSK_2020-P_0000451_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.214000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcz","pgxind-kftx7oig","pgxcs-kftx2216",626703604,0.218,438259469,0.152,188444135,0.066,"PGX_AM_BS_USARC_MSK_2020-P_0000482_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.215000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd0","pgxind-kftx7oii","pgxcs-kftx223i",587129504,0.204,371259619,0.129,215869885,0.075,"PGX_AM_BS_USARC_MSK_2020-P_0000499_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.217000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd2","pgxind-kftx7oil","pgxcs-kftx2240",1835690915,0.639,713051364,0.248,1122639551,0.39,"PGX_AM_BS_USARC_MSK_2020-P_0000576_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.218000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd4","pgxind-kftx7oin","pgxcs-kftx224i",1639024541,0.57,807986700,0.281,831037841,0.289,"PGX_AM_BS_USARC_MSK_2020-P_0000711_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.220000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd5","pgxind-kftx7oip","pgxcs-kftx2250",724982695,0.252,261222548,0.091,463760147,0.161,"PGX_AM_BS_USARC_MSK_2020-P_0001046_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.221000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b13","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddc","pgxind-kftx7oix","pgxcs-kftx227u",2219447370,0.772,1171196058,0.407,1048251312,0.365,"PGX_AM_BS_USARC_MSK_2020-P_0001439_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.226000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b14","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddd","pgxind-kftx7oiz","pgxcs-kftx228c",881994222,0.307,497080527,0.173,384913695,0.134,"PGX_AM_BS_USARC_MSK_2020-P_0001464_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.228000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b15","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddf","pgxind-kftx7oj1","pgxcs-kftx228t",1109989470,0.386,888138005,0.309,221851465,0.077,"PGX_AM_BS_USARC_MSK_2020-P_0001513_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.229000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b18","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddk","pgxind-kftx7oj7","pgxcs-kftx22aa",514327464,0.179,316451380,0.11,197876084,0.069,"PGX_AM_BS_USARC_MSK_2020-P_0001564_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.233000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b19","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddm","pgxind-kftx7oj9","pgxcs-kftx22ar",1971605805,0.686,861247457,0.3,1110358348,0.386,"PGX_AM_BS_USARC_MSK_2020-P_0001572_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.235000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b1f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddv","pgxind-kftx7ojm","pgxcs-kftx22dn",1875049386,0.652,1170841945,0.407,704207441,0.245,"PGX_AM_BS_USARC_MSK_2020-P_0001781_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.244000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b24","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlde3","pgxind-kftx7ojw","pgxcs-kftx22g2",1559064860,0.542,848055290,0.295,711009570,0.247,"PGX_AM_BS_USARC_MSK_2020-P_0001989_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.251000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b26","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde6","pgxind-kftx7ok0","pgxcs-kftx22h1",617184290,0.215,152913935,0.053,464270355,0.161,"PGX_AM_BS_USARC_MSK_2020-P_0002226_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.254000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b27","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde8","pgxind-kftx7ok2","pgxcs-kftx22hi",580578108,0.202,123518989,0.043,457059119,0.159,"PGX_AM_BS_USARC_MSK_2020-P_0002226_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.255000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde9","pgxind-kftx7ok4","pgxcs-kftx22hz",1273894921,0.443,647566473,0.225,626328448,0.218,"PGX_AM_BS_USARC_MSK_2020-P_0002256_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.257000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b29","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldeb","pgxind-kftx7ok6","pgxcs-kftx22ih",1313620580,0.457,664611949,0.231,649008631,0.226,"PGX_AM_BS_USARC_MSK_2020-P_0002272_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.258000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlded","pgxind-kftx7ok8","pgxcs-kftx22iy",806483716,0.281,454274769,0.158,352208947,0.123,"PGX_AM_BS_USARC_MSK_2020-P_0002356_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.260000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldee","pgxind-kftx7oka","pgxcs-kftx22jg",75757423,0.026,31534898,0.011,44222525,0.015,"PGX_AM_BS_USARC_MSK_2020-P_0002430_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.261000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldeh","pgxind-kftx7okf","pgxcs-kftx22ke",1996932370,0.695,1454273325,0.506,542659045,0.189,"PGX_AM_BS_USARC_MSK_2020-P_0002513_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.264000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldej","pgxind-kftx7okh","pgxcs-kftx22kw",471936789,0.164,439692647,0.153,32244142,0.011,"PGX_AM_BS_USARC_MSK_2020-P_0002679_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.265000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldel","pgxind-kftx7oki","pgxcs-kftx22ld",631418734,0.22,458238641,0.159,173180093,0.06,"PGX_AM_BS_USARC_MSK_2020-P_0002807_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.267000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldem","pgxind-kftx7okk","pgxcs-kftx22lu",1522280977,0.529,795447995,0.277,726832982,0.253,"PGX_AM_BS_USARC_MSK_2020-P_0002812_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.268000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b31","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldeo","pgxind-kftx7okn","pgxcs-kftx22mc",956090515,0.333,563284599,0.196,392805916,0.137,"PGX_AM_BS_USARC_MSK_2020-P_0002817_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.270000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b32","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldep","pgxind-kftx7okp","pgxcs-kftx22mt",2052767870,0.714,1021740416,0.355,1031027454,0.359,"PGX_AM_BS_USARC_MSK_2020-P_0002885_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.271000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b33","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlder","pgxind-kftx7okr","pgxcs-kftx22nb",114578086,0.04,56910780,0.02,57667306,0.02,"PGX_AM_BS_USARC_MSK_2020-P_0003032_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.272000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b34","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldet","pgxind-kftx7okt","pgxcs-kftx22ns",1346952356,0.469,731849024,0.255,615103332,0.214,"PGX_AM_BS_USARC_MSK_2020-P_0003109_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.274000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldew","pgxind-kftx7okx","pgxcs-kftx22oq",882935091,0.307,541956831,0.189,340978260,0.119,"PGX_AM_BS_USARC_MSK_2020-P_0003138_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.277000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b38","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldez","pgxind-kftx7ol1","pgxcs-kftx22po",895456871,0.311,476563085,0.166,418893786,0.146,"PGX_AM_BS_USARC_MSK_2020-P_0003476_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.280000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b39","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldf1","pgxind-kftx7ol3","pgxcs-kftx22q5",2252801853,0.784,968165868,0.337,1284635985,0.447,"PGX_AM_BS_USARC_MSK_2020-P_0003754_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.282000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b3a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldf2","pgxind-kftx7ol5","pgxcs-kftx22qn",2198803409,0.765,1087056751,0.378,1111746658,0.387,"PGX_AM_BS_USARC_MSK_2020-P_0003806_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.283000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b40","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfc","pgxind-kftx7olg","pgxcs-kftx22tk",1216049407,0.423,551432220,0.192,664617187,0.231,"PGX_AM_BS_USARC_MSK_2020-P_0004269_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.292000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b41","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfd","pgxind-kftx7oli","pgxcs-kftx22u2",474536863,0.165,452900597,0.158,21636266,0.008,"PGX_AM_BS_USARC_MSK_2020-P_0004467_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.293000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfm","pgxind-kftx7ols","pgxcs-kftx22wh",1086440479,0.378,769962873,0.268,316477606,0.11,"PGX_AM_BS_USARC_MSK_2020-P_0004804_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.301000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b47","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfn","pgxind-kftx7olu","pgxcs-kftx22wy",1656348827,0.576,637480869,0.222,1018867958,0.354,"PGX_AM_BS_USARC_MSK_2020-P_0004973_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.302000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfs","pgxind-kftx7om0","pgxcs-kftx22yf",1999651700,0.696,1022845434,0.356,976806266,0.34,"PGX_AM_BS_USARC_MSK_2020-P_0005149_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.306000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfx","pgxind-kftx7om6","pgxcs-kftx22zv",661862463,0.23,306898253,0.107,354964210,0.123,"PGX_AM_BS_USARC_MSK_2020-P_0005582_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.311000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfz","pgxind-kftx7om8","pgxcs-kftx230d",1962708243,0.683,1107700608,0.385,855007635,0.297,"PGX_AM_BS_USARC_MSK_2020-P_0006042_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.312000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldg2","pgxind-kftx7omd","pgxcs-kftx231c",1064063448,0.37,302684730,0.105,761378718,0.265,"PGX_AM_BS_USARC_MSK_2020-P_0007516_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.315000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b51","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldg4","pgxind-kftx7omf","pgxcs-kftx231t",1203313018,0.419,688215448,0.239,515097570,0.179,"PGX_AM_BS_USARC_MSK_2020-P_0007891_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.317000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b54","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldg9","pgxind-kftx7oml","pgxcs-kftx233a",2292727719,0.797,799472301,0.278,1493255418,0.519,"PGX_AM_BS_USARC_MSK_2020-P_0009314_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.321000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b55","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgb","pgxind-kftx7omn","pgxcs-kftx233s",878830692,0.306,362947974,0.126,515882718,0.179,"PGX_AM_BS_USARC_MSK_2020-P_0011112_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.323000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b56","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldgc","pgxind-kftx7omp","pgxcs-kftx2349",1751426112,0.609,1030743979,0.359,720682133,0.251,"PGX_AM_BS_USARC_MSK_2020-P_0011562_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.324000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b58","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgf","pgxind-kftx7omt","pgxcs-kftx2358",2002574248,0.697,1224084105,0.426,778490143,0.271,"PGX_AM_BS_USARC_MSK_2020-P_0012473_T02_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.327000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b59","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgh","pgxind-kftx7omv","pgxcs-kftx235r",1529333291,0.532,704343806,0.245,824989485,0.287,"PGX_AM_BS_USARC_MSK_2020-P_0013445_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.329000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgk","pgxind-kftx7omz","pgxcs-kftx236q",1415684135,0.492,1087439632,0.378,328244503,0.114,"PGX_AM_BS_USARC_MSK_2020-P_0013724_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.331000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgm","pgxind-kftx7on1","pgxcs-kftx2378",1400568682,0.487,476898149,0.166,923670533,0.321,"PGX_AM_BS_USARC_MSK_2020-P_0013980_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.333000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgo","pgxind-kftx7on3","pgxcs-kftx237p",1929358679,0.671,1060764012,0.369,868594667,0.302,"PGX_AM_BS_USARC_MSK_2020-P_0014134_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.334000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgp","pgxind-kftx7on5","pgxcs-kftx2387",788531806,0.274,601314828,0.209,187216978,0.065,"PGX_AM_BS_USARC_MSK_2020-P_0014679_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.336000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b61","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Uterine Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8972","Uterine Corpus Undifferentiated Sarcoma","icdom-88053","Undifferentiated sarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldgu","pgxind-kftx7onb","pgxcs-kftx239o",2457582799,0.855,1626180341,0.566,831402458,0.289,"PGX_AM_BS_USARC_MSK_2020-P_0015013_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.340000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgw","pgxind-kftx7ond","pgxcs-kftx23c7",1432085823,0.498,891546929,0.31,540538894,0.188,"PGX_AM_BS_USARC_MSK_2020-P_0015053_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.342000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b63","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvldgx","pgxind-kftx7onf","pgxcs-kftx23cq",1707734252,0.594,955536645,0.332,752197607,0.262,"PGX_AM_BS_USARC_MSK_2020-P_0015124_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.343000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgz","pgxind-kftx7onh","pgxcs-kftx23d9",617282939,0.215,521861663,0.182,95421276,0.033,"PGX_AM_BS_USARC_MSK_2020-P_0015258_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.345000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b65","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldh1","pgxind-kftx7onj","pgxcs-kftx23dq",2080228242,0.724,1056465704,0.367,1023762538,0.356,"PGX_AM_BS_USARC_MSK_2020-P_0015609_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.346000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b66","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldh3","pgxind-kftx7onl","pgxcs-kftx23e9",1812611448,0.63,1037233198,0.361,775378250,0.27,"PGX_AM_BS_USARC_MSK_2020-P_0015611_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.348000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b69","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldh7","pgxind-kftx7ons","pgxcs-kftx23fq",2117167530,0.736,1093405738,0.38,1023761792,0.356,"PGX_AM_BS_USARC_MSK_2020-P_0017242_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.352000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b6b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldhb","pgxind-kftx7onw","pgxcs-kftx23go",323842952,0.113,312027344,0.109,11815608,0.004,"PGX_AM_BS_USARC_MSK_2020-P_0017785_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.355000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b6d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldhe","pgxind-kftx7oo0","pgxcs-kftx23hn",1708139122,0.594,1211912926,0.422,496226196,0.173,"PGX_AM_BS_USARC_MSK_2020-P_0017998_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.358000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b6e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldhf","pgxind-kftx7oo2","pgxcs-kftx23i5",1770331476,0.616,1034171659,0.36,736159817,0.256,"PGX_AM_BS_USARC_MSK_2020-P_0018223_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.359000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,